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Abstract 
According to Directive 2008/105/EC (the Environmental Quality Standards Directive, EQSD), a new mechanism is 
needed to provide high-quality monitoring information on the concentrations of polluting substances in the aquatic 
environment across the EU. The aim of this mechanism is to support the identification of priority substances for 
regulation under the Water Framework Directive.  A restricted number of substances (up to 10) are to be included in 
a dynamic Watch List, remaining there for limited time. Three compounds, i.e. diclofenac, 17-beta-estradiol (E2), and 
17-alpha-ethinylestradiol (EE2) have already been identified for inclusion in the first Watch List, for the specific 
purpose of better informing the determination of suitable risk reduction measures. Therefore, up to seven additional 
substances should be identified for inclusion.  
This report describes the procedure to identify a short-list of substances, based on the suspected risk to or via the 
aquatic environment, as well as on the unavailability of sufficient monitoring data or data of sufficient quality to 
identify the risk posed by those substances, and to prioritise them at EU level. From the short-list, seven additional 
substances are proposed for inclusion in the first Watch List. 
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1. Introduction  
According to the Environmental Quality Standards Directive 2008/105/EC as amended by Directive 
2013/39/EU (EQSD) [1], a new mechanism is needed to provide high-quality monitoring information on 
the concentrations of potentially polluting substances in the aquatic environment to support future 
prioritisation exercises in line with Article 16(2) of Directive 2000/60/EC (Water Framework Directive, 
WFD) [2], and thereby to improve the protection of the aquatic environment and of human health via the 
environment. The mechanism is aimed at emerging pollutants and other substances for which the 
available monitoring data are either insufficient or of insufficient quality for the purpose of identifying 
the risk posed across the EU. It involves creating a Watch List with a limited number of such substances 
and monitoring them EU-wide for up to 4 years. A maximum number of 10 substances or groups of 
substances shall be included in the first Watch list, increasing by one at each update, up to a maximum of 
14 substances or groups of substances [1]. Frequent reviews of the list will ensure that substances are not 
monitored longer than necessary, and that substances for which a significant risk at EU level is confirmed 
are identified as candidate priority substances with as little delay as possible. 
However, three compounds, i.e. diclofenac (CAS n. 15307-79-6), 17-beta-estradiol (E2) (CAS n. 50-28-
2), and 17-alpha-ethinylestradiol (EE2) (CAS n. 57-63-3), have already been selected for inclusion in the 
first list in order to collect sufficient monitoring data for the determination of risk reduction measures. 
The Joint Research Centre (JRC) has been tasked with proposing 7 substances as candidates for the 
completion of the first Watch List and identifying analytical methods for their monitoring. 
This report describes the procedure and criteria used to identify a short-list of substances, proposed 
for inclusion in the Watch list. 
 
2. Initial List of Substances 
The main criteria for inclusion in the initial list of candidate substances were that i) the substance is 
suspected of posing a significant risk to, or via, the aquatic environment, meaning there is reliable 
evidence of hazard and of a possible exposure to aquatic organisms and mammals, but ii) there is not 
enough information to assess the EU-wide exposure for the substance, i.e. insufficient monitoring data or 
data of insufficient quality, nor sufficient modelled exposure data to decide whether to prioritise the 
substance.  
Article 8b of the EQSD [1] sets out a comprehensive list of information sources to be considered when 
establishing the Watch List. These were further elaborated in the Document on the Development of the 1st 
Watch List under the EQS Directive, produced by DG ENV and presented at the 2nd Meeting of the WFD 
CIS Working Group Chemicals in March 2014 [3], and include:  
(a) the results of the most recent regular review of Annex X to Directive 2000/60/EC provided for in 
Article 16(4) of that Directive (in particular substances ranked highly but not prioritised because of a 
paucity of monitoring data); 
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(b) research projects (even though these are likely to be the same research projects assessed in the 
priority substances review, the results would be considered more frequently for the watch list updates; 
their reliability should be considered);  
(c) recommendations from the stakeholders referred to in Article 16(5) of Directive 2000/60/EC 
(these may include recommendations from the SCHER, MS, the EP, EEA, research programmes, 
international organisations, European business organisations inc SMEs, and environmental 
organisations);  
(d) Member States’ characterisation of river basin districts and the results of monitoring programmes, 
under Articles 5 and 8 of Directive 2000/60/EC respectively (consideration of river basin specific 
pollutants (RBSPs) if there is not already enough evidence from enough MS);  
(e) Information on production volumes, use patterns, intrinsic properties (including, where relevant, 
particle size), concentrations in the environment and effects, including information gathered in 
accordance with Directives 98/8/EC, 2001/82/EC and 2001/83/EC, and with Regulations (EC) No 
1907/2006 and (EC) No 1107/2009. 
The above information sources have been considered for the compilation of the initial list of candidate 
substances (Table 1). Firstly, substances short-listed during the last review of priority substances, but not 
finally proposed for prioritisation [5] have been considered for the Watch List. Secondly, substances 
highlighted in some pieces of literature regarding research projects were considered, in particular those 
identifying emerging substances of concern. Thirdly, a few MS and Stakeholders have suggested 
substances for inclusion in the Watch List.  
The document on the Development of the 1st Watch List included, in addition to the main (primary) 
criteria for identifying substances, the following secondary criteria: i) the need for a sufficiently sensitive 
analytical method to be available by the time monitoring has to begin (e.g. LoD less than or equal to PNEC 
or 2xPNEC, depending upon likely concentrations and nature of substance); and ii) no immediate ban on 
the production or use of the substance in the EU to be foreseen (unless, in the event of a ban, emissions 
from secondary sources such as imported products might be expected, and/or the substance is PBT or 
vPvB). As regards the first point, the JRC has done a preliminary assessment, and the second point has 
been taken into account in the final recommendation, having in mind that changes in the authorisation 
conditions for some substances could lead to future changes in concentrations of substances beyond the 
Watch List monitoring period. 
The above document also identified some further criteria for prioritising substances, suggesting that 
account be taken of the particular hazardous properties of each substance, the relevance of the substance 
to drinking water quality, the irreversibility or severity of potential effects on ecosystems, the extent and 
nature of use; the possibility that monitoring data might very soon become available from other sources, 
and the ease of monitoring substances together, e.g. in same sample matrix (therefore for similar 
periods), at similar locations, as groups of substances. Some of the comments received from WG 
Chemicals members queried the value or precise meaning of some of these points, other comments were 
largely supportive. In line with the overall message, the approach presented in this document has 
focussed mainly on the risk quotient, on resolving information gaps identified during the last priority 
substances review, and on trying to give some attention to "emerging" pollutants.  
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Table 1. Initial list of substances 
CAS n. Substance name Source a 
294-62-2 Cyclododecane [5] 
60207-90-1 Propiconazole [5] 
731-27-1 Tolylfluanid [5] 
1066-51-9 
Amino-methyl phosphonic acid 
(AMPA) 
[5] 
25057-89-0 Bentazone [5] 
80-05-7 Bisphenol A [5] 
298-46-4 Carbamazepine [5] 
1897-45-6 Chlorothalonil [5] 
1333-82-0 Chromium trioxide [5] 
81103-11-9 Clarithromycin [5] 
1085-98-9 Dichlofluanid [5] 
60-00-4 Edetic Acid (EDTA) [5] 
1071-83-6 Glyphosate [5] 
15687-27-1 Ibuprofen [5] 
93-65-2; 7085-19-0 Mecoprop (MCPP) [5] 
1113-02-6 Omethoate [5] 
2303-17-5 Tri-allate [5] 
52-68-6 Trichlorfon [5] 
7440-66-6 Zinc and its compounds [5] 
57-12-5 Cyanide – free (HCN and CN-) [5] 
723-46-6 sulfamethoxazole [5] 
53-16-7 Estrone [6-8] 
128-37-0 2,6-di-tert-butyl-4-methylphenol MS 
50-00-0 Formaldehyde MS 
85-01-8; 90640-80-5 Phenanthrene MS 
52645-53-1 Permethrin EEB 
121-75-5 Malathion EEB 
61-82-5 Aminotriazole NORMAN 
83905-01-5 Azithromycin NORMAN 
5466-77-3 2-ethylhexyl 4-methoxycinnamate NORMAN 
83164-33-4 Diflufenican NORMAN 
82419-36-1 Ofloxacin NORMAN 
114-07-8 Erythromycin NORMAN 
115-86-6 Triphenyl phosphate NORMAN 
85721-33-1 Ciprofloxacin NORMAN 
87674-68-8/163515-14-8 Dimethenamid/ dimethenamid-P NORMAN 
2032-65-7 Methiocarb NORMAN 
19666-30-9 Oxadiazon NORMAN 
105827-78-9; 138261-41-3 Imidacloprid [9-11] 
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153719-23-4 Thiametoxam [9-11] 
210880-92-5 Clothianidin [9-11] 
111988-49-9 Thiacloprid [11] 
135410-20-7/160430-64-8 Acetamiprid [11] 
a Sources indicated as reference [5] are those listed in Table 4.1 of that document. 
2.1 Substances from the last review of the PS list  
During the last review of the priority substances list in accordance with Article 16(2) of the WFD [2], 
12 priority substances (PS) were added to the initial list of 33 PS in Annex X to that Directive. Both 
modelling- and monitoring-based exercises, starting from initial lists of 2014 and 316 substances, 
respectively, were performed during the prioritisation process [4], resulting in a short-list of substances. 
However, not all of those substances were ultimately prioritised, in several cases because hazard 
information was lacking or monitoring data were available for too few Member States.  
Therefore, the substances short-listed during the last review of the PS but not finally proposed for 
prioritisation, for which a detailed dossier had been produced and sometimes EQS had been derived, 
were included in the Initial List of substances as candidates for the Watch List. These substances have 
been identified in Table 4.1 of the Prioritisation scoping report [5], and are also listed above in Table 1. 
An exception is the substance musk xylene (CAS n. 81-15-2), which despite having been short-listed in the 
last prioritisation exercise, was not included in the current list of candidate substances because a ban has 
been imposed on its use in Europe.  Firstly, the International Fragrance Association decided in their 44th 
amendment a voluntary ban on the use of musk xylene in fragrance products. Secondly, the European 
Commission has issued a ban on musk xylene with a sunset date of 21/07/2014. 
2.2 Substances proposed by MS and other stakeholders and/or flagged in the literature 
Member States representatives and other stakeholders which are part of the WFD Common 
Implementation Strategy (CIS) Working Group Chemicals were invited to propose substances for the 
Watch List based on the experience gained in the implementation of monitoring programs under the WFD, 
and previous prioritisation schemes followed in Europe. The proposed substances are listed in Table 1, as 
well as some substances flagged in the literature as being of possible concern. 
 The estrogenic hormone estrone (E1) is a product of E2 oxidation and although it has lower estrogen 
receptor binding/transactivation potency than E2 in vitro [6,7], it is usually found at higher 
concentrations (by a factor of about 10) in WWTP effluents and surface waters [6-8]. Because of its 
chemical similarity, E1 is usually analysed together with E2 and EE2. 
 Other substances proposed for inclusion in the initial candidate list were 2,6-di-tert-butyl-4-
methylphenol (UV stabilizer and fuel antioxidant), formaldehyde, phenanthrene, the insecticides 
permethrin and malathion, and five neonicotinoid pesticides. The use of three of these neonicotinoids 
(imidacloprid, thiamethoxam, clothianidin) was recently restricted for two years (Regulation (EU) No 
485/2013, Art. 2) by prohibition of seed treatment, soil treatment and foliar application before flowering 
for specific crops, to address concern that they pose a risk to bees [9]. Risks to other organisms have also 
been identified, and laboratory studies suggest that some of these substances have a half-life in soil that 
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can reach three years [10], while the field DT50soil values in the EU Review Report 2005 were up to 305 d 
for clothianidin [11].  Use of the two other neonicotinoids, thiacloprid and acetamiprid, has not been 
restricted because they show lower toxicity to bees [12]. 
The initial list also includes top-ranked substances in “Category 2” 1 of the NORMAN Prioritisation 
scheme, including the plant protection products aminotriazole, diflufenican, dimethenamid, methiocarb 
and oxadiazon, the flame retardant triphenyl phosphate, the sun screen ingredient 2-ethylhexyl 4-
methoxycinnamate and the antibiotics azithromycin, ofloxacin, erythromycin and ciprofloxacin. Moreover, 
antibiotics as a group and mixtures of unknown composition were also suggested by a stakeholder for 
inclusion in the initial list. Information on exposure to antibiotics in the environment is needed not only 
because of their potential direct toxic effects, but also because of the increasing concern regarding 
antimicrobial resistance (AMR), although the latter is not the issue in the present risk assessment [13-15]. 
 
2.3 Criteria for De-selection of Substances 
From the initial list of 43 candidate substances for the Watch List, a criterion was defined to de-select 
substances with sufficient monitoring data available to conclude on a European-wide risk, i.e. with 
monitoring data from at least four MS. This is because a threshold for availability of monitoring data 
relating to at least four MS has been proposed as a criterion for including substances in the monitoring-
based ranking of the next prioritisation exercise [16]. Therefore, such substances are considered to have 
sufficient monitoring data for a possible prioritisation and were therefore excluded from the Watch List. 
To identify the number of MS for which monitoring data are available, the period 2006-2014 was 
considered, and three databases were searched, i) WATERBASE, hosted by the European Environment 
Agency (EEA) and containing official monitoring data, aggregated by year, gathered under the State of the 
Environment (SoE) reports by MS, ii) IPCheM, with regard to the monitoring data compiled during the 
previous prioritisation exercise and iii) NORMAN database containing monitoring data from official 
sources, projects and literature.  
Even though several substances on the initial list have been identified as River Basin Specific 
Pollutants (RBSP) in some MS [17], few additional data on those substances, apart from those available in 
the above databases, were forthcoming. 
The selection criteria for consideration of monitoring data were the following: 
1. Clear indication of the sampling site (site name, code, etc) 
2. Clear identification of the analysed substance (determinand) 
3. Clear identification of the measurement unit 
4. Samples collected from 2006 on 
                                                                    
1 The substances have been selected on the basis of the occurrence data available in the NORMAN EMPODAT 
database and they fulfil the following criteria: a) hazard assessment is based on experimental data (AF maximum 50 
for the derivation of the Lowest PNEC, mostly based on existing Assessment Reports) AND b) there is at least 1 site 
with exceedance of the Lowest PNEC (evidence of a potential risk) AND c) further monitoring data are needed for 
better assessment of exposure and risk at the European scale. 
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5. Either LOD or LOQ (at least one) clearly reported 
6. Identification of the analysed fraction (only for NORMAN, such information was not available for 
WATERBASE) 
7. LOD or LOQ ≤ substance-specific limits2 when the value is reported to be below LOD or LOQ3 
8. LOD or LOQ < PNEC when the value is reported to be below LOD or LOQ3 
2.4 Dataset Filtered 
After the application of the above criteria, 16 substances were de-selected based on availability of 
sufficient monitoring data. These substances are estrone, propiconazole, AMPA, bentazone, bisphenol A, 
carbamazepine, chlorothalonil, glyphosate, ibuprofen, mecoprop, omethoate, zinc, sulfamethoxazole, 
phenanthrene, permethrin and malathion. Monitoring data were available for dimethenamid from four 
MS, and only dimethenamid-P was considered for further assessment in this exercise. Therefore, a final 
number of 27 substances were taken forward for the purpose of ranking according to the risk they pose 
to the environment. 
 
3. Methodology for Ranking of Substances 
3.1 Overall Methodology 
A risk assessment of all the substances in the filtered dataset was done by combining the substance-
specific hazard data and information on exposure to the substance in or via the aquatic environment. 
According to the substance's physico-chemical properties, the receptors and compartments at risk were 
identified and an assessment done for each route of exposure, including the estimation of specific PEC 
and PNEC values, as summarized in Figure 1. In general, the criteria to identify the required assessments 
followed those specified in the Technical Guidance No. 27 of the Common Implementation Strategy (CIS) 
of the WFD [19]. 
The risk for direct toxicity to pelagic organisms from the presence of substances in the water column 
was always assessed, considering both a PECfw and a PNECfw for surface water.  
Depending on the sorption potential of a substance, a risk assessment for the sediment compartment 
was performed, i.e. whenever the organic carbon adsorption coefficient trigger value (Log Koc or Log Kow) 
 3, by estimating a PECsed and the PNECsed.  
For the protection of organisms from secondary poisoning, an assessment was made for those 
substances with a potential to bioaccumulate, using as trigger value a bioconcentration factors (BCF)  
                                                                    
2 Two substance-specific limits were calculated as the 99th percentile of all LOD and LOQ values for a certain 
substance (for NORMAN database separate limits were calculated for the dissolved fraction and for the “whole water” 
fraction). 
3 In WATERBASE data are aggregated by year, but information is available on the number of samples collected and 
the number of samples resulting below the LOQ. Hence these criteria were only applied if all samples were reported 
to be below LOQ. 
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100 or if no valid measured BCF was available a Log Kow 3 and the substance being not readily 
biodegradable [20]. In this case, a PECbiota was considered and a PNECbiota, sec pois was estimated for top 
predators, as well as a PNECbiota, hh to assess the risk for human health arising from the consumption of 
fishery products. 
Finally, an effect assessment was conducted for all substances regarding the protection of human 
health from consumption of drinking water, by estimating a PNECdw, hh to be compared to the PECfw. 
After estimating all the above PEC and PNEC values, risk quotients (PEC/PNEC) were calculated for 
the different compartment and receptor scenarios.  The highest risk quotient calculated for a substance 






Figure 1. Summary of the overall methodology for the risk assessment of candidate substances for the Watch List. 
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3.2 Data Collection 
For the collection of data, information was retrieved from several databases and reports, including 
IUCLID, ECHA, EFSA, RIVM, EMA, EU-Review reports, EU-RAR,  EU Pesticides DB, Footprint Pesticides 
Properties DB, EPA, substances dossiers prepared during the last prioritisation exercise and substances 
factsheets provided by NORMAN.  The relevance and reliability of the data retrieved from the above 
sources was deemed acceptable for the purpose of this exercise, since it was considered that the data had 
been reviewed by a competent authority, and no further review of the original study reports was 
conducted. 
Data collected for the exposure assessment and PEC calculation comprised physical and chemical 
properties (molecular weight, water solubility, vapour pressure, biodegradability, sorption potential and 
bioaccumulation potential), tonnage (of use, manufacture and import) and Environmental Release 
Category (ERC) codes.  
The collection of hazard data for the aquatic and sediment compartments included acute and chronic 
ecotoxicity (typically the most sensitive LC/EC50 or NOEC/EC10 endpoints). Regarding mammalian or 
human toxicity effects from oral exposure, data were collected for repeated dose toxicity, carcinogenicity, 
mutagenicity and effects on reproduction, focusing on typical endpoints such as NOAL, DNEL, ADI and 
TDI values. When new literature was considered that had not been retrieved from the sources listed 
above, reliability assessment of the ecotoxicological data was done by using a literature evaluation tool 
(LET), based on the Criteria for Reporting and Evaluating ecotoxicity Data (CRED) check list (Kase et al., 
personal communication). 
  
3.3 Hazard assessment – estimation of PNEC values 
3.3.1 PNEC for direct toxicity to freshwater organisms 
Chemical risk assessment in the water compartment is relevant for the protection of organisms 
inhabiting the water column. Therefore, the protection threshold concentrations PNECfw have been 
estimated for all substances. 
For the estimation of the PNECfw, a deterministic approach has been used by selecting the most 
stringent valuable endpoint from the available aquatic toxicity data, and applying an assessment factor 
(AF), which was chosen based on the guidelines for the derivation of the QSfw, eco retrieved from the TG n. 
27 - CIS WFD [18]. However, for some substances for which the PNEC was retrieved directly from other 
sources, a probabilistic method was used. 
 
3.3.2 PNEC for the toxicity to benthic species 
The threshold safety value for the protection of benthic organisms PNECsed has been derived for those 
substances with a potential for sorption into the sediment compartment using as trigger values: logKoc or 
LogKow ≥ 3. The PNECsed has been calculated following the TG n. 27- CIS WFD [18] and the ECHA 







  𝑃𝑁𝐸𝐶𝑓𝑤   1000                             (𝐴) 
 
RHOsed is the bulk density of wet sediment, Ksed-water is the partition coefficient between sediment and 
water and 1000 is the conversion factor from m3 to litre. 
 
Since the final PNECsed was calculated in terms of dry weight, a conversion step was required, by using the 




                                      (𝐵) 
 
𝑃𝑁𝐸𝐶𝑆𝑒𝑑 = 𝐶𝑂𝑁𝑉𝑠𝑒𝑑  𝑃𝑁𝐸𝐶𝑠𝑒𝑑−𝑤𝑤                                         (𝐶) 
 
For the calculation of KSed-water, the following equation D was used. 
 
𝐾𝑠𝑒𝑑−𝑤𝑎𝑡𝑒𝑟 = 𝐹𝑎𝑖𝑟𝑠𝑒𝑑𝐾𝑎𝑖𝑟−𝑤𝑎𝑡𝑒𝑟 + 𝐹𝑤𝑎𝑡𝑒𝑟𝑠𝑒𝑑 + 𝐹𝑠𝑜𝑙𝑖𝑑𝑠𝑒𝑑   
𝐾𝑝𝑆𝑒𝑑
1000
 𝑅𝐻𝑂𝑠𝑜𝑙𝑖𝑑        (𝐷) 
 
Default values for Fairsed, RHOsolid, Fwatersed, Fsolidsed and Focsed were taken from TG n. 27 - CIS WFD [18]. 
Since the given default value for Fairsed was zero [18], the first part of the equation (Fairsed × Kair-water) is 
not reported in the description of the calculations in the substances’ factsheets. 
 
3.3.3 PNEC for the toxicity to top predators from secondary poisoning 
The WFD provides for the protection of top predators such as birds and mammals from risks of 
secondary poisoning arising from the consumption of aquatic organisms from lower trophic levels 
contaminated with toxic substances.  
A PNECbiota, sec pois has been derived for all substances with a potential to bioaccumulate, as indicated 
under section 3.1. 
The derivation of a PNECbiota, sec pois started from toxicological endpoints reporting on dietary and oral 
exposure such as the no-observed adverse effect level (NOAEL) or no observed effect concentration for 
ingestion (NOECoral). Since the PNECbiota, sec pois is expressed as concentration in food, conversion factors 
from NOAEL to NOEC have been used, for bird and mammalian toxicity studies, following the TG n. 27 - 
CIS WFD [18]. 
3.3.4 PNEC for hazard to human health via consumption of fishery products 
Regarding the protection of human health from the consumption of contaminated fishery products, a 
PNECbiota, hh has been derived in a similar manner as the QSbiota, hh food in the TG n. 27 - CIS WFD [18], by 
using endpoints such as the acceptable daily intake (ADI), tolerable daily intake (TDI) or NOAELoral 





0.1  T L 70
0.115
                                        (E) 
 
The PNECbiota, hh is expressed in μg·kg-1, and uses a default value of human body weight of 70 kg, and a 
daily consumption of fishery products of 0.115 kg. In addition, it is assumed that fishery products make 
up no more than 10% of the threshold level value (0.1  TL) [18]. 
3.3.5 PNEC for hazard to human health via drinking water consumption 
Drinking water is a possible route of human exposure to substances in water, and protection 
threshold concentrations PNECdw, hh have been derived for all substances, based on human toxicity data. 
If available, WHO [21] or EU [22] drinking water standards have been used as the PNECdw, hh values for 
that substance. 
When a WHO drinking water standard was not available, the PNECdw, hh was calculated according to the 




   (F) 
 
A human body weight (bw) of 70 kg and a daily uptake of drinking water (uptakedw) of 2 litres were used. 
A fraction of 0.1 of the human toxicological standard (TLhh, usually the acceptable daily intake (ADI) or 
the tolerable daily intake (TDI)) is allocated to intake of the substance via drinking water. 
 
3.4 Exposure assessment – estimation of PEC values 
Regarding the exposure assessment, information on tonnage and use pattern for all substances was 
searched for. To facilitate the ranking of substances based on risk, it was attempted to use a similar 
method for the PEC calculation for all substances, the ECETOC PEC calculation tool based on EUSES [23] 
This tool requires tonnage information, as well as usage information as input values. Unfortunately, the 
required input information was not available for all substances, and additional models were required, as 
detailed below. When more than one PEC value was calculated by different methods, the worst case value 
was generally used for the ranking of substances. 
3.4.1 PEC for freshwater 
Tonnages and usage information were retrieved from IUCLID for six substances, also for an additional 
seven substances from the last prioritisation exercise. Thus, for these substances, with the exception of 
PPPs, the ECETOC tool was used for the PEC calculation with the respective ERC codes (when more than 
one use was reported, the ERC corresponding to the worst-case scenario was selected for the calculation).  
Unfortunately, the required input information for the remaining substances was not sufficient to run 
the model, and additional methods were sought for the PEC calculation depending on the availability of 
input data.  
For one substance the PEC was retrieved from European Union Risk Assessment Reports (EU-RAR), 
while for eleven pesticides, the PEC was calculated with the model FOCUS Step 2 [24]. Finally, for four 
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antibiotics, given the unavailability of information on production or sales at European level, PEC values 
were calculated by using the following equation G, retrieved from the publication of Besse et al, 2008 [25] 
 
 PECfw= (consumption × Fexcreta) / (WWinhab × hab × dilution × 365)  (G) 
 
where WWinhab is the volume of wastewater per person per day (default value of 200 [L/(hab*day]), hab 
are the number of inhabitants, Fexcreta is the excretion factor of the active substance (retrieved from the 
same publication), dilution is the dilution factor (default value of 10), consumption is the quantity 
(mg/year) of active ingredient consumed by the population during 1 year.  
Data on human consumption of antibiotics in the list were available for six MS (France, Greece, 
Portugal, Latvia, Germany and Denmark), retrieved respectively from Besse et al, 2008 [25], Iatrou et al, 
2014 [26], UBA report [27], and directly provided to the JRC for PT, LV and DK.  
The worst case PEC value among those estimated for each antibiotic was selected for the risk quotient 
(RQ) calculation. However, human consumption is not the only use for the considered pharmaceuticals, 
and veterinary uses and intermediate uses (for erythromycin and azithromycin), are not accounted for in 
the above mentioned calculated PEC. Moreover, data on human consumption at European scale are still 
lacking. For this reason, the upper end values from the available monitoring data were used to calculate 
the risk, which is shown for comparison in the final ranking. 
A summary of the sources of information and the models used for the PEC calculation are given in 
Table 2. 
 
Table 2. Data sources and methods used for PEC calculation. 
CAS n. Substance name Tonnage source ERC code used PEC calculation method 
128-37-0 2,6-di-tert-butyl-4-
methylphenol 
IUCLID ERC8d (a) ECETOC (b) 
135410-20-7/ 
160430-64-8 
Acetamiprid - - FOCUS Step 2 
61-82-5 Aminotriazole (Last 
prioritisation 
exercise)c 
(ERC8d)c FOCUS Step 2 
83905-01-5 Azithromycin - - Eq. G 
1333-82-0 Chromium trioxide - - EU-RAR 
85721-33-1 Ciprofloxacin - - Eq. G 
81103-11-9 Clarithromycin - - Eq. G 
210880-92-5 Clothianidin - - FOCUS Step 2 
57-12-5                                                                                                             Cyanide- free (HCN and CN- - - - 
294-62-2 Cyclododecane IUCLID ERC6a ECETOC (b) 
1085-98-9 Dichlofluanid Last 
prioritisation 
exercise 
ERC8b ECETOC (b) 
83164-33-4 Diflufenican - - FOCUS Step 2 (d) 
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163515-14-8 Dimethenamid-P - - FOCUS Step 2 
60-00-4 Edetic Acid (EDTA) IUCLID ERC10b (a) ECETOC (b) 






ERC8a ECETOC (b) 
50-00-0 Formaldehyde IUCLID ERC8d (a) ECETOC (b) 
105827-78-9/ 
138261-41-3 
Imidacloprid - - FOCUS Step 2 
2032-65-7 Methiocarb (Last 
prioritisation 
exercise)c 
(ERC8d)c FOCUS Step 2 
82419-36-1 Ofloxacin - - Eq. G  
19666-30-9 Oxadiazon - - FOCUS Step 2 (d) 
111988-49-9 Thiacloprid - - FOCUS Step 2 
153719-23-4 Thiamethoxam - - FOCUS Step 2 
731-27-1 Tolylfluanid Last 
prioritisation 
exercise 
ERC8b ECETOC (b) 
2303-17-5 Tri-allate (Last 
prioritisation 
exercise)c 
(ERC8d)c FOCUS Step 2  
52-68-6 Trichlorfon Last 
prioritisation 
exercise 
ERC8a ECETOC (b) 
115-86-6 Triphenyl phosphate IUCLID ERC8a (a) ECETOC (b) 
(a) Worst-case use scenario was selected among many others 
(b) Koc value were used, in addition to default input values 
(c) Calculations with ECETOC were made for comparison with FOCUS Step 2 results. However, the latter was used for 
the risk assessment. 
(d) Output from FOCUS Step 2 retrieved from EFSA conclusion report 
3.4.2 PEC for sediment 
For the calculation of the PECsed ECETOC results were used whenever available, and for pesticides the 
results were retrieved from Focus Step 2. Similar to the PECfw, PECsed values for chromium trioxide were 
retrieved from the EU-RAR. For those pharmaceutical substances passing the trigger value Log Koc and 
Log Kow 3, the sediment equilibrium partition method (EqP) was used considering the PECfw. Similar to 
what was done for the PNEC sediment in Section 3.3.2 (equations B-D), the PECsed-ww in terms of wet 









Since the final PECsed was calculated in terms of dry weight, a conversion step was required, by using the 




                                      (𝐼) 
 
𝑃𝐸𝐶𝑆𝑒𝑑 = 𝐶𝑂𝑁𝑉𝑠𝑒𝑑  𝑃𝐸𝐶𝑠𝑒𝑑−𝑤𝑤                                         (𝐽) 
 
For the calculation of KSed-water, the following equation K was used. 
 
𝐾𝑠𝑒𝑑−𝑤𝑎𝑡𝑒𝑟 = 𝐹𝑎𝑖𝑟𝑠𝑒𝑑𝐾𝑎𝑖𝑟−𝑤𝑎𝑡𝑒𝑟 + 𝐹𝑤𝑎𝑡𝑒𝑟𝑠𝑒𝑑 + 𝐹𝑠𝑜𝑙𝑖𝑑𝑠𝑒𝑑   
𝐾𝑝𝑆𝑒𝑑
1000
 𝑅𝐻𝑂𝑠𝑜𝑙𝑖𝑑        (𝐾) 
 
Default values for Fairsed, RHOsolid, Fwatersed, Fsolidsed and Focsed were taken from TG n. 27 - CIS WFD [18]. 
Since the given default value for Fairsed was zero [18], the first part of the equation (Fairsed × Kair-water) is 
not reported in the description of the calculations in the substances’ factsheets. 
 
3.4.3 PEC for biota 
For the calculation of the PECbiota the following equation L was used [28]. 
 
𝑃𝐸𝐶𝑏𝑖𝑜𝑡𝑎 =  𝑃𝐸𝐶𝑓𝑤   𝐵𝐶𝐹  𝐵𝑀𝐹                            (L) 
 
BCF values were retrieved when available or, for 5 substances, calculated from QSARS. 
Default BMF values were retrieved from TG n. 27 - CIS WFD [18]. 
3.5 Final Ranking  
Risk quotients (RQ) were estimated for all the relevant receptors at risk, i.e. RQfw, RQsed, RQbiota, sec pois , 
RQbiota, hh, RQdw, hh, and are available in the substances fact sheets, in Annex I. The highest RQ for the 




4.1 Overview of the exposure, hazard and risk assessment 
The current exercise has attempted to quantify the risk associated with the substances in the 
candidate list, for which a lack of EU-wide monitoring data has been identified that makes it difficult to 
decide whether to propose them as priority substances in the EU. 
Details of the considered sources of information on hazard and exposure, as well as the calculations of 
PEC and PNEC done for each individual substance for the different receptors and compartments, can be 
found in the factsheets in the Annex.  
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First results for the estimated PEC and PNEC values, as well as the different RQ, were presented and 
discussed at the Working Group Chemicals meeting (16-17 October 2014), following which Member 
States and Stakeholders provided additional comments and information in writing.  New information on 
exposure or hazard has been considered and used to update the substance assessments. The final results 
are summarised in Table 3. Substances are ranked from the highest to the lowest RQ.  The provision of 
additional monitoring data for several substances means that there are now sufficient data to evaluate 
some of them in the monitoring-based exercise of the ongoing review of PS. These substances have been 
deselected from the candidate list (Table 4). However, a detailed factsheet is still presented in the Annex 
for these substances, including information on the measured environmental concentrations. For the two 
substances with the lowest ranking, ofloxacin and EDTA, the risk quotient was below 1 in the present 
assessment and they have also been excluded from the candidate list.  
In addition to the ranking based on the risk quotient, the uncertainty of the PEC and PNEC calculations 
was also taken into account for the final recommendation. Additionally, existing or imminent non-
authorisation of use was taken into account to avoid proposing substances for inclusion in the Watch List 
for which measures are already in place that are expected to reduce the risk to the environment. Finally, 
it was considered whether methods are available to allow the monitoring of each proposed substance at 
concentrations close to its PNEC. 
A number of specific issues were identified during the risk assessment of the candidate substances, or 
brought to our attention by Member States and Stakeholders during or following the WG Chemicals 
Meeting (16-17 October 2014). In several cases, these issues relate to uncertainties in the PEC and PNEC 
calculation due to unavailability of data that could result in over or underestimation of the risk. These 






Table 3. Results from the risk-based ranking of substances using the highest risk quotient calculated for each substance 
ID 
Rank 




























Highest RQ for 
ranking 
Comment 
1 Trichlorfon 9.6E-07 NR N.R. N.R. 0.158 0.034 ECETOC 0.120 ECETOC 0.09 35312 RQfw 
High uncertainty 
regarding its 
spatial use, and 
AF 1000 for 
PNECfw 
2 Cyclododecane NA NA 5 38.043 2.188 0.468 ECETOC 306.45 ECETOC 64074.9 12815 
RQbiota, 
sec pois 















0.005 889 RQfw 
Sufficient 
monitoring data  
only pre-
restriction 






9.18 575 RQfw 
Sufficient 
monitoring data 










data is on-going.  
















3.16E-03 1.290 16.7 15.217 0.875 0.423 ECETOC 367.640 ECETOC 2115 283 RQsed 
 






0.03 218 RQfw 
 






165.20 176.12 RQfw 
 






1.19 143 RQdw,hh 
Commission vote 
is expected in Dec 
2014, regarding 
the renewal of the 
authorisation.  
11 Chromium trioxide 3.4E-03 3.4 17 0.055 0.003 0.350 EU-RAR 0.152 EU-RAR 0.98 111 RQdw,hh 
Last application 
date in 2016, 
sunset date 2017. 






0.03 78.6 RQfw 
 
























0.005 c ECETOC 0.3185 ECETOC 0.255 52.9 RQsed  
0.0002  d Eq. G  0.006 EqP 0.01 1.00 RQfw/sed 
Human 
consumption  




NA 0.2 N.R. N.R. 7.875 0.006 ECETOC 8.390 ECETOC 2.73 41.9 RQsed 
 
16 Dichlofluanid 2.65E-04 0.018 3.33 21.30 1.225 0.005 ECETOC 0.732 ECETOC 0.38 40.2 RQsed  
17 Formaldehyde 4.7E-01 2.44 N.R. N.R. 0.525 13.53 ECETOC 70.200 ECETOC 13.53 28.8 RQfw 
 











a PNEC values were updated according to the comments received. New monitoring data from Sweden and Italy were considered as well, and therefore 5 substances may be moved to 
the priority substances review because there are monitoring data from at least 4 MS. 
 




3.70E-03 0.240 N.R. N.R. 0.140 0.015 ECETOC 5.490 ECETOC 2.16 22.9 RQsed 
 






0.02 10.0 RQfw 
 
21 Ciprofloxacin 
8.9E-05 0.272 N.R. N.R. 0.006 5.4E-04 d Eq. G 1.642 EqP 0.0017 6.04 RQfw/sed 
Human 
consumption 
8.9E-05 0.272 N.R. N.R. 0.006 0.0012 MEC 3.78 EqP 0.004 13.93 RQfw/sed Monitoring 
22 Tolylfluanid 2.65E-04 0.058 8 6.087 0.350 9.7E-04 ECETOC 0.217 ECETOC 0.07 3.66 RQfw 
Sufficient 
monitoring data 
23 Clarithromycin 1.3E-04 0.0012 No info 0.012 0.001 
4.38E-04 d Eq. G 0.004 EqP 0.025 3.37 RQfw/sed 
Human 
consumption 
6E-04 MEC 0.006 EqP 0.036 4.96 RQfw/sed Monitoring 
24 Azithromycin c 
9E-05 0.014 No info 0.103 0.006 1.3E-04 d Eq. G 0.020 EqP 0.03 1.42 RQ fw/sed 
Human 
consumption 
9E-05 0.014 No info 0.103 0.006 5.83E-04 MEC 0.09 EqP 0.117 6.48 RQ fw/sed Monitoring 
25 Ofloxacin 1.3E-04 N.R. N.R. N.R. No info 9.4E-05 d Eq. G 0.0002 EqP 0.0003 0.72 RQfw RQ < 1 
26 Edetic Acid (EDTA) 2.2 118.58 N.R. N.R. 0.6 0.2486 ECETOC 26.93 ECETOC 0.447 0.41 RQdw,hh RQ < 1 
27 Cyanide-free 0.00026 - - - - - - - - - - - 
Many MS are 
monitoring CN, a 











c Erythromycin and azithromycin are registered in ECHA as having an intermediate use. 
d PECfw values for antibiotics were re-calculated by using the following formula: PECfw= (consumption X Fexcreta) / (WWinhab X hab X dilution X 365) from Besse et al. (2008)25 
where WWinhab is the volume of wastewater per person per day (default value of 200 [L/(hab*day]), hab are the number of inhabitants, Fexcreta  is the excretion factor of the active 
substance, consumption is the quantity (mg/year) of active ingredient consumed by the population during 1 year. 
Besse et al (2008)25 made calculations based on data of consumption from France. Consumption data were taken from Iatrou et al, 201426 for EL, from UBA report for DE27, and 
directly provided to JRC for PT, DK and LV by the respective MS. A similar calculation was done for these MS. The worst case PECfw value, calculated with the consumption data from 
single MS, was selected for the risk assessment. 
The above calculations of PEC values for antibiotics do not consider any veterinary use. In fact, the MEC, based on monitoring data from just a few MS, show that the calculated PEC 
are likely an underestimation of the real environmental concentrations.  
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5. Discussion and Recommendations 
 
 Trichlorfon: this substance has been banned as a PPP since 2007 but is currently still used as a 
veterinary pharmaceutical. For the PEC calculation, only a pre-banning tonnage was available (year 
2000), and no PEC value was available from the literature related to its current use. For this reason, the 
available tonnage value was used for the PEC calculation, even though it is likely an overestimation, and 
an ERC code applicable to veterinary pharmaceuticals was selected (ERC8a). Additionally, as suggested at 
the WG Chemicals meeting 16-17 Oct 2014, a simulation was done to calculate the risk considering a 
reduction in the tonnage. From this simulation, it could be seen that even reducing the tonnage by 80%, 
the substance would still rank in the 2nd position in this exercise. It should be noted that six Member 
States (MS) have derived an EQS for trichlorfon, but it is unclear whether monitoring data have been 
collected by at least four MS for the time period 2006-2014, in which case the substance could 
automatically be considered under the monitoring-based exercise of the ongoing PS review. There is also 
significant uncertainty in the derivation of the PNEC, with the use of an AF of 1000. Regarding the 
available analytical methods, there are some difficulties reported with the extraction and analysis and in 
reaching the low PNEC of the substance [29]. It is considered that additional data are required on tonnage 
and hazard to better identify the risk from trichlorfon, before recommending its inclusion into the Watch 
List, and for this reason, the substance has been deselected from the candidate list. 
 Cyclododecane: No effects on aquatic organisms found at concentrations below water solubility 
and no reliable QSARs predictions were found for the substance. Therefore, it was not possible to 
calculate PNECfw. The highest risk was calculated for biota. Even though cyclododecane has a high BCF 
and is expected to accumulate in biota, the derived PECbiota, seems like an overestimation. The PECbiota was 
calculated from the PECfw using ECETOC. However, the PECfw (also calculated using ECETOC) is about 30 
times higher than the water solubility. In addition, there is no information on how widespread the use of 
cyclododecane is in Europe and no analytical methods could be retrieved from the literature [29]. For the 
reasons stated above, it is recommended to deselect cyclododecane from the candidate list for the WL. 
 Diflufenican: The exposure of diflufenican was assessed using different FOCUS Step models and 
a risk was identified even using the high-tier FOCUS Step 3, considering the derived PNEC. The number of 
MS with monitoring data for the water compartment in the period 2006-2014 has been reassessed, and 
now reaches four MS, which is considered sufficient to assess the risk posed by the substance based on 
measured environmental concentrations in this compartment in the monitoring-based exercise of the 
ongoing review of the PS list. Even though the substance is likely to partition into the sediment (high Koc 
and DT50 sed values, see factsheet), a higher risk has been derived for the water compartment. However, 
PNEC exceedances were found in the two compartments (water and sediment). 
 Oxadiazon: The substance is a RBSP in one MS, and monitoring data are available for only two 
MS, while there is information that the substance is used in nine MS. The exposure of oxadiazon was 
assessed using FOCUS models and a risk was identified even using the high-tier FOCUS Step 3, 
considering the derived PNEC. The available monitoring data, particularly those retrieved from IPChem, 
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also indicate a risk from this substance. Furthermore, a risk was determined for drinking water (RQdw 
3.1). There are analytical methods capable of analysing the substance at low concentrations [29]. 
Although, an evaluation process of Confirmatory data on the substance is currently on-going, oxadiazon is 
still recommended for inclusion in the Watch List because of the apparently very high RQ, which could 
remain high even if the conditions of approval are changed. 
 Tri-allate: The substance was evaluated during the last review of the PS list. The highest RQ 
calculated in the present report is for surface water (RQfw). The substance seems to be in use in eight MS, 
while monitoring data are available from only two MS (for water), with no PNEC exceedance. By contrast, 
the PEC calculation with FOCUS Step models indicates an exceedance of the PNEC even using FOCUS Step 
3. There are analytical methods capable of analysing the substance at low concentrations in both water 
and soil [29].   
 Methiocarb: Following the WG Chemicals meeting (16-17 October 2014), new monitoring data 
have become available and the total number of MS with monitoring data for methiocarb is now five. A 
PECfw has been calculated using both ECETOC and FOCUS Step 1 and Step 2 models. The results from the 
first two models were quite in agreement with the measured concentrations (MEC95), except for SE, 
where all the measurements were below LOQ. Thus, both predicted and most measured concentrations 
are consistent with a risk for the water compartment in several MS. However, recently, the Commission 
Implementing Regulation (EU) No 187/2014 has restricted the uses of this active substance by 
withdrawing the authorisation for its use as a molluscicide. It is likely that this restriction will reduce the 
use of this substance in Europe and given the fast degradation of Methiocarb in the environment, no 
further aquatic exposure is expected from former use as a molluscicide. It is recommended that 
methiocarb is still considered for the Watch List to gather information on the post-banning 
environmental concentration (which at the moment is not available for any MS), in order to assess 
whether the banning as a molluscicide has been effective in eliminating the risk from this substance. In 
this respect, there are analytical methods capable of analysing the substance at low concentrations [29]. 
 Imidacloprid: This neonicotinoid has a widespread use in Europe as PPP and biocide, and some 
of its uses are currently restricted [30]. The PEC was derived using FOCUS Step models, where the PEC 
calculation was based on crop applications that accounted for the restriction in the uses of the substance. 
The calculated PEC shows an exceedance of the PNEC, even using FOCUS Step 3. Monitoring data are 
available for 5 MS (pre-restriction), and even though the MEC is lower than the predicted concentration, 
it still shows an exceedance of the PNEC. The PNEC has been derived using a probabilistic method and an 
AF of 3. Although there are monitoring data from more than 4 MS, the risk assessment of this substance in 
the prioritisation process may need to take account of the effects of the restriction, if it is extended, 
therefore monitoring data under those conditions should be obtained. There are analytical methods 
capable of analysing the substance at low concentrations [29]. 
 2,6-ditert-butyl-4-methylphenol: The substance is classified as having industrial uses with 
applications in a broad range of products. However, no monitoring data are available for the surveyed 
period (2006-2014), except from SE, for sludge and treatment plant effluents.  
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A recent tonnage value is available in IUCLID and this was used to calculate the PEC using an ECETOC 
model. Both PNECfw and PNECsed were retrieved from the ECHA file, with an AF of 100. The risk was 
higher for the sediment fraction. Given the high risk calculated for this substance, its widespread use and 
the fact that it is not readily biodegradable, and has a high BCF value, its inclusion into the Watch List is 
recommended. The literature indicates that methods are available for analysing the substance at the low 
ng/L level [29]. 
 Thiacloprid: The substance has a widespread use in Europe as PPP and biocide.  Since no 
tonnage was available for its use as biocide, the PEC calculation was done with the application rate 
considering its use as PPP only using FOCUS Step models. Even using the higher-tier Step 3, the calculated 
PEC exceeded the PNEC. Monitoring data are available from four MS, in two of which there was 
exceedance of the PNEC. Hazard data for PNEC calculation were retrieved from the Biocide Assessment 
report for the substance and the lowest endpoint from the aquatic species tested corresponded to the 
midge Chironomus riparius to which an AF of 10 was applied to derive the PNEC. Although having 
sufficient monitoring data to be included in the monitoring-based exercise, it is recommended to keep 
thiacloprid on the candidate list, since the predicted risk is already reinforced by exceedances of the 
PNEC in 50% of the four MS with monitoring data. There are analytical methods capable of analysing the 
substance at low concentrations [29]. 
 Aminotriazole: A significant risk was calculated for this substance, even considering a high-tier 
FOCUS step 3 for the calculation of the PEC. However, monitoring data are only available from one MS, 
where the MEC95 is slightly below the PNEC. A high risk was determined for drinking water (RQdw 143).  It 
was brought to our attention that a Commission vote is expected in December 2014, regarding the 
renewal of the authorisation of aminotriazole. For this reason, it is recommended to postpone the 
decision on an eventual proposal of aminotriazole for the WL until it is known whether a restriction on its 
use will be issued. The aminotriazole factsheet could then be reassessed on the occasion of the first 
revision of the WL. Furthermore, there seem to be some issues with the extraction and analysis of 
aminotriazole [29]. 
 Clothianidin: The substance has a widespread use in Europe (20 MS, according to the EU 
pesticides database) as PPP and biocide. A restriction on the use of clothianidin was imposed in 2013 
[30]. The PEC has been calculated considering the application rate as PPP using the FOCUS Step models; 
the crop used for the PEC calculation was not listed in the restricted uses. Even using the higher-tier Step 
3, the calculated PEC exceeded the PNEC. Monitoring data are available from only one MS, where all 
values were below the LOQ (which was below the PNEC). As for other neonicotinoid substances, the 
midge Chironomus riparius was the most sensitive species from all the hazard data in the Bioacide 
assessment report of the substance, and the PNEC was calculated using the deterministic approach with 
an AF of 10. Due to the high risk calculated for the aquatic environment, and insufficient information on 
environmental concentrations, it is considered that clothianidin is a good candidate for the WL, despite 
some of its uses currently being restricted. There are analytical methods capable of analysing the 
substance at low concentrations [29]. 
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 Chromium trioxide: Chromium trioxide was short-listed during the last review of the PS list. A 
ban on the use of chromium trioxide and other hexavalent ions has been recently introduced, with the last 
application date in 2016, and a sunset date of 2017. Since there are already measures in place that are 
expected to decrease the environmental concentrations for this substance, it is recommended to deselect 
chromium trioxide as candidate for the Watch List and from the review of the PS list. 
 Thiamethoxam:  This neonicotinoid has a widespread use in Europe as PPP and biocide, and 
some of its uses are currently restricted [30].  The PEC was derived using FOCUS Step models, where the 
PEC calculation was based on crop applications that accounted for the restriction in the uses of the 
substance. The calculated PEC shows an exceedance of the PNEC, even using a PEC calculated from Step 3. 
Monitoring data are available for four MS, in one of which the PNEC has been exceeded. The highest 
MEC95 is lower than the predicted concentration, and also lower than the PNEC. The PNEC was derived 
using the deterministic approach with an AF of 100, following the Biocide Assessment report. Given its 
widespread use, and significant calculated RQ, the risk assessment of this substance could benefit from 
more extensive monitoring across Europe, to resolve the discrepancy between the PEC and the MEC, 
therefore it is recommended to consider thiamethoxam as a candidate for the Watch list. There are 
analytical methods capable of analysing the substance at low concentrations [29]. 
 2-Ethylhexyl 4-methoxycinnamate: This substance and UV filters in general have a widespread 
use worldwide. The tonnage value used for the PEC calculation was relative to year 2000, and considering 
the increase in the use of UV-filters in recent years, the tonnage could be even higher currently. The 
highest risk has been calculated for the sediment fraction from the PEC estimated with ECETOC and 
estimated PNECsed and no toxicity was found for pelagic organisms below the water solubility of the 
substance. There are monitoring data for only two MS, where the MEC95 was lower than the PNEC for the 
substance. Even though other UV filters (eg. octocrylene) are found in the environment at higher 
concentrations than 2-ethylhexyl 4-methoxycinnamate, the latter is one that shows toxicity at lower 
concentrations (see factsheet for references). Furthermore EHMC is a suspected PBT and an endocrine 
disruptor, and more information on the exposure of aquatic ecosystems is required, and for this reason it 
is suggested as a good candidate for the Watch list. The available literature indicates that the substance 
can be measured at sufficiently low concentrations, including in sediment [29].  
 Dichlofluanid: this substance was short-listed under the last review of PS. Dichlofluanid is 
currently used as a biocide and has been banned as a PPP since 2003. However, for the PEC calculation, 
only a pre-banning tonnage was available (from year 1997), and no PEC value was available from the 
literature related to its current use. For this reason, the available tonnage value was used for the PEC 
calculation, even though it is likely an overestimation. As suggested at the WG Chemicals meeting 16-17 
Oct 2014, a simulation was done to calculate the risk considering a reduction in the tonnage. From this 
simulation, it could be seen that a 50% reduction in the tonnage would shift the ranking in this exercise 
from 16th to the 19th position. There is monitoring data from three MS for the time period 2006-2014, and 
the highest concentration measured is below the derived PNEC, while most measurements were below 
LOQ, even for sediment. Considering a broader time scale, also the PEC1 and PEC2 calculated from the 
monitoring data of the substance during the last review of the PS list were similar to more recent values 
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and still below the PNEC. It was also reported in the Biocide Assessment report that dichlofluanid rapidly 
degrades in aerobic aquatic systems, and that dichlofluanid does not have the potential to cause long-
lasting contamination of surface water or sediment [31]. It is considered that the risk assessment of this 
substance requires an update in tonnage values relative to its current use. The available literature 
indicates that the substance can be measured in the low ng/l and μg/kg ranges for water and sediment, 
respectively [29].  
 Formaldehyde: The substance was suggested for the WL by a MS. It is used in many different 
products, EU-wide. A confidential updated tonnage value was used for calculation of the PEC with the 
ECETOC model.  However, in recent years different uses of formaldehyde have been banned (see 
factsheet). Formaldehyde is reported as a RBSP in three MS, and monitoring data in the period 2006-2014 
is available for three MS. The MEC95 from all the databases screened in this report is below the PNEC. 
Furthermore, a decreasing trend in measured concentrations (MEC95) in surface water was apparent (FR: 
from 17.6 μg/L (2008) to 7.6 μg/L(2012); UK: from 26.2 μg/L(2010) to 21.2 μg/L(2011); SK: from 6.5 
μg/L(2007) to 0.2 μg/L(2010)). The PNEC was retrieved from ECHA and was estimated using the 
probabilistic approach with an AF of 10. A considerable risk was determined for drinking water, with a 
RQdw similar to the one for freshwater (25.8 and 28.8, respectively). It is likely that environmental 
exposure to formaldehyde will occur in many MS but it is less likely that exceedances of the PNEC are 
detected considering the restricted uses. There seem to be no issues in measuring this substance with the 
analytical methods available [29]. 
 Dimethenamid-P: dimethenamid was banned in 2006 [32] and since replaced by its active 
isomer dimethenamid-P. The PNEC values were estimated based on combined data from dimethenamid 
and dimethenamid-P, since the toxicological reference values established for dimethenamid have been 
considered applicable to dimethenamid-P by EFSA [33]. The initial assessment of the number of MS for 
which monitoring data are available was done by considering the monitoring data for dimethenamid and 
dimethenamid-P separately. In doing so, it was realised that there were monitoring data from four MS for 
dimethenamid, and only from two MS for dimethenamid-P (NL and IT). However, it was brought to our 
attention that monitoring data after the latest sales date established for dimethenamid (22 June 2008) 
can only relate to uses of dimethenamid-P PPPs, even if it has been attributed to “dimethenamid” 
(stakeholder comment (BASF)). Therefore, monitoring data after 2008 are available from five MS, and is 
considered sufficient for the evaluation of the substance in the ongoing review of PS. For this reason it is 
recommended to deselect dimethenamid-P as candidate substance for the Watch list. 
 Triphenyl phosphate: The use pattern is not clearly stated in the ECHA dossier, but an ERC code 
related to wide dispersive use is given. An updated tonnage value retrieved from IUCLID was used for the 
PEC calculation with ECETOC. Triphenyl phosphate is readily biodegradable and the DT50 water < 28 
days. The Koc value is very high and its accumulation in sediment is expected. Indeed, the highest risk 
was calculated for sediment, but no monitoring data were available for this compartment. For the water 
compartment, monitoring data are available for two MS, in both cases with concentrations lower than the 
PNEC, and the substance is reported as RBSP in 1 MS. Additional monitoring data could help in the risk 
 29 
 
assessment of the substance. There seem to be no issues in measuring this substance with the analytical 
methods available, even in sediment [29]. 
 Acetamiprid: This neonicotinoid has a widespread use in Europe as PPP and it has not been 
subject to any restriction.  The PEC calculation was done with the application rate considering its use as 
PPP using FOCUS Step models. Even using the higher-tier Step 3, the calculated PEC exceeded the PNEC. 
Monitoring data are available from only two MS, in one of which the PNEC has been exceeded. The lowest 
endpoint retrieved from the EU Review report related to Chironomus riparius and an AF of 10 was used to 
derive the PNEC. It is considered that acetamiprid is a good candidate for the Watch list and there are 
analytical methods capable of analysing the substance at low concentrations [29]. 
 Erythromycin: This pharmaceutical substance is registered in IUCLID with tonnage value given 
for an intermediate use (associated code ERC6a). By using ECETOC and ERC6a code to estimate the PEC 
value, an extremely high PECsed (50.89 mg/kg), and therefore a considerable risk, would be calculated for 
this substance, which would become the highest ranked in this exercise. However, the high PECsed value 
seemed an overestimated value and therefore, it was decided to use a different ERC code, applicable to 
pharmaceuticals, i.e. ERC8a. In addition to its intermediate use, erythromycin is a human and veterinary 
antimicrobial. Sales data were provided by PT, DK and LV and retrieved from the literature for EL [26] 
and from a report for DE [27]. The PEC calculated considering human use and excretion rates, by using a 
simplified EMA calculation retrieved from literature (see factsheet) were at least 1-order of magnitude 
lower than those using ECETOC ERC8a. The substance showed exceedance of the PNEC in measured 
concentrations in the NORMAN database (since 2002) and in monitoring data from SE, although the 
concentrations in the NORMAN database in the period 2006-2014 were all <LOQ. No consumption data 
were available for the use of erythromycin as a veterinary medicine. The risk assessment of this 
substance would greatly benefit from more information regarding both its use and environmental 
prevalence, and the inclusion into the Watch List could inform the risk assessors on the latter. There 
seems to be analytical methods available to analyse the substance at low concentrations, even regarding 
the LOQ for sediment [29]. 
 Clarithromycin: this pharmaceutical is used both as human and veterinary antimicrobial. Six 
PECfw values were calculated by using a simplified EMA calculation retrieved from the literature (see 
factsheet). According to the information available, only sales data related to human consumption from 
four MS were used for the PEC calculations, since no consumption values were available for the use of 
clarithromycin as veterinary medicine. The highest PEC value selected among those calculated was found 
to be lower than the highest MEC95 measured in SE, underlying that there may likely be an 
underestimation in the PEC calculation, due also to the missing information. The substance showed 
exceedance of the PNEC both in predicted and in measured concentrations in one MS out of three 
countries for which monitoring data are available. The risk assessment process of this substance would 
greatly benefit from more information regarding both its use and environmental prevalence, and the 
inclusion into the Watch List could inform the risk assessors on the latter. There are analytical methods 
capable of analysing the substance at low concentrations [29]. 
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 Ciprofloxacin: this pharmaceutical is used both as human and veterinary antimicrobial. Five 
PECfw values were calculated by using a simplified EMA calculation retrieved from literature (see 
factsheet). Only sales data relating to human consumption in those MS were available for the PEC 
calculations. The highest PEC value selected among those calculated was found to be lower than the 
highest MEC95 measured in SE (NORMAN database), underlining that there may likely be an 
underestimation in the PEC calculation, due at least in part to the missing information. The predicted 
concentrations and the measured concentrations in the NORMAN database and in SE exceeded the PNEC. 
Additional monitoring data gained through the inclusion of ciprofloxacin into the Watch List would 
greatly benefit the risk assessment. There are analytical methods capable of analysing the substance at 
low concentrations [29]. 
 Azithromycin: this pharmaceutical is used both as human and veterinary antimicrobial. Five 
PECfw values were calculated by using a simplified EMA calculation retrieved from literature (see 
factsheet). Only sales data relating to human consumption in those MS were available for the PEC 
calculations. The highest PEC value selected among those calculated was found to be lower than the 
highest dissolved MEC95 measured in PT (NORMAN database), underlying that there may likely be an 
underestimation in the PEC calculation, due at least in part to the missing information. The substance 
showed exceedance of the PNEC both in predicted and in dissolved measured concentrations in the 
NORMAN database. Also in the case of azithromycin, it would be advantageous to have additional 
monitoring data, and the substance is considered a good candidate for the Watch List. There are analytical 
methods capable of analysing the substance at low concentrations [29]. 
 Free cyanides: Even though there are monitoring available data for total cyanides from > four 
MS, there appears to be insufficient information with regard to the most bioavailable cyanide species. 
Furthermore, no tonnage in Europe was available in IUCLID for free cyanides and therefore ECETOC 
could not be used for PEC calculation. Moreover, no PEC value could be found in the literature. Improved 
monitoring strategies focused on free cyanide would facilitate the estimation of environmental 
concentrations, particularly considering the concern for drinking water exposure and the available 
drinking water standard in Europe for cyanides [22]. Continuous improvements in sampling and 
analytical methodologies and capabilities in the different MS promise to allow widespread adequate 
measurement of free cyanides in the near future. 
 For ofloxacin and EDTA, no risk was found in the present assessment (RQ < 1), and 




Table 4. Final ranking after removal of substances with high uncertainty (trichlorfon, cyclododecane), facing a total ban (chromium trioxide), having a RQ < 1 (EDTA and ofloxacin), 
or with sufficient monitoring data (diflufenican, dimethenamid-P, tolylfluanid). For Cyanide-free, it is expected that appropriate data will soon become available. To be noted that the 
five substances imidacloprid, thiacloprid, clothianidin, thiamethoxam, and acetamiprid have been grouped together under the “neonicotinoid class”. 
















Oxadiazon 19666-30-9 8.8E-05 mg/L 10 
0.039  
mg/L 
443.18 RQfw water yes low 
 
Methiocarb 2032-65-7 1E-05 mg/L 10 
0.004  
mg/L 













283.24 RQsed water/sediment yes low 
 




9E-06  mg/L 3 
0.008  
mg/L 






method for monitoring is 
available. 
Thiacloprid 111988-49-9 5.0E-05 mg/L 10 
0.0109  
mg/L 
218.0 RQfw water yes low 
Thiamethoxam 153719-23-4 1.4E-04 mg/L 100 
0.0110  
mg/L 
78.57 RQfw water yes low 
Clothianidin 210880-92-5 1.3E-04 mg/L 5 
0.0080  
mg/L 




5.0E-04 mg/L 10 
0.0050  
mg/L 
10.0 RQfw water yes low 
Erythromycin 114-07-8 
0.0060 





water/sediment yes 10 
ECETOC 
2 E-04 mg/L 10 
0.0006  
mg/L 

















40.2 RQsed sediment yes low  








0.015   
mg/kg dw 
22.9 RQsed sediment yes low  
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* The PNECsed was calculated with the Equilibrium Partitioning method from the PNECfw 
 
 




RQfw/sed water/sediment yes low 








RQfw/sed water/sediment yes low 
Human consumption  
6E-04 mg/L 4.96 Monitoring 




RQfw/sed water/sediment yes low 






It is recommended that in addition to diclofenac, E2 and EE2, already proposed for the Watch List, the list 
also includes the substances with the highest risk, and not excessive uncertainty in the PEC or PNEC 
calculation in this exercise. 
 
Even though E1 has been excluded from the list of candidate substances due to availability of monitoring 
data, it is a transformation product of E2 and is a considerable contributor to estrogenic activity in the 
aquatic environment. Therefore, it is recommended that E1 be analysed together with E2 to gather data 
for risk management following the reasons for inclusion of E2 into the Watch List. Both substances may 
be analysed with the same method in the same run, by GC-MS or LC-MS, without considerable additional 
burden. 
 
Regarding neonicotinoids, a risk has been predicted for all five substances in the initial list, and their use 
in Europe is widespread. Even though for imidacloprid and thiamethoxam apparently the monitoring 
data would be sufficient to consider the substances under the monitoring exercise of the ongoing review 
of PS, these are related to a period prior to the implementation of the restriction on their use.  If the 
restriction were to be extended, consideration of the substances in the priority substances review would 
have to be based on updated monitoring data. For thiacloprid, sufficient data also exist, but the exposure 
situation could also change in the light of the above restrictions. Since the neonicotinoids have similar 
properties and a similar mode of action and can be measured together with the same method, and 
without excessive costs, they could be included as a group of substances in the Watch List (Table 4). It is 
of note that just three of them were restricted due to the risk they pose for bees. However, a risk is 
identified for all five substances when other insects, relevant to the aquatic environment, are considered.  
 
For substances with more individual uses, the estimation of a more realistic risk is complicated by the 
lack of sufficient monitoring data. However, the risk estimated for the four antimicrobials was in the same 
range considering the upper-end measured concentrations in Europe. Erythromycin, clarithromycin, and 
azithromycin are members of the same class, i.e. macrolide antibiotics, and share the same mode of 
action. Since it has been suggested by some MS and stakeholders, both in the initial proposal of 
substances and during the commenting phase of the report, to consider antibiotics as a group for the 
Watch List, those three substances are now proposed as a group of substances. This proposal is also 
supported by the availability of a single analytical method [29]. The significant risk estimated for 
ciprofloxacin would also support its inclusion in the Watch List.  However, since it is in a different class of 
antimicrobials from the above group, it would need to be included as a separate substance. 
 
In conclusion, the ten substances/groups of substances most recommended for the first Watch List are 
listed below, subject to the availability of the analytical methodology to monitor them: 
 
 Diclofenac 
 17-Beta-estradiol (E2), Estrone (E1) 







Imidacloprid, Thiacloprid, Thiamethoxam, Clothianidin, Acetamiprid 
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Annex – Substances factsheets 
 
Information on exposure, hazard and risk for the Watch List candidate substances 


































Trichlorfon (CAS N. 52-68-6) 
 
1. Substance identity 
Chemical name (IUPAC) Dimethyl 2,2,2-trichloro-1-hydroxyethylphosphonate 
EC number 200-149-3 
CAS number 52-68-6 
Molecular formula C4H8Cl3O4P 




2. Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa) 2.1E-04 EFSA conclusion, 20061 
Water solubility (mg/L) 120000 EFSA conclusion, 20061 
logKow 0.43 EFSA conclusion, 20061 
 
 
3. Environmental fate 
Endpoint Value Source 
Sorption potential (Koc ) 0 EFSA conclusion, 20061 




Consensus between ADMET Predictor 
v. 7, VEGA Nic software, EPI Suite 
BCFBAF v. 3.01 
BMF 1 Default value, TG n. 27 - CIS WFD2 
 
 
4. Environmental exposure assessment 
 Description Source 
Tonnes/year 1050 (year 2000) From previous exercise 
Uses Insecticide used as veterinary 
pharmaceutical 
 
Spatial usage (by MS): Not known  
Banned uses PPP   (Commission Decision, C (2007)2096)3 
ERC code ERC8a  
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4.1 Predicted Environmental Concentration 
 Description Source 
PECfw (mg/L) 0.034 ECETOC 
PECsed (mg/kg dw) 0.12 (N.R.) ECETOC 
PECbiota (mg/kg) 0.093 (N.R.) 
Calculation based on Equation L 
(Section 3.4.3) 
N.R. Not required based on Koc and BCF values not reaching the trigger values required for sediment and biota 
assessment 
 
4.1.1 ECETOC simulation with lower tonnages 
From 25 May 2007 no authorisation for plant protection products containing trichlorfon are granted or 
renewed. Any period of grace granted by Member States shall be as short as possible and shall expire not 
later than 21 November 2008 (Commission Decision, C (2007)2096)3. 
However, the available tonnage of 1050 relates to the year 2000, which is prior to the banning of the 
substance as PPP. At the WG Chem meeting 16-17/10/2014, it was suggested to perform a simulation on 
the PEC calculated with ECETOC using reduced tonnage values of trichlorfon that could be closer to the 
actual tonnage after the banning, i.e. related to the use as veterinary pharmaceutical only. Since no 
tonnage value specific for this particular use was available, it was decided to perform the simulation 
considering a 30%, 50% or 80% decrease in tonnage values. The results of the simulations are compared 
with the pre-banning tonnage scenario in the following Table. 
 
Tonnes/year 1050 735 525 210 
Decrease respective to 
pre-banning tonnage 
- 30% 50% 80% 
PECfw (mg/L) 0.034 0.024 0.017 0.007 
RQfw 35312 24781.25 17697.92 7083.33 
Position in the ranking 
(higher RQ) 
1 (RQfw) 1 (RQfw) 1 (RQfw) 2 (RQfw) 
 
4.2 Measured Environmental Concentration 
Trichlorfon has been reported as a RBSP, with 6 MS having set EQSs ranging from 0.001 μg/L and 0.01 
μg/L4. However, monitoring data was available only for 3 MS during the period surveyed (2006-2014).  
 
n. of MS Source of monitoring data MEC values RBSP 
3 (FR, NL, IT) 
NORMAN DB, 20145 MEC95, whole: 0.428 µg/L 
6 MS4 




5. P, B, T, C, M, R, ED properties 
Trichlorfon is listed as Endocrine disruptor category 2 in the Endocrine Disruptor’s Access Database of 
the European Commission7. 
In the EFSA Conclusion 20061, it was reported that, with respect to gene mutation in vitro, equivocal 
results were obtained in the cultured mammalian cells (Chinese hamster lung cells). Positive results were 
obtained for in vitro chromosome aberrations in human lymphocytes, with and without metabolic 
activation. However the clastogenicity could not have been confirmed in vivo for somatic cells 
(micronucleus test) or germ cells (dominant lethal assay) since the studies were considered as non 
acceptable due to major deviations from the guidelines. Therefore, the genotoxic potential of trichlorfon 
in vivo could not be concluded in the EFSA Conclusion, 20061. In the same document, it was concluded 
that trichlorfon is not a carcinogenic compound and has no developmental toxicity. 
Trichlorfon is not readily biodegradable (P), and a BCF value of 2.74 L/kg (the mean value of the three 
results was used) was estimated by using VEGA Nic, ADMET and EPI Suite models. 
 
6. Hazard assessment 
6.1 Ecotoxicology data 
Trophic level Endpoint Value Reference 
Fish 
Oncorynchus mykiss, 96 h, 
LC50 
0.7 mg/L EFSA conclusion, 20061 
Aquatic invertebrates 







120 h, EC50 
10 mg/L EFSA conclusion, 20061 
 
6.2 Mammalian toxicology data 
Type of test Endpoint Value Reference 
Acute toxicity Rat, LD50, oral 212 mg/kg bw EFSA conclusion, 20061 
Long term toxicity 
Rat, NOAEL, 2 years, 
oral a 




Rabbit, NOAEL, maternal 
toxicity 
15 mg/kg bw/day EFSA conclusion, 20061 
Developmental toxicity 
Rabbit, NOAEL, offspring 
toxicity 
45 mg/kg bw/day EFSA conclusion, 20061 
Sub-chronic 
neurotoxicity 
Rat, NOAEL, oral, 90 d 6.08 mg/kg bw/day EFSA conclusion, 20061 
Long-term toxicity Rat, NOAEL 13.2 mg/kg bw/day EFSA conclusion, 20061 
Reproduction toxicity Rat, NOEL 300 ppm EFSA conclusion, 20061 
a Value used for ADI calculation in EFSA conclusion (2006) 1 
 
 
6.3 PNEC derivation 
The most sensitive endpoint is for acute toxicity in Daphnia magna. 
To be noted that in the EFSA conclusion (2006)1, the study on Daphnia magna was considered of poor 
quality. In the U.S. EPA ECOTOX DB9 the LC50/EC50 values with the same organism ranged from 0.01 
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µg/L to 750 µg/L. Evidence that D. magna showed highest sensitivity among organisms tested with 
trichlorfon are reported in Coelho et al. (2011)10. 
 
PNEC Endpoint Endpoint value AF PNEC value 
PNECfw 
Daphnia magna, 48 h, 
EC50 
0.00096 mg/L 1000 a 9.6E-07 mg/L 
PNECsed - - - N.R. 
PNECbiota,sec pois - - - N.R. 
PNECbiota, hh - - - N.R. 
PNECdw, hh ADI 0.045 mg/kg bw/day - 0.158 mg/L b 
N.R. Not required based on Koc and BCF values not reaching the trigger values required for sediment and biota 
assessment 
a Assessment factor 1000 was chosen because there was just acute toxicity data available for the main trophic levels. 
b ADI value, retrieved from EFSA Conclusion, 20061, used in equation F as TLhh. See section 3.3.5 for calculation. 
 




RQbiota,sec pois N.R. 
RQbiota, hh N.R. 
RQdw, hh 0.22 
 
8. References 
1 EFSA Scientific Report (2006) 76, 1-62, Conclusion on the peer review of trichlorfon. Available at 
http://www.efsa.europa.eu/it/efsajournal/pub/76r.htm 
2 Technical Guidance for Deriving Environmental Quality Standards – Guidance Document No. 27 (2011) Common 
Implementation Strategy of the Water Framework Directive (2000/60/EC). Available at 
http://ec.europa.eu/environment/water/water-dangersub/lib_pri_substances.htm 
3 COMMISSION DECISION of 21 May 2007 concerning the non-inclusion of trichlorfon in Annex I to Council Directive 
91/414/EEC and the withdrawal of authorisations for plant protection products containing that substance (notified 
under document number C(2007) 2096). Available at http://eur-lex.europa.eu/legal-
content/EN/ALL/?uri=CELEX:32007D0356 
4 NORMAN database at http://www.norman-network.net/?q=node/24 
5 Irmer U, Rau F, Arle J, Claussen U, Mohaupt V. (2013) Ecological Environmental Quality Standards of “River Basin 
Specific Pollutants” in Surface Waters - Update and Development Analysis of a European Comparison between 
Member States. ECOSTAT- UBA report. 
6 Italian Monitoring Programme (data provided directly to the JRC) 






10 Coelho S, Oliveira R, Pereira S, Musso C, Domingues I, Bhujel RC, Soares AM, Nogueira AJ. Assessing lethal and sub-
lethal effects of trichlorfon on different trophic levels. Aquatic Toxicology 103 (2011) 191–198.  
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Cyclododecane (CAS N. 294-62-2) 
1. Substance identity 
Chemical name (IUPAC) Cyclododecane 
EC number 206-033-9 
CAS number 294-62-2 
Molecular formula C12H24 




2. Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa) 9.83 ECHA, 20131 
Water solubility (mg/L) 0.016 ECHA, 20131 
logKow 7.6 ECHA, 20131 
 
3. Environmental fate 
Endpoint Value Source 
Sorption potential (Koc) 6513 ECHA, 20131 
Biodegradability NRB ECHA, 20131 
Bioaccumulation (BCF) 13700 ECHA, 20131 
BMF 10 Default value, TG n. 27 - CIS WFD2 
 
4. Environmental exposure assessment 
 Description Source 
Tonnes/year Confidential tonnage used for 
calculation 
IUCLID, 2013 
Uses Industrial use resulting in 
manufacture of another substance 
(use of intermediates) 
IUCLID, 2013 
Spatial usage (by MS) Not known  
Banned uses -  
ERC code ERC6a   







4.1 Predicted Environmental Concentration 
 Description Source 
PECfw (mg/L) 0.4677 ECETOC 
PECsed (mg/kg dw) 306.44 ECETOC 
PECbiota (mg/kg) 64074.90  




4.2 Measured Environmental Concentration 
n. of MS Source of monitoring data MEC values RBSP 
None - - - 
 
5. P, B, T, C, M, R, ED properties 
Both in the ECHA dossier1 and in the SVHC report3, cyclododecane is considered to be not readily 
biodegradable, according to the biodegradability screening tests available.It was also concluded that 
cyclododecane has a very high bioaccumulation potential and fulfils the B and vB criteria3. The properties 
of persistency, liability to bioaccumulate and toxicity justified placing cyclododecane in the OSPAR list of 
Chemical for Priority Action, although no background document was prepared on the grounds that the 
substance is used as an intermediates in closed systems4. 
The ECHA Member State Committee (MSC) unanimously agreed that there was no sufficient scientific 
data to justify identification of cyclododecane as a substance of very high concern (SVHC)5.  
 
6. Hazard assessment 
6.1 Ecotoxicology data 
No effects found in aquatic organisms at concentrations below water solubility1. 
 






predictor v. 7 
LC50, fish, 96 
h 
0.51 mg/L 
The substance is within the 
scope (applicability 
domain) of the model 
The endpoint value is above 
the water solubility of the 
substance. Therefore, it 
cannot be used 
ADMET 








The substance is outside 
the scope (applicability 
domain) of the model 
The prediction is not 
reliable. 
ADMET 
predictor v. 7 
pLC50, 
Daphnia 
magna, 48 h 
1565.30 g/L 
The substance is within the 
scope (applicability 
domain) of the model 
The endpoint value is above 
the water solubility of the 
substance. Therefore, it 
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The substance is outside 
the applicability domain of 
the model. 





48 h (from 
T.E.S.T tool) 
81.25 mg/L 
The substance is outside 
the applicability domain of 
the model. 










The substance is outside 
the applicability domain of 
the model. 













The substance is within the 
applicability domain of the 
model. 









< 0.01 mg/L 
According to the logKow 
value of the substance (log 
Kow 7.6), no effects at 
saturation are expected. 

















None of the chemical classes used for the models 
development seems to be representative of the molecular 
structure of the substance, leading to the consideration 
that cyclododecane could be outside of the structural 
domain of the models.  Although both molecular weight 
and logKow of the substance are below the cut-off values 
related to the chronic endpoints, the predictions are 




6.3 Mammalian toxicology data 
Type of test Endpoint Value Reference 
Acute toxicity Rat, oral, LD50 >1000 mg/kg bw ECHA, 20131  
Repeated dose toxicity Rat, oral, 29 d, NOAEL 150 mg/kg bw/day ECHA, 20131  
 
6.4 PNEC derivation 
PNEC Endpoint Endpoint value AF PNEC value 
PNECfw - - - N.A. 
Due to the fact that no effects have been seen at concentrations below solubility, it is not possible to 
calculate PNECfw (ECHA, 2013)1. No reliable QSARs predictions were found for the substance. 
PNECsed - - - N.A. 
See comment above for PNECfw 
PNECbiota,sec pois 
Rats, repeated dose 
toxicity, conversion 
150 mg/kg bw/day 300 5 mg/kg food a 
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factor 10, 29 d, NOAEL 
PNECbiota, hh 
DNEL, from repeated 
dose toxicity, oral, 
NOAEL 150 mg/kg 
bw/day, AF 240 b  
0.625 mg/kg bw/day - 
38.04 mg/kg 
bw/day c 
PNECdw, hh DNEL, same as above 0.625 mg/kg bw/day - 
2.19 mg/kg 
bw/day d 
a The following steps were followed for PNECbiota,sec pois calculation: a) conversion of NOAEL (150 mg/kg bw/day) 
retrieved from ECHA, 2013 into NOEC (1500 mg/kg)  by using the conversion factor of 10 (taken from TG n. 27- CIS 
WFD); b) To the NOEC value (1500 mg/kg), an appropriate AForal (300) (selected according to the duration test (29 
days) (TG n. 27 - CIS WFD) was applied. 
b At the beginning the DNEL value was estimated from NOAEL value of 150 mg/kg bw/day (repeated dose toxicity 
study, oral gavage, rat, 29 d), by using an AF of 600. The latter value was calculated by using the default values 
reported in Table R.8-6 of the ECHA document “Guidance on information requirements and chemical safety 
assessment Chapter R.8:  characterisation of dose [concentration]-response for human health”, available at 
http://echa.europa.eu/documents/10162/13632/information_requirements_r8_en.pdf. Specifically, an AF of 4 was 
used for the correction of differences in metabolic body weight from rat to human, an AF of 2.5 for remaining 
interspecies differences, an AF of 10 was chosen for intraspecies differences related to general population, an AF of 6 
was used for accounting differences from sub-acute to chronic study, and AF of 1 was selected both for dose-response 
differences and for issues related to the quality of the whole database. The total multiplication led to a value of 600. 
However, it was finally decided to remove the AF of 2.5(remaining interspecies differences) leading to a total AF 
value of 240, with a DNEL value of 0.624 mg/kg bw/day instead of 0.25 mg/kg bw/day. The final ranking would not 
change. However, the last considerations were included in the final risk assessment of the substance. Therefore, the 
factsheet has been amended accordingly. 
c DNEL value used for PNEC calculation according to Equation E (see section 3.3.4) 
d The DNEL value was calculated from the NOAEL value (ECHA, 20131), and thenused in equation F as TLhh for PNEC 
calculation. See section 3.3.5 for calculation.  
 





RQbiota,sec pois 12814.98 
RQbiota, hh 1684.25 




1 ECHA dissemination website: http://apps.echa.europa.eu/registered/data/dossiers/DISS-9d827c78-e4a2-5770-
e044-00144f67d249/DISS-9d827c78-e4a2-5770-e044-00144f67d249_DISS-9d827c78-e4a2-5770-e044-
00144f67d249.html 
2 Technical Guidance for Deriving Environmental Quality Standards – Guidance Document No. 27 (2011) Common 
Implementation Strategy of the Water Framework Directive (2000/60/EC). Available at 
http://ec.europa.eu/environment/water/water-dangersub/lib_pri_substances.htm 
3 SVHC SUPPORT DOCUMENT, Member State Committee Support document for Agreement on cyclododecane. 
Adopted on 8 October 2008. Available at 
http://echa.europa.eu/documents/10162/13638/svhc_supdoc_cyclododecane_en.pdf4 OSPAR list of Chemicals 







5 ECHA Press Release (ECHA/PR/08/34). ECHA Member State Committee Agrees On The Identification Of 14 





Imidacloprid (CAS N. 105827-78-9/138261-41-3)  
1. Substance identity 
EC name 1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine 
EC number 428-040-8 
CAS number 105827-78-9/138261-41-3 
Molecular formula C9H10ClN5O2 






2. Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa) 4E-10 EFSA conclusion, 2008 1 
Water solubility (mg/L) 610 EFSA conclusion, 2008 1 
logKow 0.57 EFSA conclusion, 2008 1 
 
 
3. Environmental fate 
Endpoint Value Source 
Sorption potential (Koc) 225 (mean) EFSA conclusion, 2008 1 
Biodegradability NRB EFSA conclusion, 2008 1 
Bioaccumulation (BCF) 0.61 FOOTPRINT PPDB2 
 
4. Environmental exposure assessment 
 Description Source 
Tonnes/year -  
Uses Insecticide (PPP and biocide)  
Spatial usage (by MS) 
AT, BE, BG, CY, CZ, DE, DK, EE, EL, 
ES, FI, FR, HU, IE, IT, LT, LU, LV, 
MT, NL, PL, PT, RO, SE, SI, SK, UK  
EU Pesticides DB 3 
Banned uses Restriction of usesa  EU n. 485/2013 4 
ERC code ERC8d (N.R.)  
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a the use as a seed treatment or soil treatment of plant protection products containing imidacloprid is prohibited for 
crops attractive to bees and for cereals except for uses in greenhouses and for winter cereals. Foliar treatments with 
plant protection products containing imidacloprid are prohibited for crops attractive to bees and for cereals with the 
exception of uses in greenhouses and uses after flowering4. 
 
4.1 Predicted Environmental Concentration 
PECfw (mg/L) 0.008 FOCUS Step 2 
PECsed (mg/kg dw) 0.0.018 (N.R.) FOCUS Step 2 
PECbiota (mg/kg) 0.005 (N.R.) 
Calculation based on Equation L 
(Section 3.4.3) 
N.R. Not required based on Koc and BCF values not reaching the trigger values required for sediment and biota 
assessment 
 
4.1.1 Comparison of FOCUS Pesticides models 







Koc (L/kg) 1 
DT50 whole 
system (d) 1 
Pome and Stone Fruits 
(late) 
1st appln 70 
2nd appln 105 
(40 d application  
interval) 
610 225 (mean) 90 
FOCUS Step 2      
Same parameters and conditions as above, in addition to DT50soil 82 d (although being normalized with 
the older Q10 value of 2.2, this field DT50 value was kept for Step1&2 calculations, since the PECfw value of 
Step3 retrieved from the EFSA conclusion, 20145 was based on the same value), DT50water: 90 d 1, 
DT50sediment 1000 d (conservative value)1. In the EFSA Conclusion, 20081, an earlier growth stage was 
reported for apples. However, we have considered a full canopy for FOCUS Step 1-2 calculations, in order 
to account for the restriction in the uses of the substance (post-flowering application). 
FOCUS Step 3 – SWASH Package 
No new calculations were made, PECfw value was retrieved from EFSA Conclusion, 20145. 
 
Results 
Tier PECfw (mg/L) PECsed (mg/kg) 
FOCUS Step 1 0.054 0.116 
FOCUS Step 2 0.008 0.018 
FOCUS Step 3 
0.006187 (single 










4.2 Measured Environmental Concentration 
n. of MS Source of monitoring data MEC values RBSP 
5 (FR, PT, 
NL, SE, IT) 
NORMAN DB, 2014 6 MEC95, dissolved: 0.114 µg/L 
1 MS10 
EQS set (WRc, 2012) 11 
WATERBASE, 2014 7 MEC95, whole: 0.08 µg/L 
SE pesticide monitoring 
programme 8 
MEC95: 0.21 µg/L 
IT Monitoring Programme 9 MEC95: 0.099 µg/L 
 
5. P, B, T, C, M, R, ED properties 
No evidence of genotoxic or carcinogenic effects was observed with imidacloprid1. Likewise it did not 
affect the reproductive parameters in rats, or the embryofoetal development in rats and rabbits1. In 
neurotoxicity studies, effects occurred in the functional observational battery, without histopathological 
findings in the nervous tissues1. Imidacloprid is not readily biodegradable (P). It shows a low potential to 
bioaccumulate in aquatic organism1. 
 
6. Hazard assessment 
6.1 Ecotoxicology data 
Trophic level Endpoint Value Reference 
Aquatic invertebrates 
Daphnia magna, NOEC, 
reproduction 
6 mg/L EFSA Conclusion, 20145 
Aquatic invertebrates 
Daphnia magna, NOEC, 
reproduction 
1.8 mg/L EFSA Conclusion, 20145 
Aquatic invertebrates Daphnia magna 2 mg/L EFSA Conclusion, 20145 
Aquatic invertebrates Daphnia magna 6 mg/L EFSA Conclusion, 20145 
Aquatic invertebrates 
Gammarus pulex, NOEC, 
swimming/behaviour 
0.064 mg/L EFSA Conclusion, 20145 
Aquatic invertebrates 




20145, RIVM Report12 
Aquatic invertebrates 




20145, RIVM Report12 
Aquatic invertebrates 








0.00209 mg/L EFSA Conclusion, 20145 
Aquatic invertebrates 
Chironomus riparius, 10 
d, NOEC, recovery after 4 
d exposure 
< 0.00215 mg/L EFSA Conclusion, 20145 





20145, RIVM Report12 




20145, RIVM Report12 




20145, RIVM Report12 
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20145, RIVM Report12 




20145, RIVM Report12 




20145, RIVM Report12 




20145, RIVM Report12 
Values in bold were used in the SSD (EFSA Conclusion, 20145) 
 
6.2 Mammalian toxicology data 
Type of test Endpoint Value Reference 
Acute oral toxicity Rat, LD50 500 mg/kg bw EFSA Conclusion, 20081 
Short-term toxicity 
(neurotoxicity) 
Rat, oral, 90 d, NOAEL 9.3 mg/kg bw/day EFSA Conclusion, 20081 
Short-term toxicity  
Dog, oral, 28 d and 90 d, 
NOAEL 
8 mg/kg bw/day EFSA Conclusion, 20081 
Long-term toxicity  
Rat, 2 years, NOAEL. 
Value used for ADI 
calculation in the EFSA 
Conclusion, 20081 
5.7 mg/kg bw/day 
EFSA Conclusion, 
20081 
Long-term toxicity  Mouse, 2 years, NOAEL 208 mg/kg bw/day EFSA Conclusion, 20081 
Reproductive toxicity  




a)20 mg/kg bw/day 
b)50 mg/kg bw/day 
c)20 mg/kg bw/day 
EFSA Conclusion, 20081 
Developmental toxicity 
Rat, maternal  
and developmental 
NOAEL 





a)8 mg/kg bw/day 
b)24 mg/kg bw/day 
EFSA Conclusion, 20081 
 
 
6.3 PNEC derivation 
PNEC Endpoint Endpoint value AF PNEC value 
PNECfw HC5a 0.027 µg/L 3 0.009 µg/L b 
PNECsed - - - N.R. 
PNECbiota,sec pois - - - N.R. 
PNECbiota, hh - - - N.R. 
PNECdw, hh ADI 1 
0.06 
mg/kg bw/day 
- 0.210 mg/L c 
N.R. Not required based on Koc and BCF values not reaching the trigger values required for sediment and biota 
assessment 
a HC5 from chronic SSD suggested by NL. Value retrieved from the new EFSA conclusion, 20145 
b Value retrieved from the new EFSA conclusion, 20145, as Tier-2B RACsw;ch 










RQbiota,sec pois N.R. 
RQbiota, hh N.R. 
RQdw, hh 0.04 
 
8. References 
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4 COMMISSION IMPLEMENTING REGULATION (EU) No 485/2013 of 24 May 2013 amending Implementing 
Regulation (EU) No 540/2011, as regards the conditions of approval of the active substances clothianidin, 
thiamethoxam and imidacloprid, and prohibiting the use and sale of seeds treated with plant protection products 
containing those active substances. Available at http://eur-lex.europa.eu/legal-
content/EN/TXT/?uri=CELEX:32013R0485 
5 EFSA (European Food Safety Authority), 2014. Conclusion on the peer review of the pesticide risk assessment for 
aquatic organisms for the active substance imidacloprid. EFSA Journal 2014;12(10):3835, 49 pp. 
doi:10.2903/j.efsa.2014.3835. 
6 NORMAN Database http://www.norman-network.net/?q=node/24 
7 WATERBASE Database http://www.eea.europa.eu/data-and-maps/data/waterbase-rivers-6 
8 Swedish National Screening Programme Pesticides (data provided directly to the JRC) 
9 Italian Monitoring Programme (data provided directly to the JRC) 
10 Irmer U, Rau F, Arle J, Claussen U, Mohaupt V. (2013) Ecological Environmental Quality Standards of “River Basin 
Specific Pollutants” in Surface Waters - Update and Development Analysis of a European Comparison between  
Member States. ECOSTAT- UBA report 
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Basin Management Plans' - Task 2c (Comparison of Specific Pollutants and EQS): Final Report”. WRc Ref: UC8981/1 
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Diflufenican (CAS N. 83164-33-4)  
1. Substance identity 
EC name  
EC number  
CAS number 83164-33-4 
Molecular formula C19H11F5N2O2 





2. Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa) 4.25E-06 EFSA conclusion, 2007 1 
Water solubility (mg/L) 0.05 EFSA conclusion, 2007 1 
logKow 4.2 EFSA conclusion, 2007 1 
 
 
3. Environmental fate 
Endpoint Value Source 
Sorption potential (Koc) 1989 EFSA conclusion, 2007 1 
Biodegradability NRB EFSA conclusion, 2007 1 
Bioaccumulation (BCF) 1596  EFSA conclusion, 2007 1 
BMF 1 Default value, TG n. 27 - CIS WFD2 
 
 
4. Environmental exposure assessment 
 Description Source 
Tonnes/year -  
Uses Herbicide (PPP)  
Spatial usage (by MS) AT, BE, BG, CZ, DE, DK, EE, EL, ES, 
FI, FR, HU, IE, IT, LT, LU, LV, NL, 
PL, PT, RO, SE, SI, SK, UK  
EU Pesticides DB 2 
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Banned uses -  
ERC code ERC8d  





4.1 Predicted Environmental Concentration 
PECfw (mg/L) 0.00575 FOCUS Step 2 
PECsed (mg/kg dw) 0.112 FOCUS Step 2 
PECbiota (mg/kg) 
9.18 




4.1.1 Comparison of FOCUS Pesticides models  
FOCUS Step 1 a 




Koc (L/kg) 1 
DT50 whole 
system (d) 1 
Wheat 1  120 0.05 1989 214 
FOCUS Step 2 a     
Same parameters and conditions as above, in addition to DT50soil 141.8 d 1, DT50water: 31.7 d 1, DT50sediment 
338.7 d 1, no crop interception1. 
FOCUS Step 3 – SWASH Packagea 
a No new calculations were performed, since PEC value were retrieved from EFSA conclusion, 2007 1 
 
Results 
Tier PECfw (mg/L) PECsed (mg/kg)  
FOCUS Step 1 0.012 0.218  
FOCUS Step 2 0.00575 0.112  








4.2 Measured Environmental Concentration 
n. of MS Source of monitoring data MEC values RBSP 
4 (FR, DE, FI, 
SE)* 
NORMAN DB, 2014 3 
MEC95, whole: 0.09 µg/L 
MEC95, dissolved: 0.152 µg/L 
1 MS 6 WATERBASE, 2014 4 MEC95, whole: 0.029 µg/L 
SE pesticide monitoring 
programme 5 
MEC95: 0.0314 µg/L 
* Monitoring data for the sediment compartment are available from only 1 MS (FR) from NORMAN and 




5. P, B, T, C, M, R, ED properties 
There was no concern about the genotoxic properties of diflufenican1. Diflufenican did not show any 
carcinogenic potential in the studies reported in the EFSA Conclusion, 20071. There might be some 
indications of endocrine disruption at high doses but in view of the potential link with systemic toxicity, 
no classification for fertility was proposed. In developmental studies with rats and rabbits, there was no 
evidence of teratogenic activity in the absence of maternal toxicity (EFSA Conclusion, 20071). Diflufenican 
is not readily biodegradable.  Since the BCF in fish was > 1000 and the DT90 in sediment was >100 days 
the risk of bioaccumulation in terrestrial food chains was assessed1. The BAF (bioaccumulation factor) 
was calculated as 0.77. Since the BAF is <1 the risk of bioaccumulation is considered to be low (EFSA 
Conclusion, 20071). 
 
5.1 Ecotoxicology data 
Trophic level Endpoint Value Reference 
Fish 
Cyprinus carpio, 96 h, 
LC50 
0.098 mg/L INERIS, 20127 
Fish Pimephales promelas, ELS 0.015 mg/L INERIS, 20127 
Aquatic invertebrates 
Daphnia magna, 48 h, 
EC50 
>0.24 mg/L INERIS, 20127 
Aquatic invertebrates 
Daphnia magna, 21 d, 
NOEC 
0.052 mg/L INERIS, 20127 
Algae 
Scenedesmus subspicatus, 
72 h, growth rate, EC50 
0.00045 mg/L INERIS, 20127 
Algae 
Scenedesmus 
subspicatus, 72 h, NOEC 
0.0001 mg/L INERIS, 20127 




28 d, NOEC 
2 mg/kg INERIS, 20127 
 
5.2 Mammalian toxicology data 
Type of test Endpoint Value Reference 
Acute oral toxicity Rat, LD50 >5000 mg/kg bw EFSA Conclusion, 20071 
Short-term toxicity 
Rat, oral, 13 weeks, 
NOAEL 
19.47 mg/kg bw/day 
EFSA Conclusion, 
20071 
Short-term toxicity Dog, oral, 1 year, NOAEL 100 mg/kg bw/day EFSA Conclusion, 20071 
Long-term toxicity Rat, 2 years, NOAEL 
23.27 mg/kg bw/day 










a)35.5 mg/kg bw/day 
b)206.1 mg/kg bw/day 
c)41.9 mg/kg bw/day 






a)50 mg/kg bw/day 
b)500 mg/kg bw/day 
EFSA Conclusion, 20071 
Developmental toxicity 
Rabbit, maternal and 
developmental NOAEL 
350 mg/kg bw/day EFSA Conclusion, 20071 
Reproductive toxicity 
Colinus virginianus, 20 
weeks, NOAEL 
91.84 mg/kg bw 




Both studies in bold were used for calculation of the ADI (EFSA Conclusion, 20071). 
 
5.3 PNEC derivation 





subspicatus, 72 h, NOEC 




Chironomus riparius, 28 
d, NOEC 





Rats, chronic toxicity, 
conversion factor 20, 2 
years, NOAEL 








PNECdw, hh ADI 1 0.2 mg/kg bw/day - d 0.7 mg/L 
a Three long term values were available from the main trophic levels 
b One long term test available 
c ADI value used in equation B as TL. See section 3.3.4 for calculation 
d ADI value used in equation C as TLhh. See section 3.3.5 for calculation 
 




RQbiota,sec pois 0.55 
RQbiota, hh 0.75 
RQdw, hh 0.01 
 
7. References 
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http://www.efsa.europa.eu/de/scdocs/doc/122r.pdf 
2 European Pesticides Database http://ec.europa.eu/sanco_pesticides/public/?event=homepage 
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6Irmer U, Rau F, Arle J, Claussen U, Mohaupt V. (2013) Ecological Environmental Quality Standards of “River Basin 
Specific Pollutants” in Surface Waters - Update and Development Analysis of a European Comparison between  
Member States. ECOSTAT- UBA report. 





Oxadiazon (CAS N. 19666-30-9)  
1. Substance identity 
EC name 3-[2,4-dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-
oxadiazol-2(3H)-one 
EC number 243-215-7 
CAS number 19666-30-9 
Molecular formula C15H18Cl2N2O3 




2. Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa) 1.035E-04 EFSA Conclusion, 2010 1 
Water solubility (mg/L) 0.57 EFSA Conclusion, 2010 1 
logKow 5.33 EFSA Conclusion, 2010 1 
 
 
3. Environmental fate 
Endpoint Value Source 
Sorption potential (Koc )  1294 EFSA Conclusion, 2010 1 
Biodegradability NRB EFSA Conclusion, 2010 1 
Bioaccumulation (BCF) 243 EFSA Conclusion, 2010 1 
BMF 1 Default value, TG n. 27 - CIS WFD 2 
 
 
4. Environmental exposure assessment 
 Description Source 
Tonnes/year -  
Uses Herbicide (PPP)  
Spatial usage (by MS) BE, CY, ES, FR, IT, LU, PT, SK, UK  EU Pesticides DB3 
Banned uses -  





4.1 Predicted Environmental Concentration 
PECfw (mg/L) 0.039 FOCUS Step 2 
PECsed (mg/kg dw) 0.496 FOCUS Step 2 
PECbiota (mg/kg) 9.477 




4.11 Comparison of FOCUS Pesticides models 







Koc (L/kg) 1 
DT50 whole 
system (d) 1 
Sunflower 
1  750 g/ha  
(pre-emergence) 
0.57 1294 127 
FOCUS Step 2 a     
Same parameters and conditions as above, in addition to DT50soil 120 d 1, DT50water: 127 d 1, DT50sediment 999 
d 1, no crop interception 1. 
FOCUS Step 3 – SWASH Package a 




Tier PECfw (mg/L) PECsed (mg/kg) 
FOCUS Step 1 0.0986 1.19 
FOCUS Step 2 0.039 0.496 






4.2 Measured Environmental Concentration 
n. of MS Source of monitoring data MEC values RBSP 
2 (FR, IT) 
NORMAN DB, 20144 
MEC95, whole: 0.07 µg/L 
MEC95, dissolved: 0.168 µg/L 1 MS 7 
EQS set (WRc, 
2012)8 
IPCheM5 MEC95: 12.8 µg/L  
IT Monitoring Programme6 MEC95: 0.376 µg/L 
 
5 P, B, T, C, M, R, ED properties 
Oxadiazon itself did not present genotoxic potential1. Liver tumours were observed in both the rat and 
mouse species; mechanistic studies confirmed that oxadiazon is a peroxisome proliferator1. Although 
peroxisome proliferators are hepatocarcinogens in rodents, the current scientific opinion is that humans 
are not responsive to this class of non-genotoxic carcinogens and therefore, oxadiazon is unlikely to 
present a carcinogenic risk to humans1. Effects on the reproduction (increase in gestation length and 
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irregular oestrus cycle) were more prominent in a preliminary dose-range finding study to the 
multigeneration study where total litter losses were observed at ca. 30 mg/kg bw/day, as the main study 
was conducted with much lower dose levels. On this basis a classification with the risk phrase R62 
“possible risk of impaired fertility” was proposed1. Oxadiazon was considered to be very toxic to aquatic 
organisms, with algae and fish reproduction as the most sensitive endpoints. It is not reaily biodegradable 
(P).A bioaccumulation study with bluegill sunfish (Lepomis macrochirus) gave BCF values of 243 (not B) 
based on measured oxadiazon residues in fish (EFSA Conclusion, 20101). 
 
6 Hazard assessment 
6.1 Ecotoxicology data 
Trophic level Endpoint Value Reference 
Fish 
Lepomis macrochirus, 96 
h, LC50 
1.2 mg/L EFSA Conclusion, 20101 
Fish 
Oncorhynchus mykiss, 96 
h, LC50 
1.2 mg/L EFSA Conclusion, 20101 
Fish 
Oncorhynchus mykiss, 





Daphnia magna, 48 h, 
EC50, mortality 
> 2.4 mg/L EFSA Conclusion, 20101 
Aquatic invertebrates 
Daphnia magna, 21 d, 
NOEC, reproduction 
 0.03 mg/L EFSA Conclusion, 20101 
Algae Anabaena flos-aquae, 120 
h, EC50,  growth rate 
>3.7 mg/L 




capricornutum, 120 h, 




EFSA Conclusion, 20101 
Algae Navicula pelliculosa, 120 
h, a) EC50, b) NOEC 
a)0.128 mg/L 




72 h, a) EC50 biomass, b) 




c) 0.002 mg/L 
EFSA Conclusion, 20101 
DAR, 20069 
Algae with sediment 
Scenedesmus subspicatus, 
72 h, a) EC50 biomass, b) 




c) 0.005 mg/L 
EFSA Conclusion, 20101 
DAR, 20069 
Aquatic plants 
Lemna gibba, 14 d, frond 
count, a) EC50, b) NOEC 
a)0.057 mg/L 
b) 0.0082 mg/L 




Chironomus riparius, 28 
d, NOEC 






6.2 Mammalian toxicology data 
Type of test Endpoint Value Reference 
Acute oral toxicity Rat, LD50 >5000 mg/kg bw/day EFSA Conclusion, 20101 
Chronic Rat, 2 years, NOAEL 0.36 mg/kg bw/day 
EFSA Conclusion, 
20101 
Chronic Mouse, 2 years, NOAEL 0.92 mg/kg bw/day EFSA Conclusion, 2010
1 
Chronic Dog, 2 years, NOAEL 1.2 mg/kg bw/day EFSA Conclusion, 2010
1 
Combined repeated 
dose and reproduction 
/ developmental 
screening 




Rat, NOAEL, parental and 
offspring toxicity 




Rat, NOAEL, reproductive 
toxicity 




6.3 PNEC derivation 
PNEC Endpoint Endpoint value AF PNEC value 
PNECfw 
Oncorhynchus mykiss, 
60 d, ELS NOEC 




Chironomus riparius, 28 
d, NOEC 
5 mg/L 100 b 0.05 mg/L 
PNECbiota,sec pois Rat, 2 years, NOAEL 0.36 mg/kg bw/day 30 c 0.24 mg/kg d 
PNECbiota, hh ADI 0.0036 mg/kg bw/day - 
0.22 mg/kg 
food e 
PNECdw, hh ADI 0.0036 mg/kg bw/day - 0.0126
 f 
a Three NOEC values (including algae). AF selected according to ECHA guidance and to TG n.27- CIS WFD, pg 38 
b Since just 1 NOEC value was available, used an AF of 100. Followed TG n.27- CIS WFD, pg. 96 
c AF selected based on the duration of the test of 2 y 
d The following steps were followed for PNECbiota,sec pois calculation: a) conversion of NOAEL (0.36 mg/kg bw/day) 
value into NOEC (7.2 mg/kg) by using the conversion factor of 20 (taken from TG n. 27- CIS WFD); b) Application of 
appropriate AForal (30) to the NOEC value (see Note c). 
e ADI value retrieved from EFSA Conclusion, 2010 used for PNEC calculation according to Equation E (see section 
3.3.4) 
f ADI value used in equation F as TLhh. See section 3.3.5 for calculation. 
 




RQbiota,sec pois 39.49 
RQbiota, hh 43.25 




1 EFSA Journal 2010; 8(2):1389, available at http://www.efsa.europa.eu/it/efsajournal/pub/1389.htm 
2 Technical Guidance for Deriving Environmental Quality Standards – Guidance Document No. 27 (2011) Common 
Implementation Strategy of the Water Framework Directive (2000/60/EC). Available at 
http://ec.europa.eu/environment/water/water-dangersub/lib_pri_substances.htm 
3 EU Pesticides Database http://ec.europa.eu/sanco_pesticides/public/?event=homepage 
4 NORMAN Database http://www.norman-network.net/?q=node/24 
5 IPCheM database at http://ipchem.jrc.ec.europa.eu/ 
6Italian Monitoring Programme (data provided directly to the JRC) 
7Irmer U, Rau F, Arle J, Claussen U, Mohaupt V. (2013) Ecological Environmental Quality Standards of “River Basin 
Specific Pollutants” in Surface Waters - Update and Development Analysis of a European Comparison between  
Member States. ECOSTAT- UBA report 
8 Contract No. 070311/2011/603663/ETU/D1 “Comparative Study of Pressures and Measures in the Major River 
Basin Management Plans' - Task 2c (Comparison of Specific Pollutants and EQS): Final Report”. WRc Ref: UC8981/1 
October 2012. Available at: 
http://ec.europa.eu/environment/archives/water/implrep2007/pdf/P_M%20Task%202c.pdf 




Tri-allate (CAS N. 2303-17-5)  
 
1. Substance identity 
EC name S-2,3,3-trichloroallyl diisopropylthiocarbamate 
EC number 218-962-7 
CAS number 2303-17-5 
Molecular formula C10H16Cl3NOS 





2. Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa) 0.012 EFSA conclusion, 2008 1 
Water solubility (mg/L) 4.1 EFSA conclusion, 2008 1 
logKow 4.06 EFSA conclusion, 2008 1 
 
 
3. Environmental fate 
Endpoint Value Source 
Sorption potential (Koc) 4301.4 EFSA conclusion, 2008 1 
DT50 water 103.8 d EFSA conclusion, 2008 1 
Biodegradability NRB EFSA conclusion, 2008 1 
Bioaccumulation (BCF) 1400 EFSA conclusion, 2008 1 
BMF 1 Default value, TG n. 27 - CIS WFD 2 
 
 
4. Environmental exposure assessment 
 Description Source 
Tonnes/year 10150  (year 2003) From previous prioritisation exercise 
Uses Herbicide (PPP)  
Spatial usage (by MS) AT, BE, CZ, FR, IE, IT, NL, UK  EU Pesticides DB 3 
Banned uses -  





4.1 Predicted Environmental Concentration 
PECfw (mg/L) 0.118 FOCUS Step 2 
PECsed (mg/kg dw) 2.56 FOCUS Step 2 
PECbiota (mg/kg) 165.2 




4.1.1 Comparison of FOCUS Pesticides models with ECETOC model 







Koc (L/kg) 1 
DT50 whole 
system (d) 1 
Winter cereals (for Step 
1 calculations, used 
Pome & Stone Fruits 
late, as reported in the 
EFSA Conclusion, 20081) 
1  2250 g/ha 4.1 4301.4 68.2 
FOCUS Step 2     
Same parameters and conditions as above, in addition to DT50soil 58.2 d 1, DT50water: 103.8 d 1, DT50sediment 
210.9 d 1, no crop interception 1. 
FOCUS Step 3 – SWASH Package 




Tier PECfw (mg/L) PECsed (mg/kg) 
ECETOC 0.19 86 
FOCUS Step 1 0.229 5.49 
FOCUS Step 2 0.118 2.56 





4.2 Measured Environmental Concentration 
n. of MS Source of monitoring data MEC values RBSP 
2 (FR, NL)  NORMAN DB, 2014 4  MEC95, whole: 0.1875 µg/L - 
 
 
5. P, B, T, C, M, R, ED properties 
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Tri-allate is unlikely to be genotoxic1. Tri-allate is unlikely to pose carcinogenic risk to humans1. No 
evidence of treatment-related oncogenicity was found in either rats, mice or hamsters1. No classification 
proposed for reproductive toxicity1. The substance is not readily biodegradable (P). It has a BCF value of 
14001. 
 
6. Hazard assessment 
6.1 Ecotoxicology data 
Trophic level Endpoint Value Reference 
Fish 
Oncorhynchus mykiss, 96 
h, LC50 
0.95 mg/L EFSA conclusion, 2008
1 
Fish 
Oncorhynchus mykiss, 88 
d , NOEC, growth 
0.038 mg/L EFSA conclusion, 2008
1 
Aquatic invertebrates 
Daphnia magna, 48 h, 
EC50 
0.091 mg/L EFSA conclusion, 2008
1 
Aquatic invertebrates 
Daphnia magna, 21 d, 
NOEC, reproduction 
0.013 mg/L EFSA conclusion, 20081 
Algae 
Pseudokirchneriella 
subcapitata, 96 h, 
measured 
concentrations, 
 a) EC50 biomass, b) 
NOEC biomass, c) EC50 
growth rate, d) NOEC 
growth rate 
a)0.013 mg/L 
b) 0.0034 mg/L 
c) 0.036 mg/L 
d) 0.0067 mg/L 
 
EFSA conclusion, 20081 
DAR, 2007 5 
Algae 
Anabaena flos-aquae, 96 
h, measured 
concentrations, a) NOEC 
growth rate, b) EC50 
growth rate;, c) NOEC 
biomass, d) EC50 biomass 
a) 1.6 mg/L 
b) >3.7 mg/L 
c) 1.6 mg/L 
d) 2.6 mg/L 
 
DAR, 2007 5 




Chironomus riparius, 28 
d, NOEC, EMERGENCE 




6.2 Mammalian toxicology data 
Type of test Endpoint Value Reference 




1100 mg/kg bw 
 
EFSA conclusion, 20081 





Short term oral toxicity 
Dog, 8-weeks capsule 
study, NOAEL 
12 mg/kg bw/day EFSA conclusion, 2008
1 
Short term oral 
toxicity 
Dog, 1-year capsule 
study, NOAEL 
2.5 mg/kg bw/day 
EFSA conclusion, 
20081 
Short term oral toxicity Mice, 8-weeks, NOAEL 11.5 mg/kg bw/day EFSA conclusion, 2008
1 
Short term oral toxicity Hamster, 90 d, NOAEL 43.2 mg/kg bw/day EFSA conclusion, 2008
1 
Chronic Rat, NOAEL, 2 years 2.5 mg/kg bw/day EFSA conclusion, 2008
1 
Chronic Mice, 2-year, NOAEL 12.4 mg/kg bw/day EFSA conclusion, 2008
1 
Chronic 
Hamster, 79-95 weeks, 
NOAEL 
16.2 mg/kg bw/day EFSA conclusion, 2008
1 
Reproductive toxicity NOAEL 7.7 mg/kg bw/day EFSA conclusion, 2008
1 






a)15 mg/kg bw/day 
b)5 mg/kg bw/day 
EFSA conclusion, 20081 




6.3 PNEC derivation 
PNEC Endpoint Endpoint value AF PNEC value 
PNECfw 
Pseudokirchneriella 
subcapitata, 96 h, 
NOEC5 
0.0067 mg/L 10 0.00067 mg/L a 
PNECsed - - -  0.145 mg/kg b 
PNECbiota,sec pois 
Rats, chronic toxicity, 
conversion factor 20, 
2 years, NOAEL 1 
2.5 mg/kg bw/day 30 1.67 mg/kg food c 
PNECbiota, hh ADI  0.025 mg/kg bw/day - 
1.522 mg/kg food 
d 
PNECdw, hh ADI 0.025 mg/kg bw/day - 0.088 mg/L e 
a Three NOEC values available from the three main trophic levels (fish, aquatic invertebrates, algae) 
b PNECsed calculated with the Equilibrium Partitioning Method, where Ksed-water= 108.34 m3m-3 (Eq. D), RHOsed= 1300 
kg m-3 (default value), Fsolidsed= 0.2 (default value), RHOsolid= 2500 kg m-3 (default value), Kpsed= 215.07 L/kg 
(calculated, Koc x Focsed), Koc= 4301.4 L/kg 1, Focsed= 0.05 kg kg-1 (default value). Conversion from wet weight to dry 
weight was done with eq. B (Section 3.3.2). 
c The AF of 30 was selected according to the duration test (2 years) (TG n. 27 - CIS WFD)2 The following steps were 
followed for PNECbiota,sec pois calculation: a) conversion of NOAEL (2.5 mg/kg bw/day) value into NOEC (50 mg/kg) by 
using the conversion factor of 20 (taken from TG n. 27- CIS WFD); b) Application of appropriate AForal (30) to the 
NOEC value (The AF of 30 was selected according to the duration test (2 years) (TG n. 27 - CIS WFD)4 
d ADI value retrieved from EFSA Conclusion, 2008 used for PNEC calculation according to Equation E (see section 
3.3.4) 
e ADI value used in equation F as TLhh. See section 3.3.5 for calculation. 
 






RQbiota,sec pois 99.12 
RQbiota, hh 108.56 




1 EFSA Scientific Report (2008) 181, 1-100 Conclusion on the peer review of tri-allate. Available at 
http://www.efsa.europa.eu/it/efsajournal/pub/181r.htm 
2 Technical Guidance for Deriving Environmental Quality Standards – Guidance Document No. 27 (2011) Common 
Implementation Strategy of the Water Framework Directive (2000/60/EC). Available at 
http://ec.europa.eu/environment/water/water-dangersub/lib_pri_substances.htm 
3 EU Pesticides Database http://ec.europa.eu/sanco_pesticides/public/?event=homepage 
4 NORMAN Database http://www.norman-network.net/?q=node/24 




Methiocarb (CAS N. 2032-65-7) 
1. Substance identity 
Chemical name (IUPAC) Mercaptodimethur/ 3,5-Dimethyl-4-methylthiophenyl N-methylcarbamate 
EC number 217-991-2 
CAS number 2032-65-7 
Molecular formula C11H15NO2S 




2. Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa) 1.5E-05  EFSA Conclusion, 20101 
Water solubility (mg/L) 27 EFSA Conclusion, 20101 
logKow 3.18 EFSA Conclusion, 20101 
 
3. Environmental fate 
Endpoint Value Source 
Hydrolysis (DT50) 9.1 d EFSA Conclusion, 20101 
Sorption potential (Koc ) Highest value: 1000 
Mean value: 660 (used for PEC 
calculation Step 2) 
EFSA Conclusion, 20101 
Biodegradability NRB EFSA Conclusion, 20101 
Bioaccumulation (BCF) 
75.86 
Source: Experimental value 
retrieved from VegaNIC vers. 1.0.8 
BMF 1 Default value, TG n. 27 - CIS WFD 2 
 
 
4. Environmental exposure assessment 
 Description Source 
Tonnes/year 
1500 (year 2000) 
From previous prioritisation 
exercise 
Uses Insecticide, Repellant (PPP)  
Spatial usage (by MS): Authorised in: AT, BE, BG, CY, CZ, DE, 
DK, EE, EL, ES, FI, FR, HU, IE, IT, LV, 
NL, PL, PT, RO, SI, SK, UK 






Regulation (EU) No 187/2014 4 
ERC code ERC8d  





4.1 Predicted Environmental Concentration 
PECfw (mg/L) 0.00395 FOCUS Step 2 
PECsed (mg/kg dw) 0.026 FOCUS Step 2 
PECbiota (mg/kg) 0.30 




4.1.1 Comparison of FOCUS Pesticides models with ECETOC model 
FOCUS Step 1  




Koc (L/kg) 1 DT50 (d) 1 
Maize 2150 (seed treatment) 27 660 (mean) 
15.3 d (whole 
system) 
FOCUS Step 2     
Same parameters and conditions as above, in addition to DT50soil 2.8 d 1, DT50water: 8.5 d 1, DT50sediment 20.1 d 
1, no crop interception (seed treatment) 1. 
 
Results 
Tier PECfw (mg/L) PECsed (mg/kg)  
ECETOC 0.044 4.54  
FOCUS Step 1 0.0266 0.176  
FOCUS Step 2 0.00395 0.026  
 
 
4.2 Measured Environmental Concentration 
n. of MS Source of monitoring data MEC values RBSP 
5 (FR, NL, UK, 
SE, IT) 
NORMAN DB, 2014 5 MEC95, whole: 0.0585 µg/L 
1 MS 9 
IPCheM 6 MEC95: 0.095 µg/L 
SE pesticide monitoring 
programme 7 
All values  < LOQ 
IT Monitoring Programme 8 MECsite: 0.02 µg/L 
 
5. P, B, T, C, M, R, ED properties 
Methiocarb is acutely very toxic by oral route and toxic after inhalation in rats1. Methiocarb was 
clastogenic in the chromosomal aberration assay in CHO cells but this was not confirmed in cytological 
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analysis in a micronucleus test1. There was no evidence of genotoxicity in other in vitro and in vivo 
studies1. There was no evidence of carcinogenicity in mice and rats1. Methiocarb did not affect 
reproductive and developmental parameters and did not show any potential to cause delayed 
neurotoxicity1. The substance is not readily biodegradable.It has a BCF that ranges from 60 to 90 in fish1. 
However, also a BCF experimental value of 75.86 L/kg was reported in the VEGA Nic software, and used 
for calculations. 
 
6. Hazard assessment 
 
6.1 Ecotoxicology data 
Trophic level Endpoint Value Reference 
Fish 
Lepomis macrochirus, 96 
h, LC50 
0.65 mg/L 
EFSA Conclusion, 20061 
DAR, 200410 
Fish 
Oncorhyncus mykiss, 56 d, 
NOEC 
0.05 mg/L 
EFSA Conclusion, 20061 
DAR, 200410 
Aquatic invertebrates 
Daphnia magna, 48 h, 
EC50 
0.0077 mg/L 
EFSA Conclusion, 20061 
DAR, 200410 
Aquatic invertebrates 








72 h,  a) EC50 growth rate, 
b) EC50 biomass, c) NOEC 
based on biomass 
a)2.2 mg/L 
b)0.82 mg/L 
c) 0.052 mg/L 
EFSA Conclusion, 20061 
DAR, 200410 
 
6.2 Mammalian toxicology data 
Type of test Endpoint Value Reference 
Acute oral toxicity Rat, LD50 
19 mg/kg bw (based on 
weight of evidence of 
published data with 
range of 13–135 mg/kg 
bw). 





Dog, 90 d, dietary 
study, NOAEL. Value 
also used for ADI 
calculation in the EFSA 
Conclusion. 
1.33 mg/kg bw/day 
EFSA Conclusion, 
20061 
Long term toxicity 
Dog, 2-year, dietary 
study, NOAEL 
2.2 mg/kg bw/day EFSA Conclusion, 2006
1 
Reproductive toxicity NOAEL 4.3 mg/kg bw/day EFSA Conclusion, 2006
1 
Developmental toxicity 
NOAEL, a) parental 
toxicity, b) 
developmental toxicity 
a)0.5 mg/kg bw/day 
b)10 mg/kg bw/day 





6.3 PNEC derivation 
PNEC Endpoint Endpoint value AF PNEC value 
PNECfw 
Daphnia magna, 21 d, 
NOEC 
0.0001 mg/L 10 a 
1.00E-05 
mg/L a 




Dog, 90 d, conversion 
factor 40, NOAEL 
1.33 mg/kg bw/day 90 
0.591 mg/kg 
food c 
PNECbiota, hh ADI 0.013 mg/kg bw/day - 
0.791 mg/kg 
food d 
PNECdw, hh ADI 0.013 mg/kg bw/day - 0.046 mg/L e 
a An AF of 10 was chosen based on the availability of three NOEC values from the three main trophic levels (fish, 
aquatic invertebrates, algae), according to TG n. 27- CIS WFD 
b Ksed-water= 25.8 m3m-3 (calculated with eq. D), RHOsed= 1300 kg m-3 (default value), Fsolidsed= 0.2 (default value), 
RHOsolid= 2500 kg m-3 (default value), Kpsed= 50 L/kg (calculated, Koc x Focsed), Koc= 1000 L/kg, Focsed= 0.05 kg kg-1 
(default value). Conversion from wet weight to dry weight was done with eq. B (Section 3.3.2). 
c The following steps were followed for PNECbiota,sec pois calculation: a) conversion of NOAEL (1.33 mg/kg bw/day) 
value into NOEC (53.2 mg/kg)  by using the conversion factor of 40 (taken from TG n. 27- CIS WFD); b) Application of 
appropriate AForal (90) to the NOEC value. The AF was selected according to the duration of the test (90 d) 
d ADI value retrieved from EFSA Conclusion, 2006 used for PNEC calculation according to Equation E (see section 
3.3.4) 
e ADI value used in equation F as TLhh. See section 3.3.5 for calculation. 
 




RQbiota,sec pois 0.51 
RQbiota, hh 0.38 
RQdw, hh 0.09 
 
8. References 
1 EFSA Scientific Report (2006) 79, 1-82, Conclusion on the peer review of methiocarb. Available at 
http://www.efsa.europa.eu/it/efsajournal/doc/79r.pdf 
2 Technical Guidance for Deriving Environmental Quality Standards – Guidance Document No. 27 (2011) Common 
Implementation Strategy of the Water Framework Directive (2000/60/EC). Available at 
http://ec.europa.eu/environment/water/water-dangersub/lib_pri_substances.htm 
3 European Pesticides Database: http://ec.europa.eu/sanco_pesticides/public/?event=homepage 
4 Commission Implementing Regulation (EU) No 187/2014 of 26 February 2014 amending Implementing Regulation 
(EU) No 540/2011 as regards the conditions of approval of the active substance methiocarb. Available at: 
http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32014R0187&from=EN 
5 NORMAN database at http://www.norman-network.net/?q=node/24 
6 IPCheM database at http://ipchem.jrc.ec.europa.eu/ 
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7 Swedish National Screening Programme Pesticides (data provided directly to the JRC) 
8 Italian Monitoring Programme (data provided directly to the JRC) 
9 Irmer U, Rau F, Arle J, Claussen U, Mohaupt V. (2013) Ecological Environmental Quality Standards of “River Basin 
Specific Pollutants” in Surface Waters - Update and Development Analysis of a European Comparison between  
Member States. ECOSTAT- UBA report 




2,6-di-tert-butyl-4-methylphenol (CAS N. 128-37-0)  
1. Substance identity 
EC name 2,6-di-tert-butyl-p-cresol 
EC number 204-881-4 
CAS number 128-37-0 
Molecular formula C15H24O 




2. Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa) 1.1 ECHA, 20131 
Water solubility (mg/L) 0.76 ECHA, 20131 
logKow 5.1 ECHA, 20131 
 
 
3. Environmental fate 
Endpoint Value Source 
Sorption potential (Koc) 8183 ECHA, 20131 
Biodegradability NRB ECHA, 20131 
Bioaccumulation (BCF) 2500 ECHA, 20131 
BMF 2 Default value, TG n. 27 - CIS WFD2 
 
 
4. Environmental exposure assessment 
 Description Source 
Tonnes/year 
A confidential and recent 




Industrial uses, use in plastics, 
rubber products, adhesives, 
coatings, dyes, fuel (biodiesel), 




and biocides, use as laboratory 
reagent. Used as antioxidant in 
food.  
Uses in Europe (UK 
communication): 
Stabiliser for rubber (largely 
during polymerisation) (50%) 
Stabiliser for oils, lubricants and 
fuels (25%) 
Stabiliser for plastics (10%) 
Food additive/others (15%) 
Spatial usage (by MS) Not known  
Banned uses -  
ERC code ERC8d  





4.1 Predicted Environmental Concentration 
PECfw (mg/L) 0.423 ECETOC 
PECsed (mg/kg dw) 367.64 ECETOC  
PECbiota (mg/kg) 2115 




4.2 Measured Environmental Concentration 
n. of MS Source of monitoring data MEC values RBSP 
Nonea - - - 
a Monitoring data was provided by SE but only regarding sewage treatment effluent and sludge 
 
5. P, B, T, C, M, R, ED properties 
IARC classification: group 3, as not classifiable as to its carcinogenicity to humans. There is limited 
evidence for the carcinogenicity of butylated hydroxytoluene in experimental animaIs.3  
Not genotoxic1. The substance is not readily biodegradable. The highest BCF value was of 2500 L/kg 
(ECHA, 20131). 
 
6. Hazard assessment 
6.1 Ecotoxicology data 
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Trophic level Endpoint Value Reference 
Fish Danio rerio, 96 h, LC0 ≥0.57 mg/L ECHA, 20131 
Aquatic invertebrates 
Daphnia magna, 48 h, 
EC50, mobility 
0.48 mg/L ECHA, 20131 
Aquatic invertebrates 
Daphnia magna, 21 d, 
NOEC, reproduction 
0.316 mg/L ECHA, 20131 
Algae 
Scenedesmus subspicatus, 
72 h, EC50, biomass and 
growth rate 
>0.4 mg/L ECHA, 20131 
 
6.2 Mammalian toxicology data 
Type of test Endpoint Value Reference 




Rat, oral, two-generation 
carcinogenicity study, 22 
months, NOAEL. The 
effect value was used for 
DMEL calculation in the 
ECHA report. 
25 mg/kg bw/day ECHA, 20131 
Repeated dose toxicity, 
carcinogenicity 
Rat, oral, two-generation 
carcinogenicity study, 22 
months, NOAEL 
100 mg/kg bw/day ECHA, 20131 
Reproductive toxicity 
Rat, oral, 22 months, 
NOAEL 
500 mg/kg bw/day ECHA, 20131 
Developmental toxicity 
Rat, oral, 22 months, 
NOAEL 
100 mg/kg bw/day ECHA, 20131 
 
6.3 PNEC derivation 
PNEC Endpoint Endpoint value AF PNEC value 
PNECfw 
Daphnia magna, 21 d, 
NOEC 
0.316 mg/L 100 a 3.16E-03 mg/L b 
PNECsed - - -  1.290 mg/kg dw c 
PNECbiota,sec pois -  - 30  16.7 mg/kg food d 
PNECbiota, hh DMEL  0.25 mg/kg bw/day - 
15.217 mg/kg 
food e 
PNECdw, hh DMEL  0.25 mg/kg bw/day - 0.875 mg/L f 
a One long term value from Daphnia magna was available. 
bIn IUCLID, three different PNECfw were reported. Two were calculated from QSAR estimations, and the third one was 
calculated from the same study on Daphnia magna, as reported in the table above, with the same AF.  
c Equilibrium partitioning method used in the ECHA dossier1. No new calculations were performed. 
d All values used were retrieved from ECHA dossier1 
e DMEL value, retrieved from ECHA, 20131,  used for PNEC calculation according to Equation E (see section 3.3.4) 








RQbiota,sec pois 126.65 
RQbiota, hh 138.99 
RQdw, hh 0.48 
 
8. References 
1ECHA Dissemination website:  http://apps.echa.europa.eu/registered/data/dossiers/DISS-9d82f461-e7b6-3a89-
e044-00144f67d249/AGGR-7097be3d-db74-4fb0-9968-20bfdf833cb2_DISS-9d82f461-e7b6-3a89-e044-
00144f67d249.html#AGGR-7097be3d-db74-4fb0-9968-20bfdf833cb2 
2 Technical Guidance for Deriving Environmental Quality Standards – Guidance Document No. 27 (2011) Common 
Implementation Strategy of the Water Framework Directive (2000/60/EC). Available at 
http://ec.europa.eu/environment/water/water-dangersub/lib_pri_substances.htm 
3 Complete IUCLID dossier of 2,6-di-tert-butyl-4-methylphenol 
4 Swedish National Screening Programme Pesticides (data provided directly to the JRC) 





Thiacloprid (CAS N. 111988-49-9)  
1. Substance identity 
EC name (Z)-3-(6-chloro-3-pyridylmethyl)-1,3-thiazolidin-2-ylidenecyanamide 
EC number  
CAS number 111988-49-9 
Molecular formula C10H9ClN4S 





2. Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa) 3 x 10-10 EU List of Endpoints (LoE), 20021 
Water solubility 
(mg/L) 
184 EU List of Endpoints (LoE), 20021 
logKow 1.26 EU List of Endpoints (LoE), 20021 
 
 
3. Environmental fate 
Endpoint Value Source 
DT50 (whole system) (d) 27 EU List of Endpoints (LoE), 20021 
Sorption potential (Koc) 615  EU List of Endpoints (LoE), 20021 
Biodegradability NRB  
Bioaccumulation (BCF) 3.15 EPI Suite, BCFBAF vers. 3.01 
BMF 1 Default value, TG n. 27 - CIS WFD2 
 
 
4. Environmental exposure assessment 
 Description Source 
Tonnes/year -  
Uses Insecticide (Biocide and PPP)  
Spatial usage (by MS) AT, BE, BG, CY, CZ, DE, DK, EE, EL, 
ES, FI, FR, HU, IE, IT, LT, LU, LV, 
MT, NL, PL, PT, RO, SE, SI, SK, UK  
EU Pesticides DB 3 
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Banned uses -  
ERC code ERC8d (N.R.)  
 
4.1 Predicted Environmental Concentration 
PECfw (mg/L) 0.0109 FOCUS Step 2 
PECsed (mg/kg dw) 0.042 (N.R.) FOCUS Step 2 
PECbiota (mg/kg) 0.034 (N.R.) 
Calculation based on Equation L 
(Section 3.4.3) 
N.R. Not required based on Koc and BCF values not reaching the trigger values required for sediment and biota 
assessment 
 
4.11 Comparison of FOCUS Pesticides models 







Koc (L/kg) 1 
DT50 whole 
system (d) 1 
Pome & Stone Fruits late 
2  180  
(14 d application interval 
full canopy) 
184 615 27 
FOCUS Step 2     
Same parameters and conditions as above, in addition to DT50soil 1.30 d 1, DT50water: 31 d 1, DT50sediment 62 d1 
FOCUS Step 3 – SWASH Package 
In addition to the input values listed above, it was considered an application window of 44 d (30+(n. of 
applications-1) x application interval)4 , with a foliar application and a pre-harvest interval (PHI) of 14 d. 
In accordance both with the FOCUS SW Appendix C and D5 and with the BBCH of 54-75 related to pome 
and stone fruits (as reported in the GAP table of the LoE, 20023). The following application windows were 
selected for the relevant crop scenarios for the PAT calculator: D3, D4, D5, R1, R2 from 18/06 to 31/07; 
R3 and R4 from 24/06 to 07/08. Just for the runs of D4 and D5 scenarios, no results were achieved due to 




Tier PECfw (mg/L) PECsed (mg/kg) 
FOCUS Step 1 0.085 0.457 
FOCUS Step 2 0.0109 0.042 
FOCUS Step 3 
0.0057 
 (R3 stream) 
0.004 (D3 pond) 
 
It is acknowledged that even though thiacloprid is used as PPP and biocide, the application rate approach 
is not suitable for the calculation of PEC values for biocides, but just for PPP, so the results could be an 
underestimation. However, the tonnage values related to the biocide use were not available and 






4.2 Measured Environmental Concentration 
n. of MS Source of monitoring data MEC values RBSP 
4(FI, SE, IT, NL) 
WATERBASE, 2014 6 All values < LOQ 
- 
SE pesticide monitoring 
programme 7 
MEC95: 0.116 µg/L 
IT Monitoring Programme 8 MEC95: 0.03 µg/L 
NORMAN DB, 20149 MEC95: 0.14 µg/L (NL) 
 
5 P, B, T, C, M, R, ED properties 
Increase in malignant uterine adenocarcinomas and thyroid adenomas in rats and ovarian luteomas in 
mice was observed for thiacloprid9. Tumours occur by a non-genotoxic mechanism and a threshold can be 
identified for the onset of tumours. Based on the T25 estimate of carcinogenic potency, thiacloprid is 
considered to be of medium potency within the EU. Classified as Carc Cat 3. (R40)9. Data indicate that 
thiacloprid is not mutagenic in vitro. In addition, a negative result was obtained in a standard in vivo 
micronucleus test. No classification was proposed for reproductive toxicity9. The substance is not readily 
biodegradable, however data presented in the Biocide Assessment Report show that thiacloprid did 
degrade reasonably rapidly in the aquatic environment with DT50 values of 31 and 62 d derived from an 
outdoor microcosm for the water and sediment compartments respectively. Thiacloprid has a low 
potential for bioconcentration with a mean measured log Pow = 1.26 (Biocide Assessment Report9). An 
estimated BCF value of 3.16 was provided by Episuite. Finally, according to the available data, the most 
sensitive chronic endpoint for thiacloprid is that derived for a 28 d Chironomus study (NOEC of 0.0005 
mg L-1). This means that the trigger of < 0.01 mg l-1 given in the TGD is exceeded and thiacloprid fulfils 
the toxic criterion9. 
 
6 Hazard assessment 
6.11 Ecotoxicology data 
Trophic level Endpoint Value Reference 
Fish 
Lepomis macrochirus, 96 
h, LC50 
25.2 mg/L Biocide Assessment 
Report, 20089 
Fish 
Oncorhyncus mykiss, 97 d, 






Daphnia magna, 48 h, 
immobility, EC50 
≥85.1 mg/L Biocide Assessment 
Report, 20089 
Aquatic invertebrates Daphnia magna, 48 h, 
immobility, EC50 
≥100 mg/L Biocide Assessment 
Report, 20089 





Aquatic invertebrates Hyalella azteca, 96 h, 
immobility, EC50 
≥47 mg/L Biocide Assessment 
Report, 20089 
Aquatic invertebrates Asellus aquaticus, 48h, 
mortality & immobility, 







Gammarus pulex, 48 h, 
mortality & immobility, 
EC50 
0.027 mg/L Biocide Assessment 
Report, 20089 
Aquatic invertebrates Ecydonurus pulex, 48 h, 
immobility, EC50 
0.0077 mg/L Biocide Assessment 
Report, 20089 
Aquatic invertebrates 
Daphnia magna, 21 d, 
survival, reproduction 
and growth, NOEC 




72 h, growth inhibition, 
a) NOEC, b) EC50 biomass, 







Lemna gibba, 15 d, 








28 d, a) NOEC number 
and time of emergence, 












study. Most sensitive 
group: Ceratopogonidae 
(insects), e.g. increase of 







6.12 Mammalian toxicology data 
Type of test Endpoint Value Reference 
Acute oral toxicity Rat, LD50 444 mg/kg 
Biocide Assessment 
Report, 20089 
Repeated oral dose 
toxicity 
Rat, 2 year, NOAEL. 
Values used for ADI 
calculation in the EU 





Rat, lowest dose with 
tumours 
25 mg/kg bw/day 
Biocide Assessment 
Report, 20089 











6.13 PNEC derivation 
PNEC Endpoint Endpoint value AF PNEC value 
PNECfw 
Chironomus riparius, 28 
d, NOEC a, number and 
0.0005 mg/L 10 b 5E-05 mg/L 9 
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time of emergence 
PNECsed - - - N.R. 
PNECbiota,sec pois - - - N.R. 
PNECbiota, hh - - - N.R. 
PNECdw, hh ADI c 
0.01 
mg/kg bw/day 
- 0.035 mg/L 
N.R. Not required based on Koc and BCF values not reaching the trigger values required for sediment and biota 
a Due to the mode of action of neonicotinoids, the lowest endpoint from the aquatic species tested corresponds to the 
midge Chironomus riparius. Therefore, it was selected for PNECfw calculation.  
b Three long term values were available. 
c ADI value, retrieved from EU Review Report 200310, used in equation F as TLhh. See section 3.3.5 for calculation. 
 




RQbiota,sec pois N.R. 
RQbiota, hh N.R. 
RQdw, hh 0.31 
 
8 References 
1 List of end points, 2002 (based on doc 1654/VI/94, Rev. 7, 22 Apr 1998) 
2 Technical Guidance for Deriving Environmental Quality Standards – Guidance Document No. 27 (2011) Common 
Implementation Strategy of the Water Framework Directive (2000/60/EC). Available at 
http://ec.europa.eu/environment/water/water-dangersub/lib_pri_substances.htm 
3 European Pesticides Database:  http://ec.europa.eu/sanco_pesticides/public/?event=homepage 
4 Generic guidance for FOCUS surface water scenarios 2011. Available at: http://focus.jrc.ec.europa.eu/sw/index.html 
5 Appendix C and D for parameterisation of drainage and run-off inputs, respectively. Available at: 
http://focus.jrc.ec.europa.eu/sw/index.html 
6 WATERBASE Database http://www.eea.europa.eu/data-and-maps/data/waterbase-rivers-6 
7 Swedish National Screening Programme Pesticides (data provided directly to the JRC) 
8 Italian Monitoring Programme (data provided directly to the JRC) 
9 Directive 98/8/EC concerning the placing of biocidal products on the market. Inclusion of active substances in 
Annex I or IA to Directive 98/8/EC. Assessment report, THIACLOPRID Product-type 8 (Wood Preservative) 2008. 
Available at: http://dissemination.echa.europa.eu/Biocides/factsheet?id=0053-08 





Aminotriazole (CAS N. 61-82-5)  
1. Substance identity 
Chemical name (IUPAC) 1H-1,2,4-Triazol-3-amine 
EC number 200-521-5 
CAS number 61-82-5 
Molecular formula C2H4N4 




2. Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa) 3.3E-05 INERIS, 2011 1 
Water solubility (mg/L) 2.6E+05 EC Review report, 2001 2 
logKow -0.97 INERIS, 2011 1 
 
 
3. Environmental fate 
Endpoint Value Source 
Hydrolysis (DT50) 86.1 EC Review report, 2001 2 
Sorption potential (Koc ) 94 EFSA conclusion, 2014 3 
Biodegradability NRB INERIS, 2011 1 
Bioaccumulation (BCF) 2.38 (whole fish) in 7 days EC Review report, 2001 2 
 
 
4. Environmental exposure assessment 
 Description Source 
Tonnes/year 22550  (year 1994) From previous prioritisation exercise 
Uses Herbicide (PPP)  
Spatial usage (by MS): BE, EL, ES, FR, HU, IT, LU, NL, PT, UK    EU Pesticides DB 4 
Banned uses -  
ERC code ERC8d  










FOCUS Step 2 (see Table below for 
details) 
PECsed (mg/kg dw) 0.459 (N.R.) FOCUS Step 2 
PECbiota (mg/kg) 
1.192 (N.R.) 
Calculation based on Equation L 
(Section 3.4.3) 
N.R. Not required based on Koc and BCF values not reaching the trigger values required for sediment and biota 
assessment 
 
4.1.1 Comparison of FOCUS Pesticides models with ECETOC model 







Koc (L/kg) 3 
DT50 whole 
system (d) 3 
Orchards (citrus fruits, 
pome and stone fruits, 
assorted fruits-edible or 
inedible peel, tree nuts). 
For calculations, use of 
pome and stone fruits 
(early) 
1 x 2977 g/ha 264000 94 86.1 
FOCUS Step 2     
Same parameters and conditions as above, in addition to DT50soil 7.4 d 3, DT50water: 86.1 d 3, DT50sediment 86.1 
d 3, no crop interception 3. 
FOCUS Step 3 – SWASH Package 
No new calculations were made, since PECfw and PECsed values were retrieved from EFSA Conclusion, 
2014 3. The worst case values were from orchards, Autumn application. 
 
Results 
Tier PECfw (mg/L) PECsed (mg/kg) 
ECETOC 0.73 9.27 
FOCUS Step 1 1.17 1.06 
FOCUS Step 2 0.501 0.459 
FOCUS Step 3 (D3 stream) 0.0176 0.0028 
 
 
4.2  Measured Environmental Concentration 
n. of MS Source of monitoring data MEC values RBSP 







5. P, B, T, C, M, R, ED properties 
Aminotriazole is classified, in accordance with the provisions of Regulation (EC) No 1272/2008, as toxic 
for reproduction category 2 and toxic effects were observed in endocrine organs3. It is also listed in the 
Endocrine Disruptor’s Database of the European Commission6 as an ED Category 1 (Cat. 1 Human Health, 
Cat. 3 Wildlife, Cat. 1 overall). No evidence of a genotoxic potential relevant to humans3. The substance is 
not readily biodegradable (P). It has a low BCF of 2.38 (not B) (EFSA conclusion, 2014)3. 
 
6. Hazard assessment 
6.1 Ecotoxicology data 
Trophic level Endpoint Value Reference 
Fish 
Oncorhyncus mykiss, 96 h, 
LC50 
>1000 mg/L EFSA Conclusion, 20143 
Fish 
Oncorhyncus mykiss, 21 d, 
NOEC 
100 mg/L EFSA Conclusion, 20143 
Fish 
Oncorhyncus mykiss, 96 h, 
LC50 
>22.15 mg/L EFSA Conclusion, 20143 
Aquatic invertebrate 
Daphnia magna, 48 h, 
EC50 
6.1 mg/l EFSA Conclusion, 20143 
Aquatic invertebrate 
Mysidopsis bahia, 96 h, 
EC50 
2.8 mg/l EFSA Conclusion, 20143 
Aquatic invertebrate 






Daphnia magna, 48 h, 
EC50 
2.66 mg/L EFSA Conclusion, 20143 
Algae 
Scenedesmus subspicatus, 
72 h, growth, EC50 
2.3 mg/L EFSA Conclusion, 20143 
Algae 
Anabaena flos-aquae. 120 
h, a) EC50 biomass, b) 
EC50 growth rate 
a)3.9 mg/L 
b)>4.8 mg/L 
EFSA Conclusion, 20143 
Algae 
Selenastrum 
capricornutum, 72 h 
growth, a) EC50 biomass, 
b) EC50 growth rate 
a)1.6 mg/L 
b)>5.1 mg/L 
EFSA Conclusion, 20143 
Algae 
Selenastrum 
capricornutum, 8 d, a) 




EFSA Conclusion, 20143 
Algae 
Navicula pelliculosa, 72 h, 




EFSA Conclusion, 20143 
Algae 
Selenastrum 
capricornutum, 72 h, a) 




EFSA Conclusion, 20143 
Algae 
Selenastrum 
capricornutum, 72 h, a) 








6.2 Mammalian toxicology data 
Type of test Endpoint Value Reference 
Acute oral toxicity Rat, LD50 >5000 mg/kg bw EFSA Conclusion, 20143 
Short term oral 
toxicity 
Rat, 90 d, NOAEL. Use 
for ADI calculation in 
the EFSA conclusion. 
0.1 mg/kg bw/day 
EFSA Conclusion, 
20143 
Short term oral toxicity Dog, 1 year, NOAEL 0.3 mg/kg bw/day EFSA Conclusion, 2014
3 
Long term toxicity Rat, 2 year, NOAEL 0.5 mg/kg bw/day EFSA Conclusion, 2014
3 
Long term toxicity Mice, 18 months, NOAEL 1.5 mg/kg bw/day EFSA Conclusion, 2014
3 
Long term toxicity 
Hamster, 18 months, 
NOAEL 
1 mg/kg bw/day EFSA Conclusion, 2014
3 
Reproductive toxicity 
Rat, 2 generation, 
NOAEL, a)parental 
toxicity, b) Reproductive 
toxicity, c) Offspring 
toxicity 
a)0.12 mg/kg bw/day 
b)0.9 mg/kg bw/day 
c)0.9 mg/kg bw/day 
EFSA Conclusion, 20143 




6.3 PNEC derivation 
PNEC Endpoint Endpoint value AF PNEC value 
PNECfw 
Daphnia magna, chronic 
study, 21 d, NOEC 
0.32 mg/L 10 0.032 mg/L a 
PNECsed - - - N.R. 
PNECbiota,sec pois - - - N.R. 
PNECbiota, hh - - - N.R. 
PNECdw, hh ADI b 0.001 mg/kg bw/day - 0.004 mg/L c 
N.R. Not required based on Koc and BCF values not reaching the trigger values required for sediment and biota 
assessment 
a An AF of 10 was chosen based on the availability of three NOEC values from the three main trophic levels (fish, 
aquatic invertebrates, algae). 
b ADI retrieved from the European review report (2001)  
c ADI value used in equation F as TLhh. See section 3.3.5 for calculation. 
 
 




RQbiota,sec pois N.R. 
RQbiota, hh N.R. 






1 INERIS Aminotriazole n. CAS: 61-82-5 (June, 2011). Available at: 
http://www.ineris.fr/substances/fr/substance/getDocument/3068 
2 EUROPEAN COMMISSION Review report for the active substance amitrole 6839/VI/97-final (2001). Available at 
http://ec.europa.eu/sanco_pesticides/public/?event=activesubstance.detail 
3 EFSA (European Food Safety Authority), 2014. Conclusion on the peer review of the pesticide risk assessment of the 
active substance amitrole. EFSA Journal 2014;12(7):3742, 84 pp. doi:10.2903/j.efsa.2014.3742 
4 EU Pesticides Database http://ec.europa.eu/sanco_pesticides/public/?event=homepage 
5 NORMAN database at http://www.norman-network.net/?q=node/24 







Clothianidin (CAS N. 210880-92-5)  
1. Substance identity 
EC number 433-460-1 
CAS number 210880-92-5 
Molecular formula C6H8Cl N5O2S 






2. Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa) 1.3E-10 Biocide Assessment Report, 20071 
Water solubility (mg/L) 327 Biocide Assessment Report, 20071 
logKow 0.7 Biocide Assessment Report, 20071 
 
3. Environmental fate 
Endpoint Value Source 
Sorption potential (Koc) 160 EU Review Report, 20052 
Biodegradability NRB Biocide Assessment Report, 20071 
Bioaccumulation (BCF) 
a) BCFfish  0.78 
b) BCF 3.16 (estimated)  
a) Biocide Assessment Report, 
20071 
b) EPI Suite, BCFBAF V3.013 
 
4. Environmental exposure assessment 
4.1 Predicted Environmental Concentration 
 Description Source 
Tonnes/year -  
Uses Insecticide (PPP and biocide)  
Spatial usage (by MS) 
AT, BE, BG, CZ, DE, DK, EL, ES, FI, 
FR, HU, IE, IT, LT, NL, PL, PT, RO, 
SK, UK  
EU Pesticides DB4 
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Banned uses Restriction of uses  EU n. 485/20135 
ERC code ERC8d (N.R.)  
PECfw (mg/L) 0.008 FOCUS Step 2 
PECsed (mg/kg dw) 0.014 (N.R.) FOCUS Step 2 
PECbiota (mg/kg) 0.025 (N.R.) 
Calculation based on Equation L 
(Section 3.4.3) 




4.1.1 Comparison of FOCUS Pesticides models 







Koc (L/kg) 2 
DT50 whole 
system (d) 2 
Sugar beet (seed 
treatment) 
1  78 327 160 64.8 
FOCUS Step 2     
Same parameters and conditions as above, in addition to DT50soil 274 d (geometric mean from field 
studies)1, DT50water: 64.8 d2, DT50sediment 1000 d (conservative value), no crop interception (seed 
treatment). The crop used is not listed in the restricted uses. 
FOCUS Step 3 – SWASH package 
Due the type of treatment, soil incorporation method was selected for all scenarios in SWASH and the 
chemical application method (CAM) was set to 8, “soil incorporation at one depth” with a depth of 3 cm 
for the PRZM scenarios, as specified in comments from a stakeholder. The definition of the application 
window was made by using the default application dates given by FOCUS SWASH, since the first useful 
date corresponded to a growth stage of zero, prior to the emergence date for each specific crop scenario 
(D3, D4, R1, R3). Since drift is assumed to be zero and surface runoff is assumed to be negligible due to 
the soil depth at which the seeds are drilled, only drainage scenarios were taken into account. Just for D4 




Tier PECfw (mg/L) PECsed (mg/kg) 
FOCUS Step 1 0.021 0.034 
FOCUS Step 2 0.008 0.014 





It is acknowledged that even though clothianidin is used as PPP and biocide, the application rate 
approach is not suitable for the calculation of PEC values for biocides, but just for PPP, so the results could 
be an underestimation. However, the tonnage values related to the biocide use were not available and 
therefore, no further calculation could be done.  
 
4.2 Measured Environmental Concentration 
 89 
 
n. of MS Source of monitoring data MEC values RBSP 
1 (SE) SE monitoring programme6 All value < LOQ  
 
 
5. P, B, T, C, M, R, ED properties 
Based on the results of in vitro and in vivo genotoxicity tests, clothianidin is unlikely to pose a genotoxic 
risk to humans7. Clothianidin is unlikely to pose a carcinogenic risk to humans, and is unlikely to pose a 
teratogenic risk to humans at doses below those inducing toxic effects in the mother7. Clothianidin is also 
unlikely to affect fertility and developmental parameters in humans at doses below a range that elicits 
other toxic effects in adults7. The substance is not readily biodegradable (P) 7. The low Pow indicates that 
clothianidin has low potential to bioaccumulate in organisms7. Both estimated bioconcentration factors 
for the aquatic (BCFfish = 0.78) and the terrestrial compartment (BCFearthworm = 0.9) can be classified as 
low. (Biocide Assessment Report, 20071). An estimated BCF value of 3.16 L/kg was retrieved from EPI 
Suite3. 
 
6. Hazard assessment 
6.1 Ecotoxicology data 
Trophic level Endpoint Value Reference 
Fish 
Oncorhyncus mykiss, 96 





Pimephales promelas, 33 
d, hatching, mortality 
and growth, NOEC 
≥20 mg/L Biocide Assessment 
Report, 20071 
Aquatic invertebrates 














capricornutum, 96 h, 
growth inhibition a) 

















Mesocosm study, 14 
weeks, NOEC 




6.2 Mammalian toxicology data 
Type of test Endpoint Value Reference 





repeated dose toxicity 




repeated dose toxicity 
Mouse, 90 d, mortality, 
NOEL 




Rat, 2 year, dermal, 
NOAEL. Value used for 
ADI calculation in the 
EU Review Report, 
20052. 
9.7 mg/kg bw/day 





Rat, NOAEL, a) parental, 
b) reproduction, c) 
offspring 
a)31 mg/kg bw/day 
b) 31 mg/kg bw/day 




Rabbit, NOAEL, a) 
maternal, b) foetal 
a)25 mg/kg bw/day 





6.3 PNEC derivation 
PNEC Endpoint Endpoint value AF PNEC value 
PNECfw 
Chironomus riparius, 28 
d, EC10 
0.00065 mg/L 5a 1.3E-04 mg/Lb 
PNECsed - - - N.R. 
PNECbiota,sec pois - - - N.R. 
PNECbiota, hh - - - N.R. 
PNECdw, hh ADI 0.097 mg/kg bw/day - 0.340 mg/Lc 
N.R. Not required based on Koc and BCF values not reaching the trigger values required for sediment and biota assessment 
a Due to the mode of action of neonicotinoids, the lowest endpoint from the aquatic species tested corresponds to the 
midge Chironomus riparius. Therefore, it was selected for PNECfw calculation. A lower AF of 5 was selected, due to the 
availability of the mesocosm study. The same PNEC value was used in the Biocide Assessment Report1. 
b Three long term values were available. 
c ADI value, retrieved from EU Review Report 20052, used in equation F as TLhh. See section 3.3.5 for calculation. 
 




RQbiota,sec pois N.R. 
RQbiota, hh N.R. 
RQdw, hh 0.02 
 
8. References 
1 Directive 98/8/EC concerning the placing of biocidal products on the market Inclusion of active substances in  
Annex I to Directive 98/8/EC Assessment Report CLOTHIANIDIN Product-Type 8 (Wood Preservative) 13 September 
2007 Annex I. Available at http://dissemination.echa.europa.eu/Biocides/factsheet?id=0015-08 




3 EPI Suite, BCFBAF v3.01 
4European Pesticides Database: http://ec.europa.eu/sanco_pesticides/public/?event=homepage 
5 the use as a seed treatment or soil treatment of plant protection products containing clothianidin is prohibited for 
crops attractive to bees and for cereals except for uses in greenhouses and for winter cereals. Foliar treatments with 
plant protection products containing clothianidin are prohibited for crops attractive to bees and for cereals with the 
exception of uses in greenhouses and uses after flowering, from COMMISSION IMPLEMENTING REGULATION (EU) 
No 485/2013 of 24 May 2013 amending Implementing Regulation (EU) No 540/2011, as regards the conditions of 
approval of the active substances clothianidin, thiamethoxam and imidacloprid, and prohibiting the use and sale of 
seeds treated with plant protection products containing those active substances. Available at http://eur-
lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32013R0485. 




Chromium trioxide (CAS N. 1333-82-0) 
1. Substance identity 
EC name  
EC number  
CAS number 1333-82-0 
Molecular formula CrO3 





2. Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa) 
Not available (inorganic ionic 
compound) 
EU-RAR, 20051 
Water solubility (mg/L) 1667 mg/L EU-RAR, 20051 
logKow 




3. Environmental fate 
Endpoint Value Source 
Sorption potential  
Koc   
Not available EU-RAR, 20051 
Partition coefficient solid-
water in sediment Kpsed (L/kg) 
1000 EU-RAR, 20051 
Biodegradability NRB EU-RAR, 20051 
Bioaccumulation (BCF) 2.8 EU-RAR, 20051 
 
4. Environmental exposure assessment 
4.1 Predicted Environmental Concentration 
 Description Source 
Tonnes/year - - 
Uses Manufacture of substances and of ECHA, 20132 
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preparations, formulation of preparations 
and materials, industrial use resulting in 
inclusion into or onto a matrix, use as 
laboratory reagent. 
Spatial usage (by MS) Not known - 
Banned uses 
All consumer uses, and all professional uses 
except as laboratory substance2. Chromium 
trioxide meets the criteria for inclusion in 
Annex XIV to Regulation (EC) N. 1906/20063. 
Furthermore, the latest application date 
expected for chromium trioxide is 21 March 
2016, and the sunset date is 21 September 
20174. 
ECHA, 20132  
Regulation (EC) N. 
1906/20063 
COMMISSION REGULATION 
(EU) No 348/20134 
ERC code - - 
PECfw (mg/L) 0.35 EU-RAR, 20051 
PECsed (mg/kg dw) 0.152 EU-RAR, 20051 
PECbiota (mg/kg) 0.98 (N.R.) 
Calculation based on 
Equation L (Section 3.4.3) 
N.R. Not required based on BCF value not reaching the trigger value required for biota assessment 
 
 
4.2 Measured Environmental Concentration 
n. of MS Source of monitoring data MEC values RBSP 
None - - - 
 
5. P, B, T, C, M, R, ED properties 
The evidence clearly indicates that highly water-soluble Cr(VI) compounds can produce significant  
mutagenic activity in vitro and in vivo1. The Cr (VI) compounds under consideration are therefore 
regarded as in vivo somatic cell mutagens1. In addition, toxicokinetic and dominant lethal data suggest 
that water-soluble Cr (VI) has the potential to be an in vivo germ cell mutagen1. Chrome plating workers 
exposed to chromium (VI) trioxide in aqueous solution have shown a clear excess in mortality from lung 
cancer1. Therefore chromium (VI) trioxide should be regarded as a human carcinogen1. Adverse effects on 
fertility have been found in studies in mice following repeated oral exposure1. In addition, adverse effects 
on the testes have been seen following repeated oral exposure in the rat (EU-RAR, 20051). The substance 
is not readily biodegradable (P). It shows a low potential to bioaccumulate in aquatic organism1. 
 
6. Hazard assessment 
6.1 Ecotoxicology data 
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Since chromium trioxide is recommended for deselection as candidate substance for the Watch List, 
because of the imminent ban (Last application date in 2016, sunset date 2017), no ecotoxicity data are 
reported at this stage. 
 
6.2 Mammalian toxicology data 
No mammalian toxicity data are reported at this stage due to imminent ban and deselection as Watch List 
candidate. 
 
6.3 PNEC derivation 
PNEC Endpoint Endpoint value AF PNEC value 
PNECfw HC5-50% 0.0102 mg/L 3 
3.40E-03 
mg/La 




Mouse, oral, conversion 
factor 8.3, NOAEL  








PNECdw, hh TDI 0.0009 mg/kg bw/day - 0.003 mg/Le 
N.R. Not required based on BCF value not reaching the trigger value required for biota assessment 
aNo new calculations were made. PNEC value retrieved from EU-RAR, 20051 with a probabilistic approach. 
b Equilibrium partitioning method used, with the following values: Ksed-water= 500 m3m-3 (from EU-RAR, 2005), 
RHOsed= 1300 kg m-3 (default value), Fsolidsed= 0.2 (default value), RHOsolid= 2500 kg m-3 (default value). Conversion 
from wet weight to dry weight was done with eq. B of section 3.3.2 
cNo new calculations were performed. Value retrieved from EU-RAR, 20051 
d TDI value, retrieved from WHO Report 20136,  used for PNEC calculation according to Equation E (see section 3.3.4) 
e TDI value used in equation F as TLhh. See section 3.3.5 for calculation. 
 




RQbiota,sec pois 0.058 
RQbiota, hh 17.89 




1European Risk Assessment Report on Chromium Trioxide, Sodium chromate, Sodium dichromate, Ammonium dichromate and 




2 ECHA dissemination website: http://apps.echa.europa.eu/registered/data/dossiers/DISS-9c7ac228-b090-229d-e044-
00144f67d249/DISS-9c7ac228-b090-229d-e044-00144f67d249_DISS-9c7ac228-b090-229d-e044-00144f67d249.html 
3 REGULATION (EC) No 1907/2006 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 18 December 2006, Official Journal 
of the European Union. Available at http://faolex.fao.org/docs/pdf/eur68317.pdf 
4 COMMISSION REGULATION (EU) No 348/2013 of 17 April 2013 amending Annex XIV to Regulation (EC) No 1907/2006 of the 
European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), 2013 
5 Technical Guidance for Deriving Environmental Quality Standards – Guidance Document No. 27 (2011) Common Implementation 
Strategy of the Water Framework Directive (2000/60/EC). Available at http://ec.europa.eu/environment/water/water-
dangersub/lib_pri_substances.htm 




Thiamethoxam (CAS N. 153719-23-4) 
1. Substance identity 
EC name Thiamethoxam 
EC number 428-650-4 
CAS number 153719-23-4 
Molecular formula C8H10ClN5O3S 






2. Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa) 6.6 E-09 Biocide Assessment Report1 
Water solubility (mg/L) 4100 Biocide Assessment Report1 
logKow -0.13 Biocide Assessment Report1 
 
 
3. Environmental fate 
Endpoint Value Source 
Sorption potential (Koc) 56.2 Biocide Assessment Report1 
Biodegradability NRB Biocide Assessment Report1 
Bioaccumulation (BCF) 3.16 (estimated) EPI Suite BCFBAF, v.3.01 
BMF 1 Default value, TG n. 27 - CIS WFD2 
 
4. Environmental exposure assessment 
 Description Source 
Tonnes/year   
Uses Insecticide (PPP and biocide)  
Spatial usage (by MS): AT, BE, BG, CY, CZ, DE, DK, EE, EL, ES, 
FI, FR, HU, IT, LT, LV, MT, NL, PL, PT, 
RO, SE, SI, SK, UK 
EU Pesticides DB3 
Banned uses Restriction of usesa  EU n. 485/20134 
ERC code ERC8d  
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aThe use as a seed treatment or soil treatment of plant protection products containing thiamethoxam is prohibited 
for crops attractive to bees and for cereals except for uses in greenhouses and for winter cereals. Foliar treatments 
with plant protection products containing thiamethoxam are prohibited for crops attractive to bees and for cereals 
with the exception of uses in greenhouses and uses after flowering4. 
 
4.1 Predicted Environmental cCncentration 
 Value Source 
PECfw (mg/L) 0.011 FOCUS Step 2 
PECsed (mg/kg dw) 0.0074 (N.R.) FOCUS Step 2 
PECbiota (mg/kg) 0.035 (N.R.) 
Calculation based on Equation L 
(Section 3.4.3) 
N.R. Not required based on Koc and BCF values not reaching the trigger values required for sediment and biota 
assessment 
 
4.1.1 Comparison between FOCUS Pesticides models 







Koc (L/kg) 5 
DT50 whole 
system (d)5 
Pome & Stone Fruits (late) 
2  100 
(14 d application 
interval) 
4100 56.2 46.4 
FOCUS Step 2     
Same parameters and conditions as above, in addition to DT50soil 156 d (mean)5, DT50water 38.2 d5, 
DT50sediment  1000 d (conservative value), full crop interception. 
FOCUS Step 3 – SWASH package 
In addition to the input values listed above, foliar application, and a pre-harvest interval (PHI) of 14 days. 
In accordance both with the FOCUS SW Appendix C and D6, and with a growth stage corresponding to post 
blosson (approximately BBCH 70) related to pome and stone fruits (as reported in the GAP table of the EU 
LoE5), the following application windows were selected for the relevant scenarios for the PAT calculator: 
D3 and D4 from 15.06 to 16.10, D5 from 15.06 to 26.09, R1 from 15.06 to 16.10, R2 from 15.07 to 16.09, 





    
Tier PECfw (mg/L) PECsed (mg/kg)   
FOCUS Step 1 0.071 0.048   
FOCUS Step 2 0.011 0.007   










4.2 Measured Environmental Concentration 
n. of MS Source of monitoring data MEC values RBSP 
4 (FI, SE, IT, NL) 
WATERBASE, 20147 MEC95, whole: 0.03 µg/L 
- 
SE pesticide monitoring 
programme 8 
MEC95: 0.014 µg/L 
IT monitoring programme9 MEC95: 0.0365 µg/L 
NORMAN DB, 201410 MEC95: 0.35 µg/L (NL) 
 
 
5. P, B, T, C, M, R, ED properties 
Thiamethoxam is not clastogenic or aneugenic1. On the basis of the absence of genotoxicity in vivo, the 
absence of carcinogenicity in rats and the mode of action by which liver tumours arise in mice, it was 
concluded that thiamethoxam is unlikely to pose a carcinogenic risk at human dietary exposure levels11. 
The Joint FAO/WHO Meeting concluded that thiamethoxam can cause fetotoxicity and skeletal anomalies 
(malformations and variants), but only at maternally toxic doses11. Thiamethoxam is not a neurotoxin in 
mammals at the tested dose levels, although it is a member of the neonicotinoid chemical class11. The 
substance is not readily biodegradable (P). It shows a low potential for bioaccumulation (not B) (Biocide 
Assessment Report, 20081). A BCF value of 3.16 L/kg was also estimated with EPI Suite. 
 
 
6. Hazard assessment 
6.1 Ecotoxicology data 
Trophic level Endpoint Value Reference 
Fish 96 h, LC50 >125 mg/L 
Biocide Assessment 
Report, 20081 
Fish 88 d, NOEC 20 mg/L 
Biocide Assessment 
Report, 20081 
Aquatic invertebrates Ostracoda, 48 h, EC50 0.18 mg/L 
Biocide Assessment 
Report, 20081 




Daphnia magna, 21 d, 
NOEC 
100 mg/L Biocide Assessment 
Report, 20081 
Aquatic invetebrates 
Lymnea stagnalis, 48 h, 
EC50 
100 mg/L Biocide Assessment 
Report, 20081 
























6.2 Mammalian toxicology data 
Type of test Endpoint Value Reference 
Acute oral toxicity Rat, LD50 1563 mg/kg bw 
Biocide Assessment 
Report, 20081 
Repeated oral dose 
toxicity 
Mouse, 90 d, NOAEL 1.41 mg/kg bw/day 
Biocide Assessment 
Report, 20081 
Repeated oral dose 
toxicity 




Mouse, 18 months, 
NOAEL. Value used for 
ADI calculation in the 
EU Review Report4 




Rat, 2 generation study, 
NOAEL 
62 mg/kg bw/day 
Biocide Assessment 
Report, 20081 





6.3 PNEC derivation 
PNEC Endpoint Endpoint value AF PNEC value 
PNECfw 
Cleon sp. 
(Ephemeroptera), 48 h, 
EC50 
0.014 mg/L 100 
0.00014 
mg/La 
PNECsed - - - N.R. 
PNECbiota,sec pois - - - N.R. 
PNECbiota, hh - - - N.R. 
PNECdw, hh ADIb 0.026 mg/kg bw/day - 0.091 mg/Lc 
N.R. Not required based on Koc and BCF value not reaching the trigger values required for sediment and biota 
assessment 
a Due to the mode of action of neonicotinoids, the lowest endpoint from the aquatic species tested corresponds to 
Cleon species. Therefore, it was selected for PNECfw calculation. An assessment factor of 100 was used instead of the 
TGD (Technical Guidance Document) recommended 1000 because this taxa was regarded with high probability as 
being the most sensitive and a further long-term NOEC from different taxonomic group would not be lower than the 
data already available (Biocide Assessment Report, 2008)1. 
b ADI from EU LoE, 20065.  
c ADI value used in equation F as TLhh. See section 3.3.5 for calculation. 
 
 




RQbiota,sec pois N.R. 
RQbiota, hh N.R. 
 100 
 




1 Assessment Report Thiamethoxam Product-type 8 (Wood preservative) (2008) - Directive 98/8/EC concerning the 
placing of biocidal products on the market Inclusion of active substances in Annex I or IA to Directive 98/8/EC 
2 Technical Guidance for Deriving Environmental Quality Standards – Guidance Document No. 27 (2011) Common 
Implementation Strategy of the Water Framework Directive (2000/60/EC). Available at 
http://ec.europa.eu/environment/water/water-dangersub/lib_pri_substances.htm 
3 EU Pesticides Database http://ec.europa.eu/sanco_pesticides/public/?event=homepage 
4 COMMISSION IMPLEMENTING REGULATION (EU) No 485/2013 of 24 May 2013 amending Implementing 
Regulation (EU) No 540/2011, as regards the conditions of approval of the active substances clothianidin, 
thiamethoxam and imidacloprid, and prohibiting the use and sale of seeds treated with plant protection products 
containing those active substances. Official Journal of the European Union. Available at http://eur-
lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32013R0485 
5 EUROPEAN COMMISSION Review report for the active substance thiamethoxam, SANCO/10390/2002 - rev. final. 
Available at http://ec.europa.eu/food/plant/protection/evaluation/newactive/thiamethoxam_en.pdf 
6 Appendix C and D for parameterisation of drainage and run-off inputs, respectively. Available at: 
http://focus.jrc.ec.europa.eu/sw/index.html 
7 WATERBASE Database http://www.eea.europa.eu/data-and-maps/data/waterbase-rivers-6 
8 Swedish National Screening Programme Pesticides (data provided directly to the JRC) 
9Italian Monitoring Programme (data provided directly to the JRC) 
10 NORMAN Database http://www.norman-network.net/?q=node/24 






2-Ethylhexyl 4-methoxycinnamate (CAS N. 5466-77-3)  
 
1. Substance identity 
Chemical name (IUPAC) 2-Ethylhexyl 4-methoxycinnamate 
EC number 226-775-7 
CAS number 5466-77-3 
Molecular formula C18H26O3 




2. Reasons for proposal as candidate for the Watch list and suspected environmental risk  
2-Ethylhexyl 4-methoxycinnamate (EHMC) is an organic sun-blocking agent derived from cinnamic acid 
that absorbs ultraviolet radiation in the UV-B range. It is used in sunscreen lotions to protect human skin 
from solar radiation, and to protect cosmetics and personal care products from photodegradation. 
It is part of the Draft Community Rolling Action Plan (CoRAP)1, where the initial grounds of concerned are 
listed as environment/suspected PBT, potential endocrine disruptor, possible risk; exposure/wide 
dispersive use, consumer use environmental exposure and high (aggregated) tonnage. 
UV filters may enter the aquatic environment directly, as a result of bathing and washing activities in seas, 
rivers, lakes and swimming pools, as well as industrial discharges. Alternatively, they can enter the 
aquatic environment indirectly via domestic wastewater discharges and via wastewater treatment plants 
(Giokas, 2007)2. The Cosmetics Directive 92/8/EEC restricts the use of EHMC at a maximum 
concentration of 10%3. 
EHMC is a ubiquitous sunscreen filter in European environment, having been detected in surface waters, 
sediment and biota4-10. Due to its physic-chemical properties, EHMC is expected to accumulate in 
sediments. This substance has been measured up to 4 μg/kg in river sediments5 and 34 μg/kg in lake 
sediments in Germany10 and 79 μg/kg in Tokyo bay sediments11. A seasonal variation in the 
concentrations of UV filters (including EHMC) in the aquatic environment has been observed in many 
cases with a peak during the summer period. 
 
3. Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa) 30 ECHA, 201412 
Water solubility (mg/L) 0.75 ECHA, 201412 




4. Environmental fate 
Endpoint Value Source 
Sorption potential (Koc ) 13290 ECHA, 201412 
Biodegradability RB ECHA, 201412 
Bioaccumulation (BCF) 433 ECHA, 201412 
BMF 1 Default value, TG n. 27 - CIS WFD13 
 
5. Environmental exposure assessment 
 
5.1 Predicted Environmental Concentration 
N.R. Not required because readily biodegradable. 
 
4.2 Measured Environmental Concentration 
n. of MS Source of monitoring data MEC values RBSP 
2(DE, SE) 
NORMAN DB, 2014 15  MEC95, whole: 3.98E-04 mg/L (DE) 
- 
 
SE National Screening 
Programme 2009: UV-filters4  
 
 
MEC95: 3.03E-05 mg/L (surface water) 
MEC95: 0.043 mg/kg dw (sediment) 
MEC95: 7.8E-04 mg/kg ww (biota) 
 
6. P, B, T, C, M, R, ED properties 
Endocrine disruptor-Category 1 both for human health and aquatic organisms16. In the latter case, an 
increase in plasma VTG + and increased mRNA expression levels of estrogen receptor (ER) alpha, among 
sex hormone receptors in the liver (Endocrine Disruptor database of the EU Commission)16.  
EHMC has been reported to display low but multiple hormonal activities in fish including vitellogenin 
induction, histological changes in gonads and effects on the expression of genes involved in different 
hormonal pathways in fathead minnows17. EHMC has also caused toxic effects on reproduction in snails18. 
 Description Source 
Tonnes/year 7500 (year 2000) Previous prioritisation exercise 
Uses Sunscreen ingredient in personal 
care products 
 
Spatial usage (by MS): Widespread use (worldwide) Sunscreen Ingredients, 200614 
Banned uses -  
ERC code ERC8a  




PECfw (mg/L) 0.0063 ECETOC 
PECsed (mg/kg dw) 8.39 ECETOC  
PECbiota (mg/kg) 2.73 (N.R.) 




Negative results for genotoxicity12. The substance is readily biodegradable (not P),. It has a BCF value of 
433 L/kg (ECHA, 201412). 
 
7. Hazard assessment 
7.1 Ecotoxicology data 
 
Trophic level Endpoint Value Reference 
Algae 
Selenastrum capricornutum, 
72 h, growth rate, EC50 
32 mg/L ECHA, 201412 
Algae 
Selenastrum capricornutum, 
72 h, growth rate, NOEC 
>100000 µg/L ECHA, 201412 
Aquatic 
invertebrates 
Melanoides tuberculata, 28 
d, number of embryos per 
snail, sediment toxicity 
test, NOEC 
2 mg/kg 





56 d, number of embryos 
per snail, sediment toxicity 
test, NOEC 





Daphnia magna, 48 h, EC50 >0.0271 mg/L ECHA, 201412 
Fish 
Danio rerio, 48 h, sediment 
contact test, sublethal 
effects, NOEC 
100 mg/kg 
Kaiser et al. (2012)18 
(R2) 
Fish Cyprinus carpio, 96 h, LC50 >100000 µg/L ECHA, 2014
12 
a Even though this value was lower, it was not selected for the risk assessment, because no dose-effect curve was 
seen, in contrast with the one chosen (in bold). 
(R2)  Relevance and reliability were assessed using a literature evaluation tool (LET) based on the CRED system 
(Kase et al, unpublished). Assessed to be reliable with restrictions (Klimisch score 2). 
 
7.2 Mammalian toxicology data 
Type of test Endpoint Value Reference 
Repeated dose toxicity 
Rat, oral, min 90 d, 
NOAEL 
450 mg/kg bw/day ECHA, 201412 
Reproductive toxicity 
Rat, oral, 2 generation 
study, NOAEL 
450 mg/kg bw/day ECHA, 201412 
Developmental toxicity Rabbit, oral, NOAEL 500 mg/kg bw/day ECHA, 201412 
 
 




AF PNEC value 
Comment 




tuberculata, 28 d, 
sediment toxicity 
2 mg/kg 10 b 0.2 mg/kg 




test, NOEC  
PNECbiota,sec 
pois 
N.R. - - - 
RB 
PNECbiota, hh N.R. - - - RB 
PNECdw, hh 
DNEL, repeated 











N.R. Not required because the substance is readily biodegradable. 
a The substance showed no inhibitory effect in the range of the water solubility (ECHA, 2014)12 
b Two long-term endpoints were available for two snail species Potamopyrgus antipodarum and Melanoides 
tuberculata at concentrations below water solubility. For P. antipodarum, although the NOEC was lower (0.08mg/kg), 
there was no clear dose response, and for this reason it was not selected. Additionally, for Chironomus riparius and 
Lumbriculus variegatus no effects were observed over 28 days for concentrations up to 50 mg/kg dw. Thus, there is 
data for three long-term tests with species representing different living and feeding conditions and an AF of 10 was 
selected. 
c DNEL, retrieved from ECHA, 201412, used in equation F as TLhh (see section 3.3.5) 
 




RQbiota,sec pois N.R. 
RQbiota, hh N.R. 
RQdw, hh 8E-04 
 
9. References 
1 ECHA Draft Community Rolling Action Plan (CoRAP) update for years 2015-2017. Available at: 
http://echa.europa.eu/documents/10162/13628/corap_2015_2017_en.pdf 
2 Giokas DL, Salvador A, Chisvert, A. (2007) UV filters: From sunscreens to human body and the environment. Trends 
in Analytical Chemistry, 26(5): 360-374. 
3 http://ec.europa.eu/consumers/cosmetics/cosing/index.cfm?fuseaction=search.details&id=31273 
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Dichlofluanid (CAS N. 1085-98-9)  
1. Substance identity 
EC name  
EC number 214-118-7 
CAS number 1085-98-9 
Molecular formula C9H11Cl2FN2O2S2 





2. Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa) 2.15E-05 Pa at 20 °C Biocide Assessment Report, 20061 
Water solubility (mg/L) 1.58 mg/l at 20 °C Biocide Assessment Report, 20061 
logKow 3.5 Biocide Assessment Report, 20061 
 
3. Environmental fate 
Endpoint Value Source 
Sorption potential (Koc) 1344 Biocide Assessment Report, 20061 
Biodegradability NRB Biocide Assessment Report, 20061 
Bioaccumulation (BCF) 72 Biocide Assessment Report, 20061 
DT50 water/sediment 
systems 
< 1 d  
Dichlofluanid was very rapidly 
degraded in aerobic aquatic 
systems to DMSA. DMSA stayed 
mainly in the water phase.  
Biocide Assessment Report, 20061 
BMF 1 Default value, TG n. 27 - CIS WFD2 
 
4. Environmental exposure assessment 
4.1 Predicted Environmental Concentration 
 Description Source 
Tonnes/year 10000 (year 1997) From previous prioritization exercise 
Uses Wood preservative (Biocide)  
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Spatial usage (by MS): Not known  
Banned uses 
Fungicide- PPP 
(Commission Regulation (EC) No 
2076/2002)3 
ERC code ERC8b  




PECfw (mg/L) 0.0053 ECETOC 
PECsed (mg/kg dw) 0.732 ECETOC 
PECbiota (mg/kg) 0.38 




4.1.1 ECETOC simulation with lower tonnages 
Authorisations for plant protection products containing the active substance dichlofluanid were 
withdrawn by 25 July 20033. However, the available tonnage of 10000 relates to the year 1997, which is 
prior to the banning of the substance as PPP.  
At the WG Chem meeting 16-17/10/2014 it was suggested to perform a simulation on the PEC calculated 
with ECETOC using reduced tonnage values of dichlofluanid that could be closer to the actual tonnage 
after the banning, i.e. related to the use as biocide only. Since no tonnage value specific for this particular 
use was available, it was decided to perform the simulation considering a 20%, and 30% or 50% decrease 
in tonnage values. The results of the simulations are compared with the pre-banning tonnage scenario in 
the following Table. 
 
Tonnes/year 10000 8000 7000 5000 
Decrease respective to 
pre-banning tonnage 
- 20% 30% 50% 
PECsed (mg/kg dw) 0.732 0.586 0.513 0.366 
RQsed 40.17 32.14 28.14 20.07 
Position in the ranking 
(higher RQ) 
16 (RQsed) 16 (RQsed) 17 (RQsed) 19 (RQsed) 
 
 
4.2 Measured Environmental Concentration 
n. of MS Source of monitoring data MEC values RBSP 
3 (FR, FI, IT) 
NORMAN DB, 20144 
MECsite: 0.03 µg/L 
MECsed: < LOD 
- WATERBASE, 20145 Values below LOQ 
Italian Monitoring 
Programme6 





5. P, B, T, C, M, R, ED properties 
Following repeated oral administration of dichlofluanid, the most prominent finding was fluorosis caused 
by the release of fluoride from the dichlofluanid molecule during its metabolism1. This resulted in skeletal 
osteosclerosis, observed in lifetime dietary studies in both rats and mice1. Chronic nephropathy was also 
observed following repeated oral administration, but in dogs only1. The mode of action for the 
nephropathy is uncertain and possible explanations include direct nephrotoxicity of the active substance 
or a secondary consequence of elevated systemic fluoride levels1. Dichlofluanid is not genotoxic in vivo1. 
In terms of carcinogenicity, dichlofluanid induced thyroid tumours in rats at high doses, but by a 
mechanism not considered to be relevant for human health1. No increase in tumour incidence was 
observed in mice. Overall, dichlofluanid does not show any carcinogenic potential of relevance to human 
health1. In experimental animal studies dichlofluanid did not affect fertility and did not cause 
developmental toxicity1. The evidence suggests that this substance does not possess significant potential 
with respect to toxicity for reproduction1. 
The substance is not readily biodegradable (P). It has a low BCF of 72 L/kg (not B) 1. 
 
6. Hazard assessment 
6.1 Ecotoxicology data 
Trophic level Endpoint Value Reference 
Fish 










Fish Pimephales promelas, 33 




















subspicatus, 96 h, growth 







6.2 Mammalian toxicology data 
Type of test Endpoint Value Reference 
Acute oral toxicity Rat, LD50 >5000 mg/kg 
Biocide Assessment 
Report, 20061 
Repeated dose toxicity 









Dog, 365 d, NOAEL, 















6.3 PNEC derivation 
PNEC Endpoint Endpoint value AF PNEC value 
PNECfw 
Daphnia magna, 21 d, 
reproduction, NOEC 
0.00265 mg/L 10a 
2.65E-04 
mg/L 




Dog, repeated dose 
toxicity, 365 d, oral, 
conversion factor 40, 
NOAEL 
2.5 mg/kg bw/day 30c 
3.3 mg/kg 
foodd 
PNECbiota, hh ADI 0.35mg/kg bw/day - 
21.304 mg/kg 
foode 
PNECdw, hh ADI 0.35mg/kg bw/day - 1.225 mg/Lf 
aThree long term values available from the three main trophic levels. 
bEquilibrium partitioning method used for PNECsed calculation, with the following values: Ksed-water= 34.4 m3m-3 
(calculated with eq. D of section 3.3.2), RHOsed= 1300 kg m-3 (default value), Fsolidsed= 0.2 (default value), RHOsolid= 
2500 kg m-3 (default value), Kpsed= 67.2 L/kg (calculated, Koc x Focsed), Koc= 1344 L/kg4, Focsed= 0.05 kg kg-1 (default 
value). Conversion from wet weight to dry weight was done with eq. B of section 3.3.2. 
cThe AF of 30 was selected according to the duration of the test (365 days). See TG n. 27- CIS WFD2 
d The following steps were followed for PNECbiota,sec pois calculation: a) conversion of the NOAEL (2.5 mg/kg bw/day) 
value retrieved from the Biocide Assessment Report (2006)1, into NOEC (100 mg/kg)  by using the conversion factor 
of 40 (taken from TG n. 27- CIS WFD, and it depends both on species tested and age/study); b) Application of 
appropriate AForal (30) to the NOEC value. 
e ADI value retrieved from Biocide Assessment Report (2006) 1,  used for PNEC calculation according to Equation E 
(see section 3.3.4) 
f ADI value used in equation F as TLhh. See section 3.3.5 for calculation. 
 
 




RQbiota,sec pois 0.11 
RQbiota, hh 0.02 






1 Directive 98/8/EC concerning the placing of biocidal products on the market - Inclusion of active substances in 
Annex I to Directive 98/8/EC. Assessment Report, DICHLOFLUANID PT8 (2006). Available at 
http://dissemination.echa.europa.eu/Biocides/factsheet?id=0025-08 
2 Technical Guidance for Deriving Environmental Quality Standards – Guidance Document No. 27 (2011) 
Common Implementation Strategy of the Water Framework Directive (2000/60/EC). Available at 
http://ec.europa.eu/environment/water/water-dangersub/lib_pri_substances.htm 
3 COMMISSION REGULATION (EC) No 2076/2002 of 20 November 2002 extending the time period referred to in 
Article 8(2) of Council Directive 91/414/EEC and concerning the non-inclusion of certain active substances in Annex 
I to that Directive and the withdrawal of authorisations for plant protection products containing these substances. 
Available at http://ec.europa.eu/sanco_pesticides/public/?event=activesubstance.detail 
4NORMAN database at http://www.norman-network.net/?q=node/24 
5WATERBASE Database http://www.eea.europa.eu/data-and-maps/data/waterbase-rivers-6 





Formaldehyde (CAS N. 50-00-0)  
1. Substance identity 
EC name Formaldehyde 
EC number 200-001-8 
CAS number 50-00-0 
Molecular formula CH2O 





2. Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa) 131.87 Pa ECHA, 20141 
Water solubility (mg/L) 550000 ECHA, 20141 
logKow 0.35 ECHA, 20141 
 
 
3. Environmental fate 
Endpoint Value Source 
Sorption potential (Koc) 15.9 ECHA, 20141 
Biodegradability RB ECHA, 20141 
Bioaccumulation (BCF) <1 ECHA, 20141 
 
 
4. Environmental exposure assessment 
4.1 Predicted Environmental Concentration 
 Description Source 
Tonnes/year 




Manufacture of substances, formulation in 
preparations and in materials, such as wood-
based materials, paper, impregnated paper, 




particulates, rubber, leather foam, 
firelighters, fertilized granules, cleaning 
agents (ECHA, 2014)1. 
Spatial usage (by MS) Not known  
Banned uses 
As biocide (PT1 Human hygiene, PT4 Food 
and feed area, PT5 Disinfection of Drinking 
water, PT6 Preservatives for products during 
storage, PT9 Fibre, leather, rubber and 
polymerised materials preservatives, PT11 
Preservatives for liquid-cooling and 
processing systems, PT12 Slimicides, PT13 
Working or cutting fluid preservatives, PT18 
Insecticides, acaricides and products to 
control other arthropods, PT21 Antifouling 
products, PT23 Control of other vertebrates)  
Consolidated list of non-
inclusion decisions, 20133 
ERC code ERC8d  
Fraction of tonnage to 
region 
0.1  
PECfw (mg/L) 13.53 ECETOC 
PECsed (mg/kg dw) 70.2 (N.R.) ECETOC 
PECbiota (mg/kg) 13.53 (N.R.) 
Calculation based on Equation 
L (Section 3.4.3) 




4.2 Measured Environmental Concentration 
n. of MS Source of monitoring data MEC values RBSP 
3 (FR, UK, 
SK) 
NORMAN DB, 20144 MEC95, whole: 7.165 µg/L 
3 MS7 
EQS set (WRc, 2012)8 
WATERBASE, 20145 MEC95, whole: 22.75 µg/L 
IPCheM6 MEC95: 119.75 µg/L 
 
5. P, B, T, C, M, R, ED properties 
In the ECHA dissemination website, formaldehyde is classified as: Carc. 2 H351: Suspected of causing 
cancer <state route of exposure if it is conclusively proven that no other routs of exposure cause the 
hazard> Route of exposure: inhalation (ECHA, 20141). 
Potential mechanisms underlying formaldehyde-induced reproductive and developmental toxicities, 
including chromosome and DNA damage (genotoxicity), oxidative stress, altered level and/or function of 
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enzymes, hormones and proteins, apoptosis, toxicogenomic and epigenomic effects (such as DNA 
methylation), were identified (Duong A. et al.9). 
Formaldehyde is not persistent, and not bioaccumulative (BCF < 1) (ECHA, 20141). 
 
6. Hazard assessment 
6.1 Ecotoxicology data 
Trophic level Endpoint Value Reference 
Fish Morone saxatilis, 96 h, LC50 6.7 mg/L ECHA, 2014
1  
Fish Rasbora heteromorpha, LC50, 48 h 50 mg/L ECHA, 2014
1  
Fish Ictalurus punctatus, LC50, 96 h 25.5 mg/L ECHA, 2014
1  
Fish Ictalurus melas, LC50, 96 h 25 mg/L ECHA, 2014
1  
Fish Leuciscus idus melanotus, LC50, 48h 15 mg/L ECHA, 2014
1  
Fish Pimephales promelas, LC50, 96 h 24.1 mg/L ECHA, 2014
1  
Fish Danio rerio, LC50, 96 h 41 mg/L ECHA, 2014
1  
Fish 
Oryzias latipes, NOEC, 28 d, mortality, 
target organ pathologies 
≥48 mg/L ECHA, 20141  
Fish 
Danio rerio, 144 h, LC50, Mortality of 
embryos/larvae 
6.9 mg/L ECHA, 20141  
Aquatic invertebrates 




ECHA, 20141  
Aquatic invertebrates Pinctada fucata martensii 96 h, LC50  5.3 mg/L ECHA, 2014
1  
Aquatic invertebrates Ceriodaphnia cf. dubia, 48 h, mobility, EC50 12.98 mg/L ECHA, 2014
1  
Aquatic invertebrates Daphnia magna, 24 h, LC50 52 mg/L ECHA, 2014
1  
Aquatic invertebrates Streptocephalus seali, EC10 25 mg/L ECHA, 2014
1  
Aquatic invertebrates Daphnia magna,48 h, EC50 29 mg/L ECHA, 2014
1  
Aquatic invertebrates Daphnia magna, 24h, EC50 14.7 mg/L ECHA, 2014
1  
Algae Scenedesmus subspicatus, 72 h, a) EC50 
biomass, b) EC50 growth rate 
a)3.48 mg/L 
b)4.89 mg/L 
ECHA, 20141  
Algae 
Pseudokirchnerella subcapitata, 48 h, a) 




ECHA, 20141  
Studies assigned as not reliable, or not assignable in the ECHA, 20131 were not reported. 
 
 
6.2 Mammalian toxicology data 
Type of test Endpoint Value Reference 
Acute oral toxicity 
(weight of evidence) 
Rat, LD50 460 mg/kg bw ECHA, 2014
1  
Acute oral toxicity 
(weight of evidence) 
Rat, LD50 800 mg/kg bw ECHA, 2014
1  
Repeated oral toxicity 
Rat, oral drinking water, 
105 weeks, NOAEL 
15 mg/kg bw/day ECHA, 2014
1  
Carcinogenicity 
Rat, oral, 13 weeks, 1) 















ECHA, 20141  
Carcinogenicity 
Rat, oral drinking water, 
32 weeks non-effective 
dose level for promoting 
activity 
5000 mg/L drinking 
water 
ECHA, 20141  
Reproductive toxicity 
Mouse, oral, a) NOAEL, b) 
LOAEL maternal toxicity 
a)185 mg/kg bw/day 
b)74 mg/kg bw/day 
ECHA, 20141  
 
 
6.3 PNEC derivation 
PNEC Endpoint Endpoint value AF PNEC value 
PNECfw - - 10a 0.47mg/Lb 
PNECsed - - - 
2.440 mg/kg 
dwc (N.R.) 
PNECbiota,sec pois - - - N.R. 
PNECbiota, hh - - - N.R. 
PNECdw, hh TDI 0.15 mg/kg bw - 0.525 mg/Ld 
N.R. Not required based on Koc and BCF values not reaching the trigger values required for sediment and biota assessment 
a The AF was reported in the ECHA dossier, 20141 
b In the ECHA report, the PNEC value was estimated with a probabilistic approach. No new calculations were 
performed. 
c No new calculations were done, because value was retrieved from ECHA, 20141. The equilibrium partitioning 
method was used in the dossier. 
d TDI value, retrieved from EFSA opinion, 200611, was used in equation F as TLhh. See section 3.3.5 for calculation. 
 




RQbiota,sec pois N.R. 
RQbiota, hh N.R. 
RQdw, hh 25.77 
 
8. References 
1 ECHA dissemination website: http://apps.echa.europa.eu/registered/data/dossiers/DISS-9daa7594-c409-0ed0-
e044-00144f67d249/DISS-9daa7594-c409-0ed0-e044-00144f67d249_DISS-9daa7594-c409-0ed0-e044-
00144f67d249.html 
2 Complete IUCLID dossier of formaldehyde. 
3 Existing active substances for which a decision of non-inclusion into Annex I or Ia of Directive 98/8/EC has been 
adopted - In accordance with Article 4(2) of Regulation (EC) No 2032/2003, biocidal products containing active 
substances for which a non-inclusion decision was taken shall be removed from the market within 12 months of the 
entering into force of such decision; unless otherwise stipulated in that non-inclusion decision-Dates by which 
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products containing these active substances shall no longer be placed on the market for the relevant product-types 
(February 2013). Available at: http://ec.europa.eu/environment/chemicals/biocides/pdf/list_dates_product_2.pdf 
4 NORMAN database at http://www.norman-network.net/?q=node/24 
5 WATERBASE Database http://www.eea.europa.eu/data-and-maps/data/waterbase-rivers-6 
6 IPCheM database at http://ipchem.jrc.ec.europa.eu/ 
7 Irmer U, Rau F, Arle J, Claussen U, Mohaupt V. (2013) Ecological Environmental Quality Standards of “River Basin 
Specific Pollutants” in Surface Waters - Update and Development Analysis of a European Comparison between 
Member States. ECOSTAT- UBA report. 
8 Contract No. 070311/2011/603663/ETU/D1 “Comparative Study of Pressures and Measures in the Major River 
Basin Management Plans' - Task 2c (Comparison of Specific Pollutants and EQS): Final Report”. WRc Ref: UC8981/1 
October 2012.  
Available at http://ec.europa.eu/environment/archives/water/implrep2007/pdf/P_M%20Task%202c.pdf 
9 Reproductive and Developmental Toxicity of Formaldehyde: A Systematic Review by Anh Duong, Craig Steinmaus, 
Cliona M. McHale, Charles P. Vaughan, and Luoping Zhanga. Available at 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203331/). 
10 Technical Guidance for Deriving Environmental Quality Standards – Guidance Document No. 27 (2011) Common 
Implementation Strategy of the Water Framework Directive (2000/60/EC). Available at 
http://ec.europa.eu/environment/water/water-dangersub/lib_pri_substances.htm 
11 EFSA Journal (2006) 415, 1-10. Opinion of the Scientific Panel on food additives, flavourings, processing aids and 
materials in contact with food (AFC) on a request from the Commission related to Use of formaldehyde as a 





Dimethenamid-P (CAS N. 163515-14-8)  





EC number  
CAS number 163515-14-8 
Molecular formula C12H18ClNO2S 





2. Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa)  2.5 · 10-3 EC Review, 2001 1 
Water solubility 
(mg/L) 
1449 EC Review, 2001 1 
logKow 1.89 EC Review, 2001 1 
 
 
3. Environmental fate 
Endpoint Value Source 
Hydrolysis (DT50) 33.40 d EC Review, 2001 1 
Sorption potential (Koc) 170.16 INERIS, 2011 2 
Biodegradability NRB Consensus between EPISUITE 
(Biowin), ADMET Predictor v.7 
Bioaccumulation (BCF) 58 CLP Report, 20133 
 
 
4. Environmental exposure assessment 
 Description Source 
Tonnes/year -  
Uses Herbicide  
Spatial usage (by MS) AT, BE, BG, CZ, DE, EL, ES, FR, HU, IE, IT, 
LU, NL, PL, PT, RO, SI, SK, UK 
EU Pesticides DB 4 
Banned uses Dimethenamid banned as Herbicide, PPP 
Replaced as herbicide by its active isomer, 




Crop Maize  
Application rate 
(g/ha) 
1  864 a 
Stakeholder’s comment (BASF) 
a New maximum application rates have been reported by the stakeholder (up to 0.864 kg a.s./ha), based on recent 
authorization conditions for dimethenamid-P, which will decrease the PEC estimated using the FOCUS Step models 
based on the previous application rate of  1  1000 g/ha (EC Review, 2001) 1. 
 
4.1 Predicted Environmental Concentration 
PECfw (mg/L) 0.0657 FOCUS Step 2 
PECsed (mg/kg dw) 0.109 FOCUS Step 2 
PECbiota (mg/kg) 3.81 




4.1.1 Comparison of FOCUS Pesticides models with ECETOC model 







Koc (L/kg) 1 
DT50 whole 
system (d) 1 
Maize 1  864 g/ha 1449 170.16 33.16 
FOCUS Step 2     
Same parameters and conditions as above, in addition to DT50soil 16.3 d 1, DT50water: 28 d 1, DT50sediment 33 d 
1, Minimal crop interception 1. 
 
Results 
Tier PECfw (mg/L) PECsed (mg/kg) 
FOCUS Step 1 0.243 0.402 
FOCUS Step 2 0.0656 0.109 
 
4.2 Measured Environmental Concentration 
n. of MS Source of monitoring data MEC values RBSP 
5 (IT, FR, 
DE, LU, NL) 
IPCheM6 
MEC95: 0.072 µg/L (dimethenamid) 
MECsite: 0.01 µg/L (dimethenamid-P) 
- 
NORMAN DB7 MECwhole: 0.2 µg/L  (dimethenamid) 
WATERBASE, 20148 MECsite: 0.012 µg/L (dimethenamid) 
IT monitoring programme9 
MEC95: 0.524 µg/L (dimethenamid, IT) 
MEC95: 0.1315 µg/L (dimethenamid-P, IT) 
 
5. P, B, T, C, M, R, ED properties 
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Results from genotoxicity studies do not indicate that dimethenamid-P or racemic dimethenamid possess 
a genotoxic potential3. No evidence of a carcinogenic potential in rats and mice could be established3. 
Dimethenamid-P does not show any adverse effects on sexual function and fertility in adult males and 
females or developmental toxicity in the offspring. Dimethenamid-P has not to be classified as 
reproductive toxicant3. Dimethenamid-P is considered not readily/ rapidly biodegradable (a degradation 
> 70 % within 28 days) for purposes of classification and labelling. Dimethenamid-P has a log Kow of 
1.893. The experimentally derived steady state BCF value of 58 L/kg ww (without lipid normalization) is 
below the trigger of 100 (criterion for bioaccumulating potential conform Directive 67/548/EEC) and is 
also below the trigger of 500 criterion for bioaccumulating potential conform Regulation EC 
1272/2008).3 
 
6. Hazard assessment 
6.1 Ecotoxicology data 
Trophic level Endpoint Value Reference 
Fish Oncorhyncus mykiss, 96 h, LC50 6.3 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Fish 
Lepomis macrochirus, 96 h, 
LC50 
10.4 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Fish 
Cyprinodon variegatus, 96 h, 
LC50 
12 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Fish 
Oncorhyncus mykiss, 21 d, 
NOEC 
0.630 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Fish 
Oncorhyncus mykiss, 90 d, 
NOEC (ELS) 
0.120 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Aquatic 
invertebrates 
Daphnia magna, 48 h, EC50 12 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Aquatic 
invertebrates 
Americamysis bahia, 48 h, LC50 >9.2 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Aquatic 
invertebrates 
Daphnia magna, 21 d, NOEC 1.36 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Aquatic 
invertebrates 
Daphnia magna, 21 d, NOEC 0.680 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Algae 
Pseudokirchneriella 
subcapitata, 72 h, growth rate, 
arithmetic mean: a)EC50 b)EC10 
a)0.0588 mg/L 
b)0.0159 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Algae 
Anabaena flos-aquae, 72 h, 
growth rate, a)EC50 b)EC10 
a)1.340 mg/L 
b)0.073 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Algae 
Ankistrodesmus bibraianus, 72 




Data provided from 
Stakeholder’s comment (BASF)* 
Algae 
Chlamydomonas reinhardtii, 72 
h, growth rate, a)EC50 b)EC10 
a)0.2245 mg/L 
b)0.0620 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Algae Desmodesmus subspicatus, 72 




Data provided from 
Stakeholder’s comment (BASF)* 
Algae Dictyococcus varians, 72 h, 
growth rate, a)EC50 b)EC10 
a)0.1498 mg/L 
b)0.0049 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
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Algae Monoraphidium griffithii, 72 h, 
growth rate, a)EC50 b)EC10 
a)0.0250 mg/L 
b)0.0026 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Algae Navicula pelliculosa, 72 h, 
growth rate, a)EC50 b)EC10 
a)0.287 mg/L 
b)0.082 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Algae Neochloris aquatica, 72 h, 
growth rate, a)EC50 b)EC10 
a)>1000 mg/L 
b)0.0871 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Algae Pandorina morum, 72 h, 
growth rate, a)EC50 b)EC10 
a)0.9238 mg/L 
b)0.0329 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Algae Planktosphaeria botryoides, 72 
h, growth rate, a)EC50 b)EC10 
a)0.9120 mg/L 
b)0.0517 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Algae Schroederia setigera, 72 h, 
growth rate, a)EC50 b)EC10 
a)>0.4055 mg/L 
b)0.0287 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Algae Skeletonema costatum, 72 h, 
growth rate, a)EC50 b)EC10 
a)0.309 mg/L 
b)0.060 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Algae Staurastrum punctulatum, 72 
h, growth rate, a)EC50 b)EC10 
a)>1000 mg/L 
b)0.0227 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Aquatic plants Lemna gibba, 7 d, growth rate, 
arithmetic mean: a)EC50 b)EC10 
a)0.0543 mg/L 
b)0.0089 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Aquatic plants Glyceria maxima, 14 d, growth 
rate, a)EC50 b)EC10 
a)0.184 mg/L 
b)0.027 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Aquatic plants Lemna gibba (with sediment), 
7 d, growth rate, a)EC50 b)EC10 
a)0.0990 mg/L 
b)0.0152 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Aquatic plants Acorus calamus, 13 d, growth 
rate, a)EC50 b)NOEC 
a)>1.324 mg/L 
b)≥1.324 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Aquatic plants Iris pseudacorus, 13 d, growth 
rate, a)EC50 b)NOEC 
a)0.229 mg/L 
b)0.022 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Aquatic plants Ludwigia palustris, 13 d, 
growth rate, a)EC50 b)NOEC 
a)0.047 mg/L 
b)0.011 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Aquatic plants Mentha aquatica, 13 d, growth 
rate, a)EC50 b)NOEC 
a)0.278 mg/L 
b)0.124 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Aquatic plants Sparganium erectum, 13 d, 
growth rate, a)EC50 b)NOEC 
a)0.278 mg/L 
b)0.124 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Aquatic plants Veronica beccalunga, 13 d, 
growth rate, a)EC50 b)NOEC 
a)0.129 mg/L 
b)0.011 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Aquatic plants Ceratophyllum demersum, 9 d, 
growth rate, a)EC50 b)NOEC 
a)0.0157 mg/L 
b)0.0019 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Aquatic plants Crassula recurva, 12 d, growth 
rate, a)EC50 b)NOEC 
a)0.0995 mg/L 
b)0.0400 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Aquatic plants Elodea densa, 12 d, growth 
rate, a)EC50 b)NOEC 
a)0.2044 mg/L 
b)0.0400 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Aquatic plants Myriophyllum spicatum, 9 d, 
growth rate, a)EC50 b)NOEC 
a)0.0972 mg/L 
b)0.0092 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Aquatic plants Potamogeton crispus, 9 d, 
growth rate, a)EC50 b)NOEC 
a)0.2839 mg/L 
b)0.0400 mg/L 
Data provided from 
Stakeholder’s comment (BASF)* 
Aquatic plants Vallisneria spiralis, 12 d, 




Data provided from 
Stakeholder’s comment (BASF)* 
* and submitted during Annex I inclusion and Recent Renewal Process (2014) 
 
6.2 Mammalian toxicology data 
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Type of test Endpoint Value Reference 
Acute oral toxicity  Rat, LD50 429 mg/kg bw EC Review, 2001 
1 
Short-term oral toxicity Rat, 90 d, NOAEL 10 mg/kg bw/day EC Review, 2001 
1 




Dog, 1 year, NOAEL. 
Value used for ADI 
calculation in the EC 
Review, 20011 
2 mg/kg bw/day EC Review, 2001 
1 
Long-term toxicity Rat, 105 weeks, NOAEL <5 mg/kg bw/day EC Review, 2001 
1 
Long-term toxicity Mouse, 94 weeks, NOAEL 3.8 mg/kg bw/day EC Review, 2001 
1 
Reproductive toxicity NOAEL 36 mg/kg bw/day EC Review, 2001 
1 
Developmental toxicity Rat, NOAEL 50 mg/kg bw/day EC Review, 2001 
1 
 
6.3 PNEC derivation 
PNEC Endpoint Endpoint value AF PNEC value Reference 








PNECbiota,sec pois - - - N.R. - 
PNECbiota, hh - - - N.R. - 
PNECdw, hh ADI c 0.02 mg/L - 0.070 mg/L 
INERIS, 
20112 
a Probabilistic approach used. Stakeholder’s comment. 
b Value provided from Stakeholder’s comment. 
c Same ADI for dimethenamid and dimethenamid-P. No new calculations were performed. 
 
To be noted that a further PNECfw value of 0.2 µg/L (AF 10) was derived by UBA (DE), which was also 
suggested by NORMAN.  All the available ecotoxicity data related to dimethenamid-P will be further 
assessed in the current monitoring-based prioritisation exercise. 
 
 




RQbiota,sec pois N.R. 
RQbiota, hh N.R. 





1 EUROPEAN COMMISSION Review Report for the active substance dimethenamid-p, SANCO/1402/2001-Final. 
Available at http://ec.europa.eu/sanco_pesticides/public/?event=activesubstance.detail 
2 INERIS, DIMETHENAMIDE – N° CAS : 87674-68-8 & DIMETHENAMID-P – N° CAS : 163515-14-8 (October 2011). 
Available at http://www.ineris.fr/substances/fr/substance/getDocument/3077 
3 CLH Report (2012) Proposal for Harmonised Classification and Labelling Based on Regulation (EC) No 1272/2008 
(CLP Regulation), Annex VI, Part 2 Substance Name: Dimethenamid-P. Available at: 
http://echa.europa.eu/documents/10162/7307455a-5bcf-4e09-aea3-755346b9769a 
4 European Pesticides Database: http://ec.europa.eu/sanco_pesticides/public/?event=homepage 
5 COMMISSION DECISION of 22 December 2006 concerning the non-inclusion of dimethenamid in Annex I to Council 
Directive 91/414/EEC and the withdrawal of authorisations for plant protection products containing that substance 
(notified under  document number C(2006) 6895). Available at http://eur-lex.europa.eu/legal-
content/EN/ALL/?uri=CELEX:32006D1009 
6 IPCheM database at http://ipchem.jrc.ec.europa.eu/ 
7 NORMAN Database http://www.norman-network.net/?q=node/24 
8 WATERBASE Database http://www.eea.europa.eu/data-and-maps/data/waterbase-rivers-6 




Triphenyl phosphate (CAS N. 115-86-6)  
1. Substance identity 
CAS number 115-86-6 
Molecular formula C18-H15-O4-P 





2. Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa) 0.000835 ECHA, 20131 
Water solubility 
(mg/L) 
1.9 ECHA, 20131 
logKow 4.63 ECHA, 20131 
 
 
3. Environmental fate 
Endpoint Value Source 
Sorption potential  
Koc   
3561 ECHA, 20131 
Biodegradability RB ECHA, 20131, EPA Report2 
Bioaccumulation 
(BCF) 
144 ECHA, 20131 
BMF 1 Default value, TG n. 27 - CIS WFD3 
 
 
4. Environmental exposure assessment 
4.1 Predicted Environmental Concentration 
 Description Source 
Tonnes/year A confidential and recent tonnage 
value was used for calculation 
IUCLID, 20144 
Uses Manufacture of substances, ECHA, 20131 
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formulation in materials (plastics 
and rubber), formulation of flame 
retardant/plasticizer in 
preparations and cosmetics  
Spatial usage (by MS) Not known  
Banned uses -  
ERC code ERC8a  




PECfw (mg/L) 0.015 ECETOC 
PECsed (mg/kg dw) 5.49 ECETOC 
PECbiota (mg/kg) 
2.169 (N.R.) 
Calculation based on Equation L 
(Section 3.4.3) 
N.R. Not required because the substance is readily biodegradable. 
 
 
4.2 Measured Environmental Concentration 
 
n. of MS Source of monitoring data MEC values RBSP 
2 (DE, NL) NORMAN DB, 20145 MEC95, whole: 0.07 µg/L 
1 MS (RBSP EQS 
ECOSTAT – UBA 
report)6 
 
5. P, B, T, C, M, R, ED properties 
Triphenyl-phosphate is neither carcinogenic nor toxic to reproduction2. In the ECHA report, it is not 
classified as carcinogenic (category 1 or 2), mutagenic (category 1 or 2), or toxic for reproduction 
(category 1, 2 or 3) according to Directive 67/548/EEC, or carcinogenic (category 1A or 1B), germ cell 
mutagenic (category 1A or 1B), or toxic for reproduction (category 1A, 1B or 2) according to Regulation 
EC No 1272/2008. The substance is not classified as CMR1. No other evidence of chronic toxicity, as 
identified by the classifications T, R48 or Xn, R48 according to Directive 67/548/EEC or specific target 
organ toxicity after repeated exposure (STOT RE category 1 or 2) according to Regulation EC No 
1272/2008 was reported1. 
Triphenyl phosphate is readily biodegradable (not P). It has a BCF value of 144 L/kg (not B) (EPA report2, 





6. Hazard assessment 
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6.1 Ecotoxicology data 
Trophic level Endpoint Value Reference 
Fish 
Oncorhynchus mykiss, 96 
h, EC50 
0.310 mg/L NORMAN, 20147 
Fish 
Oncorhynchus mykiss, 
30 d, EC10 
0.037mg/L NORMAN, 20147 
Aquatic invertebrates 






















6.2 Mammalian toxicology data 
Type of test Endpoint Value Reference 




Rat, feed, 4 weeks, 
NOAEL. Value used for 
DNEL calculation in the 
ECHA, 20131 
23.5 mg/kg bw/day ECHA, 2013
1 
Reproductive toxicity 
Rat, feed, 3 months, 
NOEL 
690 mg/kg bw/day ECHA, 2013
1 




6.3 PNEC derivation 
PNEC Endpoint Endpoint value AF PNEC value 
PNECfw 
Oncorhyncus mykiss, 30 
d, EC10 
0.037 mg/L 10a 
3.70E-03 
mg/Lb 
PNECsed - - - 
0.240 mg/kg 
dwc 
PNECbiota,sec pois - - - N.R.d 
PNECbiota, hh - - - N.R.d 
PNECdw, hh 
DNEL, oral, repeated 
dose toxicity 
0.04 mg/kg bw/day - 0.140 mg/Le 
N.R. Not required because the substance is readily biodegradable. 
aAF of 10, because three long term values were available. 
bNo new calculations were made, since PNEC value was retrieved from ECHA, 20131 and NORMAN, 20141. 
cNo new calculations were made, since PNEC value was retrieved from ECHA, 20131. Equilibrium partitioning method 
was used in the dossier. 
dNot required because the substance is readily biodegradable. 








RQbiota,sec pois N.R. 
RQbiota, hh N.R. 
RQdw, hh 0.11 
 
8. References 
1 ECHA dissemination website: http://apps.echa.europa.eu/registered/data/dossiers/DISS-9c823fa6-50fe-0b74-
e044-00144f67d249/DISS-9c823fa6-50fe-0b74-e044-00144f67d249_DISS-9c823fa6-50fe-0b74-e044-
00144f67d249.html 
2EPA report, available at http://www.epa.gov/dfe/pubs/flameret/altrep-v2/altrept-v2-section1a.pdf 
3 Technical Guidance for Deriving Environmental Quality Standards – Guidance Document No. 27 (2011) Common 
Implementation Strategy of the Water Framework Directive (2000/60/EC). Available at 
http://ec.europa.eu/environment/water/water-dangersub/lib_pri_substances.htm 
4Complete IUCLID dossier of triphenyl phosphate. 
5NORMAN database at http://www.norman-network.net/?q=node/24 
6 Irmer U, Rau F, Arle J, Claussen U, Mohaupt V. (2013) Ecological Environmental Quality Standards of “River Basin 
Specific Pollutants” in Surface Waters - Update and Development Analysis of a European Comparison between 
Member States. ECOSTAT- UBA report. 
7 NORMAN factsheet on triphenyl phosphate, version of 31.08.2014 (available on CIRCA BC). 
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Acetamiprid (CAS N. 135410-20-7/160430-64-8)  
1. Substance identity 
EC name  
EC number  
CAS number 135410-20-7/160430-64-8 
Molecular formula C10-H11-Cl-N4 





2. Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa) 1E-06Pa (25ᵒC) EU Review Report, 20041 
Water solubility (mg/L) 2950 (pH 7, 25ᵒC) EU Review Report, 20041 
logKow 0.8 (25ᵒC) EU Review Report, 20041 
 
 
3. Environmental fate 
Endpoint Value Source 
Sorption potential (Koc) 106.5 EU Review Report, 20041 
Biodegradability NRB EU Review Report, 20041 
Bioaccumulation (BCF) 3.16 (estimated) EPisuite, BCFBAF v3.012 
 
 
4. Environmental exposure assessment 
4.1 Predicted Environmental Concentration 
 Description Source 
Tonnes/year -  
Uses Insecticide (Plant Protection Product) EU Pesticides DB3 
Spatial usage (by MS) 
AT, BE, BG, CY, CZ, DE, DK, EL, ES, FI, 
FR, HU, IE, IT, LT, LU, MT, NL, PL, PT, 
RO, SE, SI, SK, UK  
EU Pesticides DB3 
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Banned uses -  
ERC code ERC8d (N.R.)  
PECfw (mg/L) 0.0050  FOCUS Step 2 
PECsed (mg/kg dw) 0.0045 (N.R.) FOCUS Step 2 
PECbiota (mg/kg) 0.016 (N.R.) 
Calculation based on Equation L 
(Section 3.4.3) 
N.R. Not required based on Koc and BCF values not reaching the trigger values required for sediment and biota 
assessment 
 
4.1.1 FOCUS Pesticides models 
FOCUS Step 1  




Koc (L/kg) 3 DT50 water (d) 3 
Citrus 
2 x 100 
 (30 d interval of 
application) 
2950 106.5 5.8  
FOCUS Step 2     
Same parameters and conditions as above, in addition to DT50soil 2.6 d (mean) 3, DT50water: 5.8 d3, 
DT50sediment 1000 d (conservative value), minimal crop interception (application on young citrus)3. 
FOCUS Step 3 - SWASH package  
Foliar interception and an application window of 60 days were considered. Thus, an application window 
from 15/01 to 16/03 was chosen for D3 and R4 crop-specific scenarios for the PAT calculator. 
 
Results 
Tier PECfw (mg/L) PECsed (mg/kg) 
FOCUS Step 1 0.034 0.032 
FOCUS Step 2 
0.005 
(higher value with single 
appln) 
0.0045 
(higher value with single 
appln) 







4.2 Measured Environmental Concentration 
n. of MS Source of monitoring data MEC values RBSP 
2 (SE, IT) 
WATERBASE (2014)4 Values < LOD 
- 
SE pesticide monitoring 
programme5 
MEC95, SE: 0.0054 µg/L 





5. P, B, T, C, M, R, ED properties 
Acetamiprid is not readily biodegradable (P)1. The potential for bioaccumulation is low, and has been 
estimated with EPISuite to be of 3.16 (not B). Also in the EU Review Report1 the bioaccumulation 
potential was considered to be not relevant.  
Evidence of clastogenic potential in vitro1. Τhis event was found to be not relevant for the in vivo 
situation with a negative mouse micronucleus assay and metaphase analysis in rat bone marrow1. No 
carcinogenic potential, treatment related mammary glands hyperplasia was found at 1000 ppm1. No 
teratogenicity or fetotoxicity was observed at the tested doses, but in the reproductive toxicity study 
reduced postnatal survival and decreased pup weight was found at parental toxic doses (EU Review 
Report, 20041). 
 
6. Hazard assessment 
6.1 Ecotoxicology data 
 
Trophic level Endpoint Value Reference 
Fish 
Oncorhyncus mykiss, 96 h 
, mortality, EC50 
>100 mg/L 
EU Review Report, 
20041 
Fish 
Pimephales promelas,  35 
d , growth, NOEC 
19.2 mg/L 
EU Review Report, 
20041 
Aquatic invertebrates 
Daphnia magna,  48 h , 
mortality, EC50  
49.8 mg/L 
EU Review Report, 
20041 
Aquatic invertebrates 
Daphnia magna,  21 d , 
reproduction, NOEC 
5 mg/L 
EU Review Report, 
20041 
Algae 
Scenedesmus subspicatus,  
72 h, biomass, EC50 
>98.3 mg/L 









EU Review Report, 
20041 
Aquatic plants 
Lemna gibba, 14 d, frond, 
EC50 
1 mg/L 




6.2 Mammalian toxicology data 
Type of test Endpoint Value Reference 
Acute oral toxicity Rat, LD50 417 mg/kg bw 
EU Review Report, 
20041 
Short term oral 
toxicity 
Rat, 90 d, NOAEL 12.4 mg/kg bw/day 
EU Review Report, 
20041 
Long term toxicity Rat, 2 year, NOAEL. 7 mg/kg bw/day EU Review Report, 
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Value used for ADI 
calculation in the EU 
Review Report1, with 






Rat, NOAEL 6.5 mg/kg bw/day 




Rabbit, NOAEL 15 mg/kg bw/day 




6.3 PNEC derivation 
PNEC Endpoint Endpoint value AF PNEC value 
PNECfw 
Chironomus riparius, 28 
d, emergence and 
developmental rate, 
NOECa 
0.005 mg/Lb 10c 
5.00E-04 
mg/L 
PNECsed - - - N.R. 
PNECbiota,sec pois - - - N.R. 
PNECbiota, hh - - - N.R. 
PNECdw, hh ADI 0.07mg/kg bw/day - 0.245 mg/Ld 
N.R. Not required based on Koc and BCF values not reaching the trigger values required for sediment and biota assessment 
a Due to the mode of action of neonicotinoids, the lowest endpoint from the aquatic species tested corresponds to the 
midge Chironomus riparius. Therefore, it was selected for PNECfw calculation.  
b Value retrieved from EU Review Report, 20041 
c Three long-term values were available. 
dADI value, retrieved from EU Review Report, 20041, used in equation F as TLhh. See section 3.3.5 for calculation. 
 




RQbiota,sec pois N.R. 
RQbiota, hh N.R. 
RQdw, hh 0.02 
 
8. References 
1 EUROPEAN COMMISSION Review report for the active substance acetamiprid, SANCO/1392/2001– Final. Available 
at http://ec.europa.eu/food/plant/protection/evaluation/newactive/acetamiprid.pdf 
2 EPISuite BCFBAF v3.01 (2012) 
3 http://ec.europa.eu/sanco_pesticides/public/?event=homepage 
4 WATERBASE Database http://www.eea.europa.eu/data-and-maps/data/waterbase-rivers-6 
5 Swedish National Screening Programme Pesticides (data provided directly to the JRC) 






Erythromycin (CAS N. 114-07-8)  
1. Substance identity 
EC name Erythromycin 
EC number 204-040-1 
CAS number 114-07-8 
Molecular formula C37H67NO13 







2. Reason for proposal as candidate for the Watch list and suspected environmental risk  
Erythromycin is a macrolide antibiotic produced by Streptomyces erythreus. It inhibits bacterial protein 
synthesis by binding to bacterial 50S ribosomal subunits; binding inhibits peptidyl transferase activity 
and interferes with translocation of amino acids during translation and assembly of proteins. 
Erythromycin may be bacteriostatic or bactericidal depending on the organism and drug concentration.1 
Erythromycin has been classified as Category 2 according to the NORMAN Prioritisation Methodology2. In 
the NORMAN factsheet3 it was reported a frequency of exceedance of 12% and an extent of exceedance of 
3.74-fold of the lowest PNEC3, considering monitoring data from 2002-2011 in the NORMAN database4.  
Besides the use as human and veterinary medicine, it is reported to have Industrial use resulting in 
manufacture of another substance (use of intermediates)5. 
 
3. Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa) 3.04E-25 ChemIDPlus 6 
Water solubility (mg/L) 2000 Drugbank 1 





4. Environmental fate 
Endpoint Value Source 
Sorption potential (Koc) 570 PubChem 7 
Biodegradability NRB NORMAN, 2014 3 
Bioaccumulation (BCF) 48.5 NORMAN, 2014 3 
BMF 1 Default value, TG n. 27 - CIS WFD 8 
 
 
5. Environmental exposure assessment 
 Description Source 
Tonnes/year 




Industrial use resulting in 
manufacture of another substance 




Pharmaceutical (human and 
veterinary medicine) 
- 
Spatial usage (by MS) Widespread use Drugs.com 10 
Banned uses -  
ERC code ERC6a * ECHA, 2014 5 
Fraction of tonnage to 
region 
0.1  
* This substance is registered as having an environmental release category ERC6a. However, the PEC sediment 
calculated using this code with ECETOC seemed unrealistically high and it was decided to use instead ERC8a in this 
exercise, suitable for pharmaceuticals (see section 4.1.1 of this factsheet). 
 
5.1 Predicted Environmental Concentration 
 ECETOCa 
Human consumption  
(Eq. G)b 
MECc 
PECfw (mg/L) 0.00526 0.0002 0.000613 
PECsed (mg/kg dw) 0.3185d 0.006e 0.0185e 
PECbiota (mg/kg) 0.255f 0.010f 0.030f 
a Intermediate use 
b Besse et al., 2008 11 (Equation G) for PEC equation, human consumption data from DK.  
c MEC95 (SE) 
d PECsed calculated from ECETOC 
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e PECsed calculated with the Equilibrium Partitioning Method, where Ksed-water= 15.05 m3m-3 (calculated with eq. K of 
section 3.4.2), RHOsed= 1300 kg m-3 (default value), Fsolidsed= 0.2 (default value), RHOsolid= 2500 kg m-3 (default 
value), Kpsed= 28.5 L/kg (calculated, Koc x Focsed), Koc= 570 L/kg (from PubChem7), Focsed= 0.05 kg kg-1 (default value). 
Conversion from wet weight to dry weight was done with eq. I (see section 3.4.2). 
f Calculation with Equation L (Section 3.4.3) 
 
5.1.1 PEC calculation considering different uses or sales data from MS 
Uses Calculation tool/ equation Country PECfw (μg/L) 
Intermediate use  
ECETOC tool 
ERC8a was used, instead of 
ERC6a 
Europe  
(use of tonnes registered 
in IUCLID) 
5.26 
Human use PECba Portugal 0.150 
Human use PECba Latvia 0.073 
Human use PECba Greece 0.0614 
Human use PECba Germany 0.132 
Human use PECba Denmark 0.2 
Veterinary use No sales data - - 
a PECb equation was retrieved from Besse et al, 2008 11 
PECb equation:  PECfw= (consumption  Fexcreta) / (WWinhab  hab  dilution  365) 
where WWinhab is the volume of wastewater per person per day (default value of 200 [L/(hab*day]), hab are the 
number of inhabitants in the respective country (retrieved from  PT12, LV13, EL14, DE15, and DK16 official sources). 
Fexcreta is the excretion factor of the active substance11, dilution is the dilution factor (default value of 10), consumption 
is the quantity (mg/year) of active ingredient consumed by the population during 1 year. Consumption data were 
taken from Besse et al, 200811 for FR, from Iatrou et al, 201417 for EL, from UBA report18 for DE, and directly provided 
to the JRC for PT, LV, and DK19.  
 
5.2 Measured Environmental Concentration 
From an analysis of pharmaceutical datasets in river systems worldwide collected from the literature, 
Hughes et al. (2013)20 report that erythromycin has a mean detection frequency worldwide of 55.5% 
(from all the records for that particular substance), and median and maximum concentration worldwide 
of 0.05 and 90 μg/L, respectively. The frequency of quantification of erythromycin in the NORMAN 
database is 15%3. However, considering just the monitoring data for the period 2006-2014, all values 
were < LOQ. 
 
n. of MS Source of monitoring data MEC values RBSP 
3 (NL, CH, SE) 
NORMAN DB, 2014 4 All values < LOQ (CH, NL)* 
- SE Screening Programme 
Pharmaceuticals 21 
MEC95: 0.613 µg/L (SE) 
* To be noted that these values correspond to the period 2006-2014, while higher MEC values were available if 




6. P, B, T, C, M, R, ED properties 
Reported to be not carcinogenic and genotoxic, as erythromycin stearate form22.  
Utilizing the Closed Bottle Test, -3% of the theoretical BOD was reported in 4 weeks, indicating that 
biodegradation is not an important environmental fate process in water (P) (PubChem)7. A pKa of 8.9 
indicates erythromycin will exist almost entirely in the cation form at pH values of 5 to 9 and therefore 
volatilization from water surfaces is not expected to be an important fate process. An estimated BCF of 49 
suggests the potential for bioconcentration in aquatic organisms is moderate (Not B) (PubChem)7.  
 
7. Hazard assessment 
7.1 Ecotoxicology data 
Trophic level Endpoint Value Reference a 
Fish 
Morone saxatilis, 96 h, 
LC50 
349 mg/L 
Bills et al. 
199323(NORMAN, 
20143 and UBA, 201424) 
Fish 
Danio rerio, 96 h, 
mortality, LC50 
>1000 mg/L 
Isidori et al. 200527 
(UBA, 201424) 
Fish 
Pimephales promelas, 96 
h, mortality, LC50 
61 mg/L 
Sanderson et al. 200326 
(UBA, 201424) 
Fish 
Oryzias latipes, 10 d, 
hatchability, time to 
hatch, NOEC 
1000 mg/L 
Ji et al. 201227 (UBA, 
201424) 
Fish 
Oryzias latipes, 40 d, 
juvenile survival, NOEC 
100 mg/L 
Ji et al. 201227 (UBA, 
201424) 
Fish 
Oryzias latipes, 40 d, 
juvenile growth, NOEC 
1000 mg/L 
Ji et al. 201227 (UBA, 
201424) 
Fish 
Oryzias latipes, 100 d, 
adult survival growth, 
NOEC 
10 mg/L 
Ji et al. 201227 (UBA, 
201424) 
Aquatic invertebrates 
Ceriodaphnia dubia, 48 h, 
EC50 
10.23 mg/L 
Isidori et al. 200525 




24 h, mortality, LC50 
27.53 mg/L 




48 h, mortality, EC50 
0.940 mg/L 
Isidori et al. 200525 
(UBA, 201424) 
Aquatic invertebrates 
Daphnia magna, 24 h, 
mobility, EC50 
22.45 mg/L 




platyrus, 24 h, mobility, 
EC50 
17.68 mg/L 





Daphnia magna, 48 h, 
mobility, EC50 
207.8 mg/L 
Ji et al. 201227 (UBA, 
201424) 
Aquatic invertebrates 
Moina macrocopa, 48 h, 
mobility, EC50 
135.5 mg/L 
Ji et al. 201227(UBA, 
201424) 
Aquatic invertebrates 
Penaeus vannamei, 48 h, 
mobility, EC50 
0.0227 mg/L 
Williams et al. 199228 
(UBA, 201424) 
Aquatic invertebrates 
Daphnia magna, 21 d, 
reproduction, NOEC 
0.248 mg/L 
Meinertz et al. 201029 
(NORMAN, 20143 and 
UBA, 201424) 
Aquatic invertebrates 
Ceriodaphnia dubia, 7 d, 
population growth, EC50 
0.220 mg/L 
Isidori et al. 200525 
(UBA, 201423) 
Aquatic invertebrates 




Ji et al. 201227 (UBA, 
201424) 
Aquatic invertebrates 
Daphnia magna, 21 d, 
survival, NOEC 
33.3 mg/L 
Ji et al. 201227 (UBA, 
201424) 
Aquatic invertebrates 








subcapitata, 72 h, 
growth, EC50 
0.020 mg/L 
Isidori et al. 200525 




subcapitata, 72 h, 
biomass, NOEC 
0.0103 mg/L 
Eguchi et al. 200430 




subcapitata, 72 h, 
biomass, EC50 
0.0366 mg/L 
Eguchi et al. 200430 








Gonzaléz-Pleiter et al. 
201331 (UBA, 201424) 
Algae 
Chlorella vulgaris, 72 h, 
biomass, EC50 
33.8 mg/L 
Eguchi et al. 200430 
(NORMAN, 20143 and 
UBA, 201424) 
Algae Pseudokirchneriella 




Gonzaléz-Pleiter et al. 
201331 (UBA, 201424) 
Algae Chlorella vulgaris, 72 h, 
biomass, NOEC 
12.5 mg/L 
Eguchi et al. 200430 
(UBA, 201424) 
Cyanobacteria Microcystis wesenbergii 0.023 mg/L Ando et al. 200732 
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144 h,  biomass, NOEC 
0.002 mg/L 
Ando et al. 200732 
(NORMAN, 20143 and 
UBA, 201424) 
Cyanobacteria Nostoc sp PCC 7120, 144 
h, biomass, EC50 
0.2 mg/L 
Ando et al. 200732 
(UBA, 201424) 
Cyanobacteria Anabaena variabilis 
NIES-23, 144 h, biomass, 
EC50 
0.430 mg/L 




NIES-107, 144 h, 
biomass, NOEC 
0.0047 mg/L 
Ando et al. 200732 
(UBA, 201424) 
Cyanobacteria Synechococcus sp. PCC 
7002, 144 h,  biomass, 
EC50 
0.230 mg/L 




leopoldensis IAM-M6, 144 
h,  EC50 
0.160 mg/L 
Ando et al. 200732 
(UBA, 201424) 
Cyanobacteria Microcystis aeruginosa 
NIES-44, 144 h,  biomass, 
EC50 
0.023 mg/L 
Ando et al. 200732 
(UBA, 201424) 
Cyanobacteria Anabaena flos-aquae 




Ando et al. 200732 
(UBA, 201424) 
Cyanobacteria Anabaena cylindrica 
NIES-19, 144 h,  biomass, 
EC50   
0.035 mg/L 
Ando et al. 200732 (UBA, 
201424) 
Cyanobacteria Anabaena flos-aquae, 72 
h, yield, EC50 
  
0.140 mg/L 
Förster et al. 201333 
(UBA, 201424) 
Cyanobacteria Anabaena flos-aquae, 72 
h, growth rate, EC50 
0.348 mg/L 
Förster et al. 201333 
(UBA, 201424) 
Cyanobacteria Anabaena sp., 72 h, 




Gonzaléz-Pleiter et al. 
201331 (UBA, 201424) 
Cyanobacteria Anabaena variabilis 
NIES-23, 144 h, biomass, 
NOEC 
0.047 mg/L 
Ando et al. 200732 
(UBA, 201424) 
Cyanobacteria Nostoc sp PCC 7120, 144 
h, biomass, NOEC 
0.1 mg/L 
Ando et al. 200732 (UBA, 
201424) 
Cyanobacteria Synechococcus sp. PCC 
7002, 144 h,  biomass, 
NOEC 
0.0078 mg/L 
Ando et al. 200732 
(UBA, 201424) 
Cyanobacteria Microcystis aeruginosa 0.010 mg/L Ando et al. 200732 
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NIES-44, 144 h,  biomass, 
NOEC 
(UBA, 201424) 
Cyanobacteria Anabaena flos-aquae 
ATCC 29413, 144 h,  
biomass, NOEC  
0.047 mg/L 
Ando et al. 200732 
(UBA, 201424) 
Cyanobacteria Anabaena cylindrica 
NIES-19, 144 h,  biomass, 
NOEC   
0.0031 mg/L 
Ando et al. 200732 
(UBA, 201424) 
Cyanobacteria Anabaena flos-aquae, 72 
h, yield, growth rate, 
NOEC   
0.030 mg/L 
Förster et al. 201333 
(UBA, 201424) 
Cyanobacteria Anabaena flos-aquae, 72 
h, yield. growth rate, 
LOEC 
0.090 mg/L 
Förster et al. 201333 
(UBA, 201424) 
Cyanobacteria Anabaena sp., 72 h, 




Gonzaléz-Pleiter et al. 
201331 (UBA, 201424) 
Cyanobacteria Synechocystis sp., 5 d, 
growth, NOEC 
0.010 mg/L 
Pomati et al. 200434 
(UBA, 201424) 
Aquatic plants Lemna minor, frond 
number, 7 d, EC50 
5.62 mg/L 
Pomati et al 200434 
(UBA, 201424) 
Aquatic plants Lemna minor, frond 
number, 7 d, NOEC 
0.010 mg/L 
Pomati et al 200434 
(UBA, 201424) 
a The references were taken from the NORMAN factsheet on erythromycin3, and from the UBA report24, where the 
reliability of the studies have been assessed and considered reliable. 
 
7.2 Mammalian toxicology data 
No information retrieved 
 
7.3 PNEC derivation 
PNEC Endpoint Endpoint value AF PNEC value 
PNECfw 
Synechococcus leopoldensis 
IAM-M6, 144 h, NOEC 
0.002 mg/L 10 0.0002 mg/l 23 
PNECsed - - - 
0.0060 mg/kg 
dw a 
PNECbiota,sec pois - - - - b 






PNECdw, hh ADI 
0.0007 
mg/kg bw/day 
- 0.002 mg/L d 
a Calculated with the Equilibrium partitioning method. Ksed-water= 15.05 m3m-3 (calculated with eq. D), RHOsed= 1300 kg 
m-3 (default value), Fsolidsed= 0.2 (default value), RHOsolid= 2500 kg m-3 (default value), Kpsed= 28.5 L/kg (calculated, 
Koc x Focsed), Koc= 570 L/kg, Focsed= 0.05 kg kg-1 (default value). Conversion from wet weight to dry weight was done 
with eq. B (Section 3.3.2). 
b Mammalian toxicity values lacking. 
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c ADI value retrieved from the WHO report (see reference 35) used in equation E as TL. See section 3.3.4 for 
calculation 
d ADI value used in equation F as TLhh. See section 3.3.5 for calculation 
 
8. Risk Quotient (PEC/PNEC) 
RQ ECETOCa 
Human consumption  
(Eq. G)b 
MECc 
RQfw 26.3 1.00 3.07 
RQsed 52.9 1.00 3.07 
RQbiota,sec pois No info No info No info 
RQbiota, hh 5.99 0.23 0.7 
RQdw, hh 2.15 0.08 0.25 
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Clarithromycin (CAS N. 81103-11-9) 







EC number - 
CAS number 81103-11-9 
Chemical class Aazalide, a subclass of macrolide antibiotics 
Molecular formula C38H69NO13 








2. Reason for proposal as candidate for the Watch list and suspected environmental risk  
Clarithromycin, a semisynthetic macrolide antibiotic derived from erythromycin, inhibits bacterial 
protein synthesis by binding to the bacterial 50S ribosomal subunit. Binding inhibits peptidyl transferase 
activity and interferes with amino acid translocation during the translation and protein assembly 
process1. 
Clarithromycin has been classified as Category 2 according to the NORMAN Prioritisation Methodology2, 
with a frequency of exceedance of 15% and an extent of exceedance of 2.33-fold of the lowest PNEC1, 
considering monitoring data from 2002-2011in the NORMAN database3.  
A significant ecotoxicological risk due to the presence of clarithromycin in treated waste water in EL was 
estimated from acute and chronic toxicity data in algae 4. In addition, a risk indicator considered adverse 
to ecosystems was calculated for clarithromycin 5 considering the presence of this substance in the 
Llobregat river in ES6. Furthermore, clarithromycin was considered to pose a potential risk to the 
environment considering the predicted exposure in Turkey 7. 
 
3. Physico-chemical Properties 
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Endpoint Value Source 
Vapour Pressure (mm Hg) 2.32E-25 PubChem, 20148 
Water solubility (mg/L) 0.33 Drugbank, 20149 
logKow 3.16 Drugbank, 2014 9 
 
 
4. Environmental fate 
Endpoint Value Source 
Sorption potential (Koc) 150 PubChem, 20148 
Biodegradability NRB PubChem, 20148 
Bioaccumulation (BCF) 56.49 (estimated) PubChem, 20148 
BMF 1 Default value, TG n. 27 - CIS WFD 10 
 
5. Environmental exposure assessment 
 Description Source 
Tonnes/year -  
Uses Pharmaceutical  
Spatial usage (by MS) Wide dispersive use  (diffuse 
sources, present 
in urban wastewater) 
Drugbank, 2014 9 
Banned uses -  
ERC code -  





5.1 Predicted Environmental Concentration 
 
Human consumption  
(Eq. G)a 
MECb 
PECfw (mg/L) 0.000438 0.000645 
PECsed (mg/kg dw) 0.0040c  0.0059c 
PECbiota (mg/kg) 0.025d 0.036d 
aBesse et al., 200814 (Equation G) for PEC equation, human consumption data from EL.  
b MEC95 (SE) 
c PECsed calculated with the Equilibrium Partitioning Method, where Ksed-water= 4.55 m3m-3 (calculated with eq. K of 
section 3.4.2), RHOsed= 1300 kg m-3 (default value), Fsolidsed= 0.2 (default value), RHOsolid= 2500 kg m-3 (default 
value), Kpsed= 7.5 L/kg (calculated, Koc x Focsed), Koc= 150 L/kg (from PubChem8), Focsed= 0.05 kg kg-1 (default value). 
Conversion from wet weight to dry weight was done with eq. I (see section 3.4.2). 






5.1.1 PEC calculation considering different uses or sales data from MS 
Uses Calculation tool/ equation Country PECfw (μg/L) 
Human use PECba France 0.062 
Human use PECba Portugal 0.080 
Human use PECba Latvia 0.073 
Human use PECba Greece 0.438 
Human use PECba Germany 0.0406 
Human use PECba Denmark 0.0188 
Veterinary use No sales data - - 
a PECb equation was retrieved from Besse et al, 2008 11 
PECb equation:  PECfw= (consumption  Fexcreta) / (WWinhab  hab  dilution  365) 
where WWinhab is the volume of wastewater per person per day (default value of 200 [L/(hab*day]), hab are the 
number of inhabitants in the respective country (retrieved from  PT12, LV13, EL14, DE15  and DK16 official sources). 
Fexcreta is the excretion factor of the active substance11, dilution is the dilution factor (default value of 10), consumption 
is the quantity (mg/year) of active ingredient consumed by the population during 1 year. Consumption data were 
taken from Besse et al, 200811 for FR, from Iatrou et al, 20144 for EL, from UBA report for DE17, and directly provided 
to the JRC for PT, LV, and DK18.  
 
 
5.2 Measured Environmental Concentration 
From an analysis of pharmaceutical datasets in river systems worldwide collected from the literature, 
Hughes et al. (2013)19 report that clarithromycin has a mean detection frequency worldwide of 54% 
(from all the records for that particular substance), median and maximum concentration worldwide of 
0.016 and 0.260 μg/L, respectively, while median and maximum concentrations in European studies were 
around 0.05 and 0.5 μg/L, respectively (exact values for European studies could not be retrieved from the 
plot in the publication). The frequency of detection of clarithromycin in the NORMAN database is 33% 
(NORMAN, 2014)1.  
 
n. of MS Source of monitoring data MEC values RBSP 
3 (NL, CH, SE) 
NORMAN DB, 20143 
MEC95, whole: 0.096 µg/L (CH, NL*) 
MECsite, dissolved: 0.001 µg/L (CH) 
- 
SE Screening Programme 
Pharmaceuticals20 
MEC95: 0.645 µg/L (SE) 




6. P, B, T, C, M, R, ED properties 
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Clarithromycin failed to exhibit mutagenic potential in several in vitro tests, including the Salmonella 
mammalian microsome test, bacterial induced mutation frequency test, rat hepatocyte DNA synthesis 
assay, mouse lymphoma assay, mouse dominant lethal test, and mouse micronucleus test8. 
P: Very persistent (DT50 sediment = 379 days) NORMAN, 20141 
B: Not Bioaccumulative (BCFestimated = 56.49) NORMAN, 20141 
 
7. Hazard assessment 




Endpoint Value Referencea 
Algae 
Pseudokirchneriella subcapitata, 
72 h, biomass, EC50 
2 µg/L Isidori et al. 200521 
Algae 
Pseudokirchneriella subcapitata, 
96 h, NOEC 
4 µg/L Yamashita et al. 200622 
Algae 
Anabaena flos-aquae, 72 h, 
growth rate, EC10 
2.6 µg/L UBA, 201423 
Invertebrates 
Ceriodaphnia dubia, 
48 h, LC50 (static) 
18 660 µg/L Isidori et al. 200521 
Invertebrates 
Daphnia magna, 
21 d, NOEC (semi-static) 
3.1 µg/L Yamashita et al. 200622 
Rotifera 
Brachionus calyciflorus, 
24 h, LC50 
35 460 µg/L Isidori et al. 200521 
Fish 
Oryzias latipes, 
96 h, EC50 
> 100,000 Kim et al. 200924 
a The references were taken from the NORMAN factsheet on clarithromycin1, and the studies were considered 
reliable. 
 
7.2 Mammalian toxicology data 
No studies found. 
 
7.3 PNEC derivation 
PNEC Endpoint Endpoint value AF PNEC value 
PNECfw 
Anabaena flos-aquae, 72 
h, EC10 
2.6 µg/L 10*2 0.13 µg/L a 
PNECsed - - - 
0.0012 mg/kg 
dwb 
PNECbiota,sec pois - - - Info missing 





PNECdw, hh ADI 0.0002 mg/kg bw/day - 0.001 mg/L d 
a The PNEC value was retrieved from the UBA factsheet23 on the substance. The additional AF of 2 was used because 
the toxic metabolite 14-Hydroxy-Claritromycin occur up to about 50% in surface water and is equivalent toxic. 
b Calculated using the equilibrium partitioning method. The following values were used:  Ksed-water= 4.55 m3m-3 
(calculated with eq. D of section 3.3.2), RHOsed= 1300 kg m-3 (default value), Fsolidsed= 0.2 (default value), RHOsolid= 
2500 kg m-3 (default value), Kpsed= 7.5 L/kg (calculated, Koc x Focsed), Koc= 150 L/kg (from PubChem8), Focsed= 0.05 kg 
kg-1 (default value). Conversion from wet weight to dry weight was done with eq. B (see section 3.3.2). 
cADI value retrieved from Leung et al., 2013 (see reference 25) used in equation E as TL. See section 3.3.4 for 
calculation 
d ADI value used in equation F as TLhh. See section 3.3.5 for calculation 
 
8. Risk Quotient (PEC/PNEC) 
RQ Human consumption (Eq. G)a MECb 
RQfw 3.37 4.96 
RQsed 3.37 4.96 
RQbiota,sec pois No info No info 
RQbiota, hh 2.03 2.99 
RQdw, hh 0.63 0.92 
aBesse et al., 200814 (Equation G) for PEC equation, human consumption data from EL.  
b MEC95 (SE) 
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Ciprofloxacin (CAS N. 85721-33-1) 





EC number - 
CAS number 85721-33-1 
Chemical class Carboxy-fluoroquinoline 
Molecular formula C17H18FN3O3 





2. Reason for proposal as candidate for the Watch list and suspected environmental risk  
Ciprofloxacin is a broad-spectrum antiinfective agent of the fluoroquinolone class. Ciprofloxacin has in 
vitro activity against a wide range of gram-negative and gram-positive microorganisms1. Ciprofloxacycin 
has been classified as Category 2 according to the NORMAN Prioritisation Methodology2, with a frequency 
of exceedancy of 18% and an extent of exceedancy of 7.53-fold of the lowest PNEC3, considering 
monitoring data from 2002-2011 in the NORMAN database4.  
Ciprofloxacin has been classified as posing moderate risk from the Stockholm County Council5. In 
addition, a risk quotient greater than 1 was determined for this substance by performing an 
environmental risk assessment according to the guideline recommended by the European Medicines 
Agency (EMA), and measured concentrations confirmed that the release of ciprofloxacin from wastewater 
treatment works may potentially be of environmental concern in NO6. A significant ecotoxicological risk 
due to the presence of ciprofloxacin in treated waste water in EL was estimated from acute toxicity data 
in algae7.  
In addition, a risk indicator considered adverse to ecosystems was calculated for ciprofloxacin8 
considering the presence of this substance in the Llobregat river in ES9. Ciprofloxacin is one of the most 
frequently detected fluoroquinolone antibiotics in hospital wastewater and concentrations in surface 





3. Physico-chemical Properties 
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Endpoint Value Source 
Vapour Pressure (mm Hg) 2.85E-13 Pubchem, 201411 
Water solubility (mg/L) 30000 Pubchem, 201411 
logKow 0.28 Pubchem, 201411 , Schwab et al. 200512 
 
 
4. Environmental fate 
Endpoint Value Source 
Sorption potential (Koc) 61000 Pubchem, 201411 
Biodegradability NRB Pubchem, 201411 
Bioaccumulation (BCF) 3.2 L/kg Schwab et al. 200512 
BMF 1 Default value, TG n. 27 - CIS WFD 13 
 
 
5. Environmental exposure assessment  
 Description Source 
Tonnes/year -  
Uses Pharmaceutical  
Spatial usage (by MS) Wide dispersive use (diffuse sources, 
present in urban wastewater) 
NORMAN, 20143 
Banned uses -  
ERC code -  





5.1 Predicted Environmental Concentration 
 
Human consumption  
(Eq. G)a 
MECb 
PECfw (mg/L) 0.000538 0.00124 
PECsed (mg/kg dw) 1.6418c 3.78c 
PECbiota (mg/kg) 0.0017d 0.004d 
aBesse et al., 200814 (Equation G) for PEC equation, human consumption data from PT.  
b MEC95 (SE – NORMAN DB) 
c PECsed calculated with the Equilibrium Partitioning Method, where Ksed-water= 1525.8 m3m-3 (calculated with eq. K of 
section 3.4.2), RHOsed= 1300 kg m-3 (default value), Fsolidsed= 0.2 (default value), RHOsolid= 2500 kg m-3 (default 
value), Kpsed= 3050 L/kg (calculated, Koc x Focsed), Koc= 61000 L/kg (from PubChem11), Focsed= 0.05 kg kg-1 (default 
value). Conversion from wet weight to dry weight was done with eq. I (see section 3.4.2). 





5.1.1 PEC calculation considering different uses or sales data from MS 
Uses Calculation tool/ equation Country PECfw (μg/L) 
Human use PECba France 0.139 
Human use PECba Portugal 0.540 
Human use PECba Latvia 0.210 
Human use PECba Greece 0.530 
Human use PECba Denmark 0.166 
Veterinary use No sales data - - 
a PECb equation was retrieved from Besse et al, 200814 
PECb equation:  PECfw= (consumption  Fexcreta) / (WWinhab  hab  dilution  365) 
where WWinhab is the volume of wastewater per person per day (default value of 200 [L/(hab*day]), hab are the 
number of inhabitants in the respective country (retrieved from  PT16, LV17, EL18, DK19 official sources). Fexcreta is the 
excretion factor of the active substance retrieved from Besse et al, 200814, dilution is the dilution factor (default value 
of 10), consumption is the quantity (mg/year) of active ingredient consumed by the population during 1 year. 
Consumption data were taken from Besse et al, 200814 for FR, from Iatrou et al, 20147 for EL, and directly provided to 
the JRC for PT15. DK and LV20.  
 
5.2 Measured Environmental Concentration 
From an analysis of pharmaceutical datasets in river systems worldwide collected from the literature, 
Hughes et al. (2013)21 report that ciprofloxacin has a mean detection frequency worldwide of 33.4% 
(from all the records for that particular substance) and median and maximum concentrations worldwide 
of 164 and 6500 μg/L, respectively. The frequency of quantification of ciprofloxacin in the NORMAN 
database is 18% (NORMAN, 2014)3. 
 
n. of MS Source of monitoring data MEC values RBSP 
2 (SE, PT) 
NORMAN DB, 20144  
MEC95, whole: 1.24 µg/L (SE) 
MEC95, dissolved: 0.22 µg/La (PT) 
- 
SE Screening Programme 
Pharmaceuticals22 
MEC95: 0.206 µg/L (SE) 
a outlier has been removed from the monitoring dataset. 
 
6. P, B, T, C, M, R, ED properties 
Eight in vitro mutagenicity tests have been conducted with Ciprofloxacin, 2 of the 8 tests were positive, 
but results of the further 3 in vivo test systems gave negative results23. Long-term carcinogenicity studies 
in rats and mice resulted in no carcinogenic or tumorigenic effects23. Fertility studies performed in rats at 
oral doses of Ciprofloxacin up to 100 mg/kg (approximately 0.7-times the highest recommended 
therapeutic dose based upon mg/m2) revealed no evidence of impairment23. 
An estimated BCF of 3 (SRC), from its log Kow of 0.28, suggests the potential for bioconcentration in 
aquatic organisms is low (SRC)11. Using the OECD closed bottle biodegradation study, 0% degradation 
 150 
 
over a 40-day incubation period was observed indicating that biodegradation is not an important 
environmental fate process in water11. 
 
7. Hazard assessment 
7.1 Ecotoxicology data 
Trophic level Endpoint Value Referencea 
Fish 
Oncorhyncus mykiss, 96 h, 
LC50 
>9.4 mg/L 
Gagliano & McNamara 
199624 
Aquatic invertebrates 
Daphnia magna, 48 h, 
EC50 
58.8 mg/L Martins et al. 201225 
Aquatic invertebrates 
Daphnia magna, 21 d, 
NOEC 
4.67 mg/L Martins et al. 201225 
Cyanobacteria 
Anabaena flos-aquae, 72 
h, EC50 
0.036 mg/L Ebert et al. 201126 
Cyanobacteria 
Anabaena flos-aquae, 
72 h, EC10 
0.00447 mg/L Ebert et al. 201126 
Aquatic plants Lemna minor, 7 d, EC50 0.499 mg/L Ebert et al. 2011
26 
Aquatic plants Lemna minor, 7 d, EC10 0.149 mg/L Brain et al. 2004
27 
a The references were taken from the NORMAN factsheet on ciprofloxacin13, and the studies were considered reliable. 
 
7.2 Mammalian toxicology data 
No information retrieved 
 
7.3 PNEC derivation 
PNEC Endpoint Endpoint value AF PNEC value 
PNECfw 
Anabaena flos-aquae, 72 
h, EC10 
0.00447 mg/L 50 
8.9E-05 mg/L 
a 
PNECsed - - - 
0.272  
mg/kg dw b 
PNECbiota,sec pois - - - N.R. 
PNECbiota, hh - - - N.R. 
PNECdw, hh ADI 0.0016 mg/kg day - 0.006 mg/L c 
N.R. Not required based on BCF value not reaching the trigger value required for biota assessment 
a Two long-term values available from the main trophic levels. No new calculations were performed, since PNEC 
value was retrieved from NORMAN factsheet, 20143 
b Calculated using the equilibrium partitioning method. The following values were used:  Ksed-water= 1525.8 m3m-3 
(calculated with eq. D of section 3.3.2), RHOsed= 1300 kg m-3 (default value), Fsolidsed= 0.2 (default value), RHOsolid= 
2500 kg m-3 (default value), Kpsed= 3050 L/kg (calculated, Koc x Focsed), Koc= 61000 L/kg (from PubChem11), Focsed= 
0.05 kg kg-1 (default value). Conversion from wet weight to dry weight was done with eq. B (see section 3.3.2). 
c ADI value (from Schwab et al. 200512) used in equation Fas TLhh (see section 3.3.5) 
 
 
8. Risk Quotient (PEC/PNEC) 
RQ Human consumption (Eq. G)a MECb 
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RQfw 6.045 13.93 
RQsed 6.045 13.93 
RQbiota,sec pois N.R. N.R. 
RQbiota, hh N.R. N.R. 
RQdw, hh 0.10 0.22 
a Besse et al., 200814 (Equation G) for PEC equation, human consumption data from PT.  
b MEC95 (SE – NORMAN DB) 
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Tolylfluanid (CAS N. 731-27-1)  
1. Substance identity 
EC name  
EC number 211-986-9 
CAS number 731-27-1 
Molecular formula C10H13Cl2FN2O2S2 





2. Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa) 2 x 10-4 Biocide Assessment Report, 20091 
Water solubility (mg/L) 0.90 EFSA Conclusion, 20052 
logKow 3.9 EFSA Conclusion, 20052 
 
 
3. Environmental fate 
Endpoint Value Source 
Sorption potential (Koc) 2200 EFSA Conclusion, 20052 
Biodegradability NRB EFSA Conclusion, 20052 
Bioaccumulation (BCF) 74 EFSA Conclusion, 20052 
BMF 1 Default value, TG n. 27 - CIS WFD3 
 
 
4. Environmental exposure assessment 
4.1 Predicted Environmental Concentration 
 Description Source 
Tonnes/year 2000 (year 2000) From previous prioritisation exercise 
Uses Biocide  
Spatial usage (by MS) Not known  
Banned uses Fungicide - PPP Commission Directive 2010/20/EU4 
 154 
 
ERC code ERC8b  
Fraction of tonnage to 
region 
0.1  
PECfw (mg/L) 0.00097 ECETOC 
PECsed (mg/kg dw) 0.217 ECETOC 
PECbiota (mg/kg) 0.072 
Calculation based on Equation L 
(Section 3.4.3) 
 
4.1.1 ECETOC simulation with lower tonnages 
Authorisations for plant protection products containing the active substance tolylfluanid were withdrawn 
by 30 November 2010. No authorisations for plant protection products containing tolylfluanid are 
granted or renewed from 1 December 20104.  
However, the available tonnage of 2000 relates to the year 2000, which is prior to the banning of the 
substance as PPP.  
At the WG Chem meeting 16-17/10/2014 it was suggested to perform a simulation on the PEC calculated 
with ECETOC using reduced tonnage values of tolylfluanid that could be closer to the actual tonnage after 
the banning, i.e. related to the use as biocide only. Since no tonnage value specific for this particular use 
was available, it was decided to perform the simulation considering a 20%, and 30% or 50% decrease in 
tonnage values. The results of the simulations are compared with the pre-banning tonnage scenario in the 
following Table. 
 
Tonnes/year 2000 1600 1400 1000 
Decrease respective to 
pre-banning tonnage 
- 20% 30% 50% 
PECfw (mg/L) 9.7E-04 7.8E-04 6.8E-04 4.9E-04 
RQfw 3.66 2.94 2.56 1.85 
Position in the ranking 
(higher RQ) 
22 (RQfw) 22 (RQfw) 22 (RQfw) 22 (RQfw) 
 
 
4.2 Measured Environmental Concentration 
n. of MS Source of monitoring data MEC values RBSP 
5 (FR, NL, FI, SE, 
IT) 
NORMAN DB, 20145 MECsite, whole: 0.01 µg/L  
- 
WATERBASE, 20146 all values < LOQ 
IPCheM7 all values < LOQ 
SE pesticide monitoring 
programme8 
all values < LOQ 
IT monitoring programme9 MEC95: 0.048 µg/L 
 
5. P, B, T, C, M, R, ED properties 
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Tolylfluanid is neither genotoxic nor carcinogenic1. There were no classification-relevant effects on 
reproductive or developmental toxicity1. The substance is not readily biodegradable (P).It shows a low 
potential for bioaccumulation1. 
 
6. Hazard assessment 
6.1 Ecotoxicology data 
Since the substance will be de-selected from the Watch List, because of sufficient monitoring data, 
ecotoxicity data are not reported at this stage. 
 
6.2 Mammalian toxicology data 
Since the substance will be de-selected from the Watch List, because of sufficient monitoring data, 
mammalian toxicity data are not reported at this stage. 
 
6.3 PNEC derivation 
PNEC Endpoint Endpoint value AF PNEC value 
PNECfw 
Daphnia magna, 21 d, 
NOEC 




Chironomus riparius, 28 
d, EC15 
5.75 mg/L 100c 0.058 mg/Ld 
PNECbiota,sec pois 
Rat, 2-generation study, 
conversion factor 20, 
NOAEL 
12 mg/kg bw/day 30e 
8 mg/kg 
bw/dayf 
PNECbiota, hh ADI 0.1 mg/kg bw/day - 
6.087 mg/kg 
foodg 
PNECdw, hh ADI 0.1 mg/kg bw/day - 0.350 mg/Lh 
a AF of 10 because three long term values were available from the main trophic levels. 
b PNEC value retrieved from the Biocide Assessment Report, 20091 
c AF of 100 because one long term value was available. 
d Due to the fast degradation of the substance in sediment, no studies with the active substance on sediment dwelling 
organisms were considered necessary, and no sediment risk assessment was carried out (EFSA, 20052, Biocide AR, 
20091). Thus, the endpoint value used in this report is referred to its metabolite. 
e AF of 30 selected according to the duration of the test (see TG n. 27 - CIS WFD3) 
f The following steps were followed for PNECbiota,sec pois calculation: a) conversion of NOAEL (12 mg/kg bw/day) value, 
retrieved from EFSA Conclusion 20052, into NOEC (240 mg/kg)  by using the conversion factor of 20 ((taken from TG 
n. 27- CIS WFD, which depends both on species tested and age/study); b) Application of appropriate AForal (30) to the 
NOEC value. 
g ADI value retrieved from EFSA Conclusion 20052,  used for PNEC calculation according to Equation E (see section 
3.3.4) 













RQbiota,sec pois 0.009 
RQbiota, hh 0.01 
RQdw, hh 0.003 
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Azithromycin (CAS N. 83905-01-5) 







EC number - 
CAS number 83905-01-5 
Chemical class Aazalide, a subclass of macrolide antibiotics 
Molecular formula C38H72N2O12 








2. Reason for proposal as candidate for the Watch list and suspected environmental risk  
Azithromycin is a semi-synthetic macrolide antibiotic of the azalide class. Like other macrolide 
antibiotics, azithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit of 
the bacterial 70S ribosome.1 
Azithromycin has been classified as Category 2 according to the NORMAN Prioritisation Methodology2, 
with a frequency of exceedance of 13% and an extent of exceedance of 1611-fold of the lowest PNEC3, 
considering monitoring data from 2002-2011 in the NORMAN database4.  
 
3. Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (mm Hg) 2.65E-24 PubChem, 20145 
Water solubility (mg/L) 2.37 PubChem, 20145 





4. Environmental fate 
Endpoint Value Source 
Sorption potential (Koc) 3100 PubChem, 20145 
Biodegradability NRB NORMAN, 20143 
Bioaccumulation (BCF) 200 (estimated) PubChem, 20145 
BMF 1 Default value, TG n. 27 - CIS WFD 6 
 
 
5. Environmental exposure assessment 
 Description Source 
Tonnes/year -  
Uses Pharmaceutical 
Intermediate use (no tonnage 
available) 
ECHA, 20147 
Spatial usage (by MS) Wide dispersive use (diffuse sources, 
present in urban wastewater) 
NORMAN, 20143 
Banned uses -  
ERC code ERC6a (intermediate use), ERC8a 
(suitable for pharmaceutical use) 
 






5.1 Predicted Environmental Concentration 
 
Human consumption  
(Eq. G)a 
MECb 
PECfw (mg/L) 0.000128 0.000583 
PECsed (mg/kg dw) 0.0200c 0.0913c 
PECbiota (mg/kg) 0.026d 0.117d 
aBesse et al., 200814 (Equation G) for PEC equation, human consumption data from PT.  
b MEC95 (NORMAN: PT) 
c PECsed calculated with the Equilibrium Partitioning Method, where Ksed-water= 78.3 m3m-3 (calculated with eq. K of 
section 3.4.2), RHOsed= 1300 kg m-3 (default value), Fsolidsed= 0.2 (default value), RHOsolid= 2500 kg m-3 (default 
value), Kpsed= 155 L/kg (calculated, Koc x Focsed), Koc= 3100 L/kg (from PubChem5), Focsed= 0.05 kg kg-1 (default 
value). Conversion from wet weight to dry weight was done with eq. I (see section 3.4.2). 




5.1.1 PEC calculation considering different uses or sales data from MS 
Uses Calculation tool/ equation Country PECfw (μg/L) 
Human use PECba France 0.046 
Human use PECba Portugal 0.130 (rounded) 
Human use PECba Latvia 0.043 
Human use PECba Greece 0.114 
Human use PECba Denmark 0.037 
Veterinary use No sales data - - 
a PECb equation was retrieved from Besse et al, 20088 
PECb equation:  PECfw= (consumption  Fexcreta) / (WWinhab  hab  dilution  365) 
where WWinhab is the volume of wastewater per person per day (default value of 200 [L/(hab*day]), hab are the 
number of inhabitants in the respective country (retrieved from  PT10, LV11, EL12 and DK13 official sources). Fexcreta is 
the excretion factor of the active substance retrieved from Besse et al, 20088, dilution is the dilution factor (default 
value of 10), consumption is the quantity (mg/year) of active ingredient consumed by the population during 1 year. 
Consumption data were taken from Besse et al, 20088 for FR, from Iatrou et al, 201414 for EL, and directly provided to 
the JRC for PT9, DK and LV15.  
 
5.2 Measured Environmental Concentration 
From an analysis of pharmaceutical datasets in river systems worldwide collected from the literature, 
Hughes et al. (2013)16 report that azithromycin has a mean detection frequency worldwide of 41% (from 
all the records for that particular substance) and median and maximum concentrations worldwide of 0.19 
and 1.5 μg/L, respectively. The frequency of quantification of azithromycin in the NORMAN database is 
15%3. 
  
n. of MS Source of monitoring data MEC values RBSP 
3 (NL, PT, 
SE) 
NORMAN DB, 20144  
MEC95, whole: (NLa) 
MEC95, dissolved: 0.583 µg/Lb (PT) 
- 
SE Screening Programme 
Pharmaceuticals17 
MEC95: 0.030 µg/L 
a All values<LOQ 
b Outliers from monitoring data were removed. 
 
6. P, B, T, C, M, R, ED properties 
Azithromycin does not cause gene mutations in microbial or mammalian cells, or chromosomal 
aberrations in cultured human lymphocytes or in mouse bone marrow in vivo5. A BCF value of 200 L/kg 
was reported in PubChem5. 
P: Very persistent (DT50 water > 3 years) - NORMAN, 20143 
 
 
7. Hazard assessment 
7.1 Ecotoxicology data 
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Trophic level Endpoint Value Reference 
Fish Fish, 96 h, EC50 84 mg/L Mattson, 2010
18 
Aquatic invertebrates 
Daphnia magna , 48h, 
LC50  
120 mg/L Mattson, 201018 
Aquatic invertebrates 
Ceriodaphnia dubia, 7 
d, NOEC 
0.0044 mg/L Mattson, 201018 
Algae 
Pseudokirchneriella 
subcapitata, 96 h, 
biomass, EC50 
0.019 mg/L Harada et al. 200819 
Algae 
Pseudokirchneriella 
subcapitata, 96 h, NOEC 
0.0052 mg/L Harada et al. 200819 
a The references were taken from the NORMAN factsheet on azithromycin (see reference 3), and the studies were 
considered reliable. 
 
7.2 Mammalian toxicology data 
No study found 
 
7.3 PNEC derivation 
PNEC Endpoint Endpoint value AF PNEC value 
PNECfw 
Ceriodaphnia dubia, 7 d, 
NOEC 
0.0044 mg/L 50 9.00E-05 mg/L a 
PNECsed - - - 
0.014 
 mg/kg dw b 
PNECbiota,sec pois - - - No info 
PNECbiota, hh ADI 0.0017 mg/kg day - 
0.103  
mg/kg food c 
PNECdw, hh ADI 0.0017 mg/kg day - 0.006 mg/L d 
a An AF of 50 was selected based on availability of two long-term values from the main trophic levels. 
b Equilibrium partitioning method used with the following values: Ksed-water= 78.3 m3m-3 (calculated with eq. D of 
section 3.3.2), RHOsed= 1300 kg m-3 (default value), Fsolidsed= 0.2 (default value), RHOsolid= 2500 kg m-3 (default 
value), Kpsed= 155 L/kg (calculated, Koc x Focsed), Koc= 3100 L/kg (from PubChem5), Focsed= 0.05 kg kg-1 (default 
value). Conversion from wet weight to dry weight was done with eq. B (section 3.3.2). 
c ADI value retrieved from Leung 2013 (see reference 20) used in equation E as TL. See section 3.3.4 for calculation 
d ADI value used in equation F as TLhh. See section 3.3.5 for calculation 
 
8. Risk Quotient (PEC/PNEC) 
RQ Human consumption (Eq. G)a MECb 
RQfw 1.422 6.48 
RQsed 1.422 6.48 
RQbiota,sec pois No info No info 
RQbiota, hh 0.25 1.13 
RQdw, hh 0.02 0.10 
aBesse et al., 200814 (Equation G) for PEC equation, human consumption data from PT.  
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Cyanide-Free (CAS N. 57-12-5)  
1. Substance identity 
EC name  
EC number  
CAS number 57-12-5 
Molecular formula HCN, CN- 





2. Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure  620 mmHg at 20°C (as HCN) WFD – UK TAG Report, 20121 
Water solubility 
(mg/L) 
1,000,000 at 25°C (as HCN) WFD – UK TAG Report, 20121 
logKow 0.35–1.07 (as HCN) WFD – UK TAG Report, 20121 
 
 
3. Environmental fate 
Endpoint Value Source 
Biodegradability Biodegradation is an important 
transformation process for cyanide in 
natural surface waters and is 
dependent on such factors as cyanide 
concentrations, pH, temperature, 
availability of nutrients and 
acclimation of microbes. 
 
WFD – UK TAG Report, 20121 
Bioaccumulation 
(BCF) 
Experimental BCF values for rainbow 
trout range from 1.69–4.12. 
WFD – UK TAG Report, 20121 
 
 
4. Environmental exposure assessment 
4.1 Predicted Environmental Concentration 
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 Description Source 
Tonnes/year -  
Uses Cyanides are used extensively in 
industry and are also emitted from 
car exhaust fumes. They also occur 
ubiquitously in the environment and 
are found in a range of aquatic 
organisms such as arthropods, 
macrophytes, fungi and bacteria. 
WFD – UK TAG Report, 20121 
Spatial usage (by MS): Widespread use  
Banned uses -  
ERC code -  




PECfw (mg/L) -  
PECsed (mg/kg dw) -  
PECbiota (mg/kg) -  
 
 
4.2 Measured Environmental Concentration 
 
n. of MS Source of monitoring data MEC values RBSP 
14 (CZ, SI, EL, 
FR, DE, AT, ES, 
UK, IE, NL, PL, 
RO, SK, IT) 
Reported as  
cyanide in the 
databases 
NORMAN DB, 20142 MEC95, whole: 1.07 µg/L 
MEC95, dissolved: 5 µg/L 10 MS (RBSP EQS 
ECOSTAT – UBA 
report)5 
EQS set for cyanide ion 
and total (WRc, 2012)6 
WATERBASE, 20143 
MEC95, whole: 20 µg/L 
MEC95, dissolved: 20 µg/L 
IPCheM4 MEC95: 14  µg/L 
 
5. P, B, T, C, M, R, ED properties 
Volatilisation and biodegradation are important transformation processes for cyanide in ambient waters. 
Hydrogen cyanide can be biodegraded by acclimated microbial cultures, but is usually toxic to 
unacclimated microbial systems at high concentrations (WFD- UK TAG Report, 20121). 
 
6. Hazard assessment 
6.1 Ecotoxicology data 
 
Trophic level Endpoint Value Reference 
Fish 
Rainbow trout, 20 d, 
LOEC 
0.005 mg/L 
WFD- UK TAG Report 
(2012)1 
Fish Lepomis macrochirus, 0.0052 mg/L WFD- UK TAG Report 
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289 d, total inhibiotin 
of spawning, LOEC 
(2012)1 
Fish 
Salvelinus fontinalis, egg 
production, NOEC 
0.0057 mg/L 




5 d, reproduction, NOEC 
0.0096 mg/L 
WFD- UK TAG Report 
(2012)1 
Aquatic Invertebrates Gammarus 
pseudolimnaeus, 98 d, 
growth, NOEC 
0.004 mg/L 
WFD- UK TAG Report 
(2012)1 
Aquatic Invertebrates Hydra viridissima, 6 d, 
population growth, NOEC 
0.110 mg/L 




subcapitata, 72 h,growth 
rate and biomass,  NOEC 
0.010 mg/L 




6.2 Mammalian toxicology data 
No information retrieved 
 
6.3 PNEC derivation 








0.0052 mg/L 20 
2.6E-04 
(mg/L)a 
PNECsed - - - - 
PNECbiota,sec pois - - - - 
PNECbiota, hh - - - - 
PNECdw, hh - - - 0.05 (mg/L)b 
N.R. Not required based on Koc and BCF values not reaching the trigger values required for sediment and biota assessment 
a Value retrieved from WFD- UK TAG Report (2012)1 . A more recent freshwater AA-EQS derivation of 5E-04 mg/l 
needs also to be considered. 
b EU Drinking Water QS7, refered to cyanide. 
 




RQbiota,sec pois - 
RQbiota, hh - 





1 Proposed EQS for Water Framework Directive Annex VIII substances: cyanide (free) (For consultation), Water 
Framework Directive - United Kingdom Technical Advisory Group (WFD-UKTAG), 2012. Available at 
http://www.wfduk.org/sites/default/files/Media/Cyanide_Final_.pdf 
2 NORMAN Database http://www.norman-network.net/?q=node/24 
3 WATERBASE Database http://www.eea.europa.eu/data-and-maps/data/waterbase-rivers-6 
4 IPCheM database at http://ipchem.jrc.ec.europa.eu/ 
5 Ecological Environmental Quality Standards of “River Basin Specific Pollutants” in Surface Waters - Update and 
Development  analysis of a European Comparison between Member States, by U. Irmer, F. Rau, J. Arle, U. Claussen, V. 
Mohaupt - Annex 
6 Contract No. 070311/2011/603663/ETU/D1 “Comparative Study of Pressures and Measures in the Major River 
Basin Management Plans' - Task 2c (Comparison of Specific Pollutants and EQS): Final Report”. WRc Ref: UC8981/1 
October 2012. Available at 
http://ec.europa.eu/environment/archives/water/implrep2007/pdf/P_M%20Task%202c.pdf 
7 COUNCIL DIRECTIVE 98/83/EC of 3 November 1998 on the quality of water intended for human consumption, 
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